Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,A1BG,Alpha-1B-glycoprotein,19935,1892,1.49 [1.13-1.95],0.003991441809656
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AAMDC,Mth938 domain-containing protein,19360,1834,1.02 [0.94-1.11],0.6833457246017332
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AARSD1,Alanyl-tRNA editing protein Aarsd1,22833,2139,1.02 [0.96-1.10],0.4910369160051018
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ABCA2,ATP-binding cassette sub-family A member 2,19234,1836,1.45 [1.28-1.63],9.95519110319954e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ABHD14B,Protein ABHD14B,22680,2144,1.02 [0.96-1.10],0.501560481047105
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ABL1,Tyrosine-protein kinase ABL1,22833,2139,1.16 [1.09-1.22],2.186045268956835e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ABO,Histo-blood group ABO system transferase,19935,1893,1.00 [0.97-1.03],0.9887259985846596
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ABRAXAS2,BRISC complex subunit Abraxas 2,19234,1836,1.08 [1.01-1.15],0.0247008946995214
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",22405,2098,1.35 [1.29-1.40],4.216891965750463e-43
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",19560,1852,1.07 [1.01-1.14],0.0268689427089307
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",19913,1888,1.03 [0.98-1.08],0.2802653223501375
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACAN,Aggrecan core protein,22706,2139,0.50 [0.44-0.58],7.659071547716284e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACE,Angiotensin-converting enzyme,19935,1893,1.89 [1.62-2.20],6.222627868041164e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACE2,Angiotensin-converting enzyme 2,22530,2127,1.68 [1.59-1.78],3.9754772720042313e-72
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACHE,Acetylcholinesterase,19456,1848,1.28 [1.13-1.46],9.516500624835904e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACOT13,Acyl-coenzyme A thioesterase 13,19848,1888,1.05 [1.01-1.09],0.009727166935182
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,22943,2160,1.10 [1.02-1.18],0.0105337262202116
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACP1,Low molecular weight phosphotyrosine protein phosphatase,19320,1836,0.88 [0.80-0.97],0.011365255009416
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACP5,Tartrate-resistant acid phosphatase type 5,23040,2178,2.09 [1.87-2.33],5.864718523295305e-40
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACP6,Lysophosphatidic acid phosphatase type 6,23119,2174,1.00 [0.95-1.06],0.8868059258426427
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACRBP,Acrosin-binding protein,19841,1877,1.11 [1.00-1.24],0.0492753922866254
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACRV1,Acrosomal protein SP-10,19320,1836,1.07 [1.03-1.12],0.001688475252676
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACSL1,Long-chain-fatty-acid--CoA ligase 1,19234,1836,1.04 [0.92-1.18],0.5269184157892248
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACTA2,"Actin, aortic smooth muscle",22530,2127,1.07 [0.98-1.16],0.1575790279811081
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACTN2,Alpha-actinin-2,19234,1836,1.11 [1.03-1.18],0.0037325665782891
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACTN4,Alpha-actinin-4,22537,2110,0.96 [0.85-1.08],0.4998265587011878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACVRL1,Serine/threonine-protein kinase receptor R3,22707,2149,1.27 [1.09-1.47],0.0015878763618437
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACY1,Aminoacylase-1,22943,2160,1.81 [1.71-1.91],1.246561919001007e-103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,19234,1836,1.60 [1.49-1.72],2.775070856294501e-39
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACYP1,Acylphosphatase-1,19389,1841,1.04 [0.97-1.11],0.2932326590289997
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADA,Adenosine deaminase,23215,2189,1.20 [1.09-1.32],0.0003221237832545
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADA2,Adenosine deaminase 2,22831,2143,2.21 [2.04-2.40],3.502533556297486e-84
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,19320,1836,1.56 [1.38-1.77],2.3652636498568825e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,22530,2127,1.43 [1.27-1.62],7.898551429973064e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,22750,2153,1.01 [0.91-1.12],0.8275701227987576
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,23215,2189,1.05 [0.94-1.17],0.3852684715409659
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,23118,2173,1.51 [1.33-1.70],4.9398328976503615e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,19848,1888,1.59 [1.39-1.82],3.7854299839779786e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,19320,1836,1.30 [1.14-1.49],0.0001260727875842
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,23232,2193,1.83 [1.56-2.14],5.3875670566222563e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,22833,2139,1.31 [1.19-1.43],2.0063305010526132e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,22530,2127,1.17 [1.05-1.30],0.0038918340799235
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,19320,1836,1.23 [1.09-1.38],0.0006598916669991
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,23005,2159,0.84 [0.77-0.91],4.902620542982299e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAMTSL2,ADAMTS-like protein 2,19921,1897,2.96 [2.70-3.26],2.453353617122168e-113
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAMTSL4,ADAMTS-like protein 4,19360,1834,1.10 [0.92-1.33],0.3060565274869203
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAMTSL5,ADAMTS-like protein 5,19913,1888,0.83 [0.75-0.93],0.0013741185298172
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,22405,2098,0.98 [0.87-1.11],0.7761732601383488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADD1,Alpha-adducin,19456,1848,1.00 [0.94-1.07],0.9744995982339604
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADGRB3,Adhesion G protein-coupled receptor B3,22707,2149,1.40 [1.25-1.56],3.470061724923672e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADGRD1,Adhesion G-protein coupled receptor D1,19456,1848,1.59 [1.43-1.76],1.9154290541356812e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADGRE1,Adhesion G protein-coupled receptor E1,19848,1888,1.23 [1.13-1.33],4.040698988193693e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADGRE2,Adhesion G protein-coupled receptor E2,23025,2168,2.05 [1.81-2.33],4.1198129815750707e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADGRE5,Adhesion G protein-coupled receptor E5,23120,2184,2.04 [1.85-2.26],5.9220410078542826e-43
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADGRF5,Adhesion G protein-coupled receptor F5,19913,1888,1.18 [1.00-1.39],0.0497342907487278
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADGRG1,Adhesion G-protein coupled receptor G1,22833,2139,1.54 [1.49-1.59],2.211396052826737e-141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADGRG2,Adhesion G-protein coupled receptor G2,22943,2160,0.58 [0.52-0.64],8.451613710145959e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADGRV1,Adhesion G-protein coupled receptor V1,19272,1835,0.99 [0.93-1.05],0.7229992931106162
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADH1B,All-trans-retinol dehydrogenase,19456,1848,1.37 [1.30-1.44],1.5179817696941255e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,22530,2127,1.44 [1.38-1.51],1.114712158505903e-52
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADIPOQ,Adiponectin,19935,1892,0.58 [0.54-0.62],3.9594815845169603e-63
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADM,Pro-adrenomedullin,23146,2176,1.72 [1.48-2.00],5.910632869469289e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADRA2A,Alpha-2A adrenergic receptor,19234,1836,1.02 [0.95-1.09],0.6034791416230663
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AFAP1,Actin filament-associated protein 1,19456,1848,1.04 [0.99-1.10],0.1224166439837371
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AFM,Afamin,19935,1892,4.17 [3.39-5.14],4.4228892273706047e-41
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AFP,Alpha-fetoprotein,22665,2146,0.92 [0.86-0.97],0.0050734805769015
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AGBL2,Cytosolic carboxypeptidase 2,19272,1835,0.96 [0.91-1.01],0.090473077111238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AGER,Advanced glycosylation end product-specific receptor,22873,2155,0.87 [0.79-0.95],0.0023736897409316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AGR2,Anterior gradient protein 2 homolog,22282,2095,1.18 [1.13-1.22],1.0049492264700684e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AGR3,Anterior gradient protein 3,22369,2093,1.29 [1.21-1.37],7.527617043819606e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AGRN,Agrin,23025,2168,1.77 [1.62-1.93],7.704887360033912e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AGRP,Agouti-related protein,23215,2189,1.17 [1.09-1.26],3.3510814770661485e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AGT,Angiotensinogen,19935,1893,1.08 [0.88-1.33],0.468089905307735
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AGXT,Serine--pyruvate aminotransferase,22943,2160,1.44 [1.37-1.50],1.1214973404027448e-54
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AHCY,Adenosylhomocysteinase,22943,2160,1.06 [1.01-1.13],0.0297873807133796
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AHNAK,Neuroblast differentiation-associated protein AHNAK,19360,1834,1.01 [0.88-1.17],0.8381834601242117
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AHNAK2,Protein AHNAK2,19360,1834,0.91 [0.79-1.06],0.2496521819636932
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,19841,1877,0.96 [0.89-1.03],0.2306835035255339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AHSG,Alpha-2-HS-glycoprotein,19935,1893,1.64 [1.39-1.93],2.500618143922708e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AHSP,Alpha-hemoglobin-stabilizing protein,22910,2160,1.07 [1.03-1.12],0.0021433433735015
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AIDA,"Axin interactor, dorsalization-associated protein",19370,1843,1.02 [0.97-1.08],0.470851507731107
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AIF1,Allograft inflammatory factor 1,22405,2098,1.00 [0.93-1.08],0.9556621863482204
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AIF1L,Allograft inflammatory factor 1-like,19360,1834,1.05 [0.97-1.14],0.2540612855658942
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",22801,2137,1.17 [1.13-1.21],6.877364708583967e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AK1,Adenylate kinase isoenzyme 1,22943,2160,0.98 [0.93-1.04],0.5594033995797992
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AK2,"Adenylate kinase 2, mitochondrial",19860,1881,1.03 [0.99-1.08],0.1363111937110808
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AKAP12,A-kinase anchor protein 12,19456,1848,0.55 [0.44-0.70],5.734019404674499e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AKR1B1,Aldo-keto reductase family 1 member B1,22405,2098,1.02 [0.97-1.08],0.4166610589397052
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AKR1B10,Aldo-keto reductase family 1 member B10,19370,1843,1.38 [1.31-1.46],1.6208589074613268e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AKR1C4,Aldo-keto reductase family 1 member C4,22530,2127,1.15 [1.08-1.23],3.149060058405368e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AKR7L,Aflatoxin B1 aldehyde reductase member 4,19320,1836,1.41 [1.33-1.48],5.929415342694164e-35
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AKT1S1,Proline-rich AKT1 substrate 1,22446,2110,1.07 [1.01-1.13],0.0333957531207373
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AKT2,RAC-beta serine/threonine-protein kinase,19874,1884,1.01 [0.98-1.05],0.5362320635345827
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AKT3,RAC-gamma serine/threonine-protein kinase,22302,2084,0.99 [0.93-1.06],0.8505673922710474
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ALCAM,CD166 antigen,23232,2193,2.76 [2.32-3.30],1.4409571874632738e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ALDH1A1,Retinal dehydrogenase 1,22954,2166,1.48 [1.40-1.57],3.771521176645812e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ALDH2,"Aldehyde dehydrogenase, mitochondrial",19841,1877,1.13 [1.05-1.22],0.0011623790791889
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",22878,2161,1.31 [1.25-1.36],6.617569985694633e-35
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",19874,1884,1.31 [1.21-1.43],4.86886012614759e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ALMS1,Alstrom syndrome protein 1,19560,1852,1.01 [0.91-1.12],0.9043807766682186
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ALPI,Intestinal-type alkaline phosphatase,19320,1836,1.07 [1.03-1.11],0.000116792761861
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ALPP,"Alkaline phosphatase, placental type",22833,2139,1.10 [1.06-1.14],2.3997030992245335e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AMBN,Ameloblastin,22537,2110,0.91 [0.79-1.06],0.2334763327454049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AMBP,Protein AMBP,23111,2175,2.13 [1.77-2.56],1.602445440656291e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,19921,1897,1.06 [0.89-1.25],0.5198436902957065
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AMFR,E3 ubiquitin-protein ligase AMFR,22446,2110,1.08 [1.02-1.15],0.0069874283986958
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AMIGO1,Amphoterin-induced protein 1,19370,1843,0.96 [0.87-1.05],0.388985710679359
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AMIGO2,Amphoterin-induced protein 2,22833,2139,1.97 [1.68-2.31],6.130770524059808e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AMN,Protein amnionless,22537,2110,1.08 [0.99-1.17],0.0704925468009535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AMOT,Angiomotin,19456,1848,1.73 [1.55-1.93],1.0038900549718852e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AMOTL2,Angiomotin-like protein 2,19755,1866,1.05 [0.96-1.16],0.2675646403886203
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AMPD3,AMP deaminase 3,19860,1881,1.04 [0.98-1.10],0.207652849643153
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,18689,1769,0.81 [0.74-0.90],2.144379020157184e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AMY2A,Pancreatic alpha-amylase,22081,2086,0.81 [0.74-0.87],1.424067796071367e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AMY2B,Alpha-amylase 2B,21388,2024,0.79 [0.73-0.86],2.3017132284828986e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANG,Angiogenin,22909,2156,1.25 [1.12-1.40],7.162306525386865e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANGPT1,Angiopoietin-1,22855,2151,1.04 [1.00-1.09],0.0760333346572826
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANGPT2,Angiopoietin-2,23146,2176,2.04 [1.85-2.24],8.447642121986415e-49
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANGPTL1,Angiopoietin-related protein 1,22576,2121,1.34 [1.17-1.53],2.264384302146534e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANGPTL2,Angiopoietin-related protein 2,22946,2160,1.67 [1.52-1.83],2.9992464365252128e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANGPTL3,Angiopoietin-related protein 3,22986,2161,0.58 [0.53-0.64],1.7490460697016206e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANGPTL4,Angiopoietin-related protein 4,22989,2166,1.47 [1.35-1.60],3.8921353790343103e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANGPTL7,Angiopoietin-related protein 7,23146,2176,1.92 [1.75-2.11],2.1785989419796402e-44
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANK2,Ankyrin-2,19234,1836,0.98 [0.92-1.05],0.6176466464446133
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,19320,1836,1.05 [0.99-1.11],0.10681340022479
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANKRA2,Ankyrin repeat family A protein 2,19204,1817,0.97 [0.89-1.05],0.457244178110358
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANKRD54,Ankyrin repeat domain-containing protein 54,22405,2098,1.01 [0.95-1.08],0.7769272535986832
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,19360,1834,0.98 [0.87-1.10],0.7349395055429178
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANPEP,Aminopeptidase N,23023,2158,1.47 [1.28-1.68],3.4927355024958093e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANXA1,Annexin A1,19354,1835,1.12 [1.02-1.23],0.013179027287325
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANXA10,Annexin A10,22446,2110,1.15 [1.10-1.21],1.5864071626620562e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANXA11,Annexin A11,22879,2162,1.03 [0.97-1.09],0.3545843365865968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANXA2,Annexin A2,19071,1803,1.15 [1.08-1.22],5.300104355908617e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANXA3,Annexin A3,23118,2173,1.07 [1.02-1.13],0.0117309954380943
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANXA4,Annexin A4,22845,2148,1.02 [0.96-1.07],0.5480226054990858
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANXA5,Annexin A5,22364,2103,1.18 [1.04-1.34],0.010088557861789
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AOC1,Amiloride-sensitive amine oxidase [copper-containing],22537,2110,0.99 [0.92-1.06],0.7269990799595097
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AOC3,Membrane primary amine oxidase,23056,2165,2.77 [2.46-3.12],3.5010557472818572e-62
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AP1G2,AP-1 complex subunit gamma-like 2,19841,1877,1.14 [1.08-1.21],1.1195158079403236e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AP2B1,AP-2 complex subunit beta,19370,1843,1.05 [0.96-1.15],0.3032499504381985
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AP3B1,AP-3 complex subunit beta-1,19848,1888,1.09 [1.03-1.15],0.0036928903263939
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AP3S2,AP-3 complex subunit sigma-2,19860,1881,1.09 [1.00-1.19],0.0524406702575526
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,22833,2139,1.24 [1.15-1.33],3.572963269726535e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APCS,Serum amyloid P-component,19756,1870,0.89 [0.77-1.02],0.1023537393628314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,23084,2173,1.18 [1.11-1.26],1.4096931238683578e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APLP1,Amyloid-like protein 1,22943,2160,0.81 [0.75-0.88],6.724874693834106e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOA1,Apolipoprotein A-I,19935,1892,0.44 [0.36-0.53],1.5358851932304451e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOA2,Apolipoprotein A-II,19935,1893,0.86 [0.79-0.94],0.0008169856179854
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOA4,Apolipoprotein A-IV,19935,1892,1.76 [1.58-1.95],4.069823596602129e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOB,Apolipoprotein B-100,19935,1893,1.14 [0.94-1.38],0.1712321880564299
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOBR,Apolipoprotein B receptor,19360,1834,0.86 [0.78-0.95],0.0034388266437538
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOC1,Apolipoprotein C-I,19902,1887,0.48 [0.43-0.54],1.1800325764945183e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOD,Apolipoprotein D,19058,1808,0.34 [0.29-0.39],2.1089375037124808e-48
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOE,Apolipoprotein E,19935,1892,0.93 [0.87-1.00],0.047966646394516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOF,Apolipoprotein F,19935,1893,0.43 [0.38-0.48],1.0692734764762512e-48
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOH,Beta-2-glycoprotein 1,22954,2166,1.16 [1.05-1.28],0.0030280668130284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOL1,Apolipoprotein L1,19935,1893,0.82 [0.76-0.89],3.394200112755505e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOM,Apolipoprotein M,23022,2164,0.34 [0.30-0.38],3.4027931273407447e-68
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APP,Amyloid-beta precursor protein,22917,2164,1.05 [0.99-1.11],0.0968471675257633
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APPL2,DCC-interacting protein 13-beta,19456,1848,1.02 [0.98-1.07],0.2306727501891811
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APRT,Adenine phosphoribosyltransferase,22707,2152,1.10 [1.01-1.19],0.0205570388622854
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARAF,Serine/threonine-protein kinase A-Raf,19560,1852,1.05 [0.98-1.12],0.1416644703531437
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AREG,Amphiregulin,22833,2139,2.20 [2.03-2.38],5.362806625460642e-82
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARF6,ADP-ribosylation factor 6,19848,1888,1.06 [1.02-1.10],0.0053556221272405
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARFIP1,Arfaptin-1,19874,1884,1.06 [1.00-1.13],0.0656572737948104
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARG1,Arginase-1,22792,2130,0.97 [0.90-1.04],0.4023147355205106
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARG2,"Arginase-2, mitochondrial",19841,1877,1.07 [0.96-1.18],0.2086237269034469
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARHGAP1,Rho GTPase-activating protein 1,22405,2098,0.89 [0.82-0.97],0.0058404450658496
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARHGAP25,Rho GTPase-activating protein 25,22405,2098,1.02 [0.96-1.09],0.4599754061780643
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARHGAP30,Rho GTPase-activating protein 30,19560,1852,0.94 [0.84-1.06],0.3460455900621361
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARHGAP45,Rho GTPase-activating protein 45,19456,1848,1.04 [0.99-1.10],0.1442070738337076
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARHGAP5,Rho GTPase-activating protein 5,19204,1817,1.05 [0.99-1.11],0.1055942418843155
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARHGEF1,Rho guanine nucleotide exchange factor 1,19860,1881,1.11 [1.05-1.16],6.34177589808248e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARHGEF10,Rho guanine nucleotide exchange factor 10,19874,1884,1.06 [1.01-1.11],0.0136764651709662
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARHGEF12,Rho guanine nucleotide exchange factor 12,22920,2165,1.05 [1.01-1.09],0.0124360952513256
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARHGEF5,Rho guanine nucleotide exchange factor 5,19272,1835,1.06 [1.00-1.13],0.049598975968859
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARID3A,AT-rich interactive domain-containing protein 3A,19272,1835,0.86 [0.77-0.97],0.0115830659894227
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARID4B,AT-rich interactive domain-containing protein 4B,22446,2110,1.02 [0.94-1.12],0.6278338010399238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARL13B,ADP-ribosylation factor-like protein 13B,19234,1836,1.07 [1.01-1.14],0.0307553448195995
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,19234,1836,1.03 [0.92-1.15],0.6459863768059625
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARMCX2,Armadillo repeat-containing X-linked protein 2,19272,1835,0.93 [0.85-1.01],0.071759732190071
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARNT,Aryl hydrocarbon receptor nuclear translocator,22537,2110,0.98 [0.88-1.09],0.706340359195009
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,19234,1836,0.95 [0.86-1.04],0.2384192701995118
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARSA,Arylsulfatase A,22954,2166,1.38 [1.28-1.49],8.417883452423223e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARSB,Arylsulfatase B,22833,2139,1.18 [1.10-1.26],1.0073356174323197e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ART3,Ecto-ADP-ribosyltransferase 3,23056,2165,0.76 [0.69-0.85],4.178772371550805e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ART5,Ecto-ADP-ribosyltransferase 5,19272,1835,1.01 [0.94-1.09],0.7257584262791218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARTN,Artemin,22537,2110,0.99 [0.91-1.08],0.8296598047345513
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ASAH1,Acid ceramidase,19737,1882,1.27 [1.17-1.38],3.10978447205413e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ASAH2,Neutral ceramidase,22750,2153,1.81 [1.67-1.97],2.6353504629549908e-43
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ASGR1,Asialoglycoprotein receptor 1,22750,2153,2.66 [2.39-2.96],2.6170645986545e-73
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ASGR2,Asialoglycoprotein receptor 2,19935,1893,1.19 [1.01-1.40],0.0408504000728085
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ASPN,Asporin,19913,1888,1.36 [1.18-1.56],1.2590668512819546e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ASPSCR1,Tether containing UBX domain for GLUT4,19874,1884,1.05 [0.98-1.12],0.1619019079171089
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ASRGL1,Isoaspartyl peptidase/L-asparaginase,19360,1834,0.98 [0.93-1.02],0.3377834719155586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ASS1,Argininosuccinate synthase,19234,1836,1.31 [1.24-1.39],2.094482310493264e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATF2,Cyclic AMP-dependent transcription factor ATF-2,22446,2110,1.02 [0.96-1.08],0.5125373746003854
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATF4,Cyclic AMP-dependent transcription factor ATF-4,19204,1817,1.15 [1.01-1.31],0.0393901015919221
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATG16L1,Autophagy-related protein 16-1,19848,1888,1.11 [1.05-1.17],6.74572598746051e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATG4A,Cysteine protease ATG4A,22405,2098,1.01 [0.95-1.08],0.6836219806032996
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATOX1,Copper transport protein ATOX1,23005,2159,1.11 [1.05-1.17],0.0002350772783639
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,19234,1836,1.02 [0.93-1.12],0.7090366998530429
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,19234,1836,1.12 [0.98-1.29],0.0911364995072732
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,19234,1836,1.09 [0.97-1.22],0.1298909967884596
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATP1B4,Protein ATP1B4,19204,1817,1.01 [0.91-1.13],0.8379706975133203
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATP2B4,Plasma membrane calcium-transporting ATPase 4,19234,1836,0.98 [0.91-1.05],0.5551324726207745
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATP5F1D,"ATP synthase subunit delta, mitochondrial",19234,1836,1.00 [0.91-1.09],0.974902743643248
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATP5IF1,"ATPase inhibitor, mitochondrial",23025,2168,1.03 [1.00-1.07],0.0703776500696688
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATP5PO,"ATP synthase subunit O, mitochondrial",22446,2110,0.95 [0.86-1.04],0.2509270506134907
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATP6AP2,Renin receptor,22405,2098,1.17 [1.07-1.29],0.0005349822746287
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATP6V1D,V-type proton ATPase subunit D,22833,2139,1.00 [0.87-1.16],0.9709001598234432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATP6V1F,V-type proton ATPase subunit F,22414,2105,1.05 [0.99-1.11],0.101583765116152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATP6V1G1,V-type proton ATPase subunit G 1,19360,1834,1.06 [1.00-1.13],0.0493021307259704
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATP6V1G2,V-type proton ATPase subunit G 2,19234,1836,1.00 [0.96-1.05],0.8960687552956997
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATRAID,All-trans retinoic acid-induced differentiation factor,19848,1888,1.27 [1.11-1.45],0.0003735863783817
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATRN,"Attractin, Isoform 2",19935,1892,3.97 [3.13-5.05],1.7035365449073625e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATXN10,Ataxin-10,22446,2110,1.03 [0.98-1.09],0.2732684204544712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATXN2,Ataxin-2,19272,1835,1.04 [1.00-1.09],0.0374230286339573
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATXN2L,Ataxin-2-like protein,19874,1884,1.15 [1.06-1.25],0.0006183543657465
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATXN3,Ataxin-3,19860,1881,1.04 [0.98-1.12],0.2088737692547495
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AXIN1,Axin-1,22920,2165,1.05 [1.01-1.09],0.0240463708633307
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AXL,Tyrosine-protein kinase receptor UFO,23056,2165,1.44 [1.25-1.65],1.898375727093307e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AZI2,5-azacytidine-induced protein 2,19874,1884,1.16 [1.08-1.25],0.0001191468328624
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AZU1,Azurocidin,22293,2106,1.06 [1.01-1.12],0.0110924927073421
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,B2M,Beta-2-microglobulin,19935,1892,1.29 [1.16-1.44],3.03295632442992e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,19234,1836,1.02 [0.82-1.27],0.8556548818571319
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",19360,1834,2.62 [2.32-2.95],2.5417971192415168e-55
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,B4GALT1,"Beta-1,4-galactosyltransferase 1",23025,2168,1.64 [1.43-1.87],3.8107410832653894e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,B4GAT1,"Beta-1,4-glucuronyltransferase 1",22954,2166,0.83 [0.71-0.97],0.020518035326859
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BABAM1,BRISC and BRCA1-A complex member 1,19320,1836,1.10 [0.94-1.28],0.2412999990021437
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BACH1,Transcription regulator protein BACH1,22920,2165,1.08 [1.02-1.13],0.0048659747736982
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BAG3,BAG family molecular chaperone regulator 3,22707,2149,0.90 [0.82-0.98],0.0201693631443739
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BAG4,BAG family molecular chaperone regulator 4,19320,1836,1.16 [1.07-1.26],0.0006681626897432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BAG6,Large proline-rich protein BAG6,22530,2127,1.02 [0.92-1.14],0.6670256595223464
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,22405,2098,1.56 [1.48-1.64],4.631554530421803e-64
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BAMBI,BMP and activin membrane-bound inhibitor homolog,22405,2098,1.28 [1.12-1.45],0.0001875406016891
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BANK1,B-cell scaffold protein with ankyrin repeats,22920,2165,1.06 [1.02-1.10],0.001293354376377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BAP18,Chromatin complexes subunit BAP18,19860,1881,1.19 [1.13-1.26],4.598263845432153e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BATF,Basic leucine zipper transcriptional factor ATF-like,19370,1843,1.00 [0.95-1.06],0.9387346035413436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BAX,Apoptosis regulator BAX,22405,2105,1.05 [1.00-1.09],0.0292055539517474
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BCAM,Basal cell adhesion molecule,22954,2166,1.58 [1.37-1.83],4.0884247075353005e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BCAN,Brevican core protein,22750,2153,0.54 [0.49-0.60],8.844221140788106e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",19913,1888,1.29 [1.13-1.48],0.0002381949164797
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",19272,1835,0.98 [0.90-1.07],0.7150663416606263
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BCHE,Cholinesterase,19555,1847,1.64 [1.38-1.95],2.1128555068032764e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BCL2,Apoptosis regulator Bcl-2,19848,1888,1.05 [0.97-1.14],0.1917368048671628
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BCL2L1,Bcl-2-like protein 1,19860,1881,1.04 [0.99-1.09],0.0872318752043536
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",22920,2165,1.22 [1.11-1.34],6.850389985422395e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BCL2L15,Bcl-2-like protein 15,19320,1836,1.20 [1.12-1.28],3.2883034630441946e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BCL7A,B-cell CLL/lymphoma 7 protein family member A,19204,1817,1.05 [0.98-1.13],0.160832990001743
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BCL7B,B-cell CLL/lymphoma 7 protein family member B,19841,1877,0.98 [0.89-1.08],0.68122733093216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BCR,Breakpoint cluster region protein,22920,2165,1.06 [1.01-1.10],0.0087244196642126
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BDNF,Brain-derived neurotrophic factor,19921,1897,1.05 [1.00-1.11],0.0657724653172479
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BECN1,Beclin-1,19360,1834,1.12 [1.04-1.21],0.0019181009075457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BEX3,Protein BEX3,19204,1817,0.96 [0.86-1.06],0.3733758406514644
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BGLAP,Osteocalcin,19921,1897,0.84 [0.80-0.88],1.9885540009218564e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BGN,Biglycan,22370,2097,1.00 [0.97-1.03],0.9548489602112856
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BHLHE40,Class E basic helix-loop-helix protein 40,19272,1835,0.99 [0.93-1.05],0.6486635093132369
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,19234,1836,1.19 [1.00-1.42],0.0489204171573164
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BID,BH3-interacting domain death agonist,22920,2165,1.07 [1.02-1.13],0.0114305129277375
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BIN2,Bridging integrator 2,22954,2166,1.05 [1.01-1.10],0.0185666938725392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BIRC2,Baculoviral IAP repeat-containing protein 2,22405,2098,1.03 [0.97-1.09],0.3733262473506811
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BLMH,Bleomycin hydrolase,23232,2193,0.84 [0.74-0.94],0.0036693064845663
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BLNK,B-cell linker protein,19320,1836,1.11 [1.00-1.23],0.0452869787879721
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,19272,1835,0.99 [0.94-1.06],0.8557307443681457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,19860,1881,1.09 [0.98-1.21],0.1151442510147405
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BLVRB,Flavin reductase,22954,2166,1.02 [0.96-1.08],0.5410499911307258
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BMP10,Bone morphogenetic protein 10,19456,1848,1.36 [1.16-1.60],0.0001452669980331
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BMP4,Bone morphogenetic protein 4,22707,2149,1.22 [1.14-1.32],1.6424413673781677e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BMP6,Bone morphogenetic protein 6,22494,2126,1.35 [1.23-1.48],4.779054361862506e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BMPER,BMP-binding endothelial regulator protein,19456,1848,3.14 [2.65-3.73],4.828702273692092e-39
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,19913,1888,1.07 [0.94-1.21],0.3154856633584609
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,19320,1836,1.22 [1.11-1.34],4.126050534220065e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BOC,Brother of CDO,22530,2127,1.44 [1.22-1.70],1.8967934780949112e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BOLA1,BolA-like protein 1,19272,1835,1.09 [1.01-1.18],0.0311712449871727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BOLA2_BOLA2B,BolA-like protein 2,19360,1834,0.99 [0.91-1.08],0.8799712714087483
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BPIFA2,BPI fold-containing family A member 2,18701,1774,0.98 [0.94-1.02],0.2552979830739064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BPIFB1,BPI fold-containing family B member 1,22907,2169,0.90 [0.85-0.95],0.0002532574128
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BPIFB2,BPI fold-containing family B member 2,19878,1887,1.41 [1.33-1.49],3.4616523384458626e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BRAP,BRCA1-associated protein,19653,1870,1.05 [1.01-1.09],0.0240053967527581
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BRD1,Bromodomain-containing protein 1,19560,1852,1.07 [0.93-1.24],0.3378912277327645
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BRD2,Bromodomain-containing protein 2,19272,1835,1.05 [0.92-1.19],0.5010496178459412
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BRD3,Bromodomain-containing protein 3,19234,1836,1.05 [0.96-1.15],0.3115918976217101
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BRDT,Bromodomain testis-specific protein,19234,1836,1.22 [1.09-1.38],0.0009616409969163
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BRK1,Protein BRICK1,22446,2110,0.99 [0.91-1.07],0.7392240188886278
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BRME1,Break repair meiotic recombinase recruitment factor 1,19272,1835,1.01 [0.91-1.13],0.8430979738781457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BRSK2,Serine/threonine-protein kinase BRSK2,19874,1884,1.04 [0.93-1.17],0.5213733598673809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BSG,Basigin,23178,2185,1.57 [1.31-1.89],1.7026206762661452e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BSND,Barttin,19204,1817,1.06 [0.93-1.21],0.3608132490062616
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,23155,2176,1.19 [1.09-1.30],0.000136983343725
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BST2,Bone marrow stromal antigen 2,23155,2176,1.45 [1.36-1.54],2.4379497862365524e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BTC,Probetacellulin,22405,2098,0.95 [0.90-1.00],0.0727899104144592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BTD,Biotinidase,19935,1892,1.78 [1.43-2.21],2.8661683020460626e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BTLA,B- and T-lymphocyte attenuator,19204,1817,1.02 [0.97-1.08],0.3405408973112562
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BTN1A1,Butyrophilin subfamily 1 member A1,19802,1874,1.01 [0.90-1.13],0.8543893466734369
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BTN2A1,Butyrophilin subfamily 2 member A1,23025,2168,1.59 [1.40-1.82],5.1429658183260676e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BTN3A2,Butyrophilin subfamily 3 member A2,22920,2165,1.17 [1.07-1.30],0.0012022588280402
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BTNL10,Butyrophilin-like protein 10,19204,1817,0.94 [0.83-1.06],0.3224412504287726
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C19orf12,Protein C19orf12,22446,2110,1.39 [1.33-1.46],1.5297604887428862e-47
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C1GALT1C1,C1GALT1-specific chaperone 1,19234,1836,1.15 [1.00-1.31],0.0449658149245394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C1QA,Complement C1q subcomponent subunit A,23108,2179,1.25 [1.05-1.49],0.010476195232865
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",19874,1884,1.03 [0.97-1.10],0.3420713072172309
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C1QL2,Complement C1q-like protein 2,19320,1836,0.92 [0.83-1.02],0.1021762471986525
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,23056,2165,1.83 [1.70-1.97],5.469819276918148e-57
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,19456,1848,0.97 [0.86-1.10],0.6490969216011496
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,19874,1884,1.28 [1.13-1.44],9.02523480419652e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,19426,1845,0.85 [0.78-0.92],0.0002191821637604
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C1R,Complement C1r subcomponent,19935,1892,1.11 [0.87-1.41],0.4036743360337553
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C1RL,Complement C1r subcomponent-like protein,19895,1886,2.13 [1.69-2.68],1.2507712798611864e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C1S,Complement C1s subcomponent,19935,1892,1.19 [0.96-1.47],0.1044062564787866
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C2,Complement C2,23022,2164,3.26 [2.69-3.96],8.487899455890946e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C2CD2L,Phospholipid transfer protein C2CD2L,22414,2105,1.08 [0.98-1.18],0.106261575361386
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C2orf69,UPF0565 protein C2orf69,19370,1843,1.03 [0.96-1.11],0.4358064825325075
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C3,Complement C3,18905,1784,1.43 [1.31-1.55],7.586707581195854e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C4BPB,C4b-binding protein beta chain,23005,2159,0.85 [0.77-0.94],0.0017343785614434
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C5,Complement C5,19935,1892,1.65 [1.24-2.18],0.0004880638181224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C7,Complement component C7,19450,1848,2.76 [2.42-3.15],8.3325778449253305e-53
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C7orf50,Uncharacterized protein C7orf50,19860,1881,1.22 [1.04-1.44],0.0135911637395589
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C8B,Complement component C8 beta chain,19935,1892,1.12 [0.97-1.29],0.136358725713616
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C9,Complement component C9,19935,1893,0.80 [0.74-0.86],4.739730718902014e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C9orf40,Uncharacterized protein C9orf40,19848,1888,0.97 [0.92-1.03],0.3489167038442669
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CA1,Carbonic anhydrase 1,22464,2122,1.00 [0.94-1.07],0.9496270260317056
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CA11,Carbonic anhydrase-related protein 11,22405,2098,1.20 [1.07-1.34],0.0017221592973156
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CA12,Carbonic anhydrase 12,22833,2139,1.58 [1.41-1.76],4.732618519838452e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CA13,Carbonic anhydrase 13,22679,2141,1.01 [0.97-1.04],0.6939304230538623
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CA14,Carbonic anhydrase 14,23146,2176,0.48 [0.43-0.53],8.960053693773728e-44
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CA2,Carbonic anhydrase 2,22875,2155,1.03 [0.98-1.09],0.2481749879825202
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CA3,Carbonic anhydrase 3,23201,2191,1.04 [0.98-1.11],0.2030956270397928
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CA4,Carbonic anhydrase 4,23232,2193,0.83 [0.71-0.97],0.0203207149413726
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CA5A,"Carbonic anhydrase 5A, mitochondrial",22530,2127,1.23 [1.19-1.28],6.530781407249825e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CA6,Carbonic anhydrase 6,22887,2158,0.78 [0.74-0.83],2.6816625471341668e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CA7,Carbonic anhydrase 7,19560,1852,0.93 [0.82-1.06],0.2839042589500413
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CA8,Carbonic anhydrase-related protein,19320,1836,1.18 [1.01-1.39],0.0368269283296685
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CA9,Carbonic anhydrase 9,23146,2176,1.40 [1.30-1.51],1.049295456055574e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CABP2,Calcium-binding protein 2,19370,1843,1.02 [0.95-1.09],0.603650648377276
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,19272,1835,0.92 [0.79-1.06],0.2364445041385049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,19234,1836,1.00 [0.92-1.08],0.928746921877557
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,19272,1835,0.99 [0.92-1.07],0.758943231170676
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,19874,1884,1.11 [1.06-1.17],6.12343302533161e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CACYBP,Calcyclin-binding protein,19425,1846,1.07 [1.02-1.12],0.0022421551858814
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CADPS,Calcium-dependent secretion activator 1,19370,1843,0.98 [0.88-1.10],0.7754809608639246
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CALB1,Calbindin,22833,2139,1.07 [0.98-1.16],0.1367548652608903
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CALB2,Calretinin,22446,2110,1.26 [1.14-1.39],3.708428296129462e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CALCA,Calcitonin,22718,2148,1.14 [1.09-1.21],5.882107221387714e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CALCB,Calcitonin gene-related peptide 2,19860,1881,1.00 [0.89-1.12],0.9929435419291897
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,23078,2171,1.03 [0.99-1.07],0.1379165430067757
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,19360,1834,1.12 [1.05-1.18],0.0003112904292083
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CALY,Neuron-specific vesicular protein calcyon,19234,1836,1.07 [0.96-1.20],0.2293011964803925
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,22405,2098,1.09 [1.00-1.19],0.0426608596148873
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,19370,1843,1.02 [0.94-1.11],0.6680894232989324
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,19874,1884,1.07 [1.03-1.11],0.0015750161576081
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CANT1,Soluble calcium-activated nucleotidase 1,22866,2152,1.37 [1.14-1.65],0.000873742667634
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CAPG,Macrophage-capping protein,22788,2144,1.14 [1.07-1.21],4.7821588587672845e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CAPN3,Calpain-3,19841,1877,1.08 [0.96-1.21],0.1930106190268565
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CAPS,Calcyphosin,19860,1881,1.04 [1.00-1.09],0.0543477800202858
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CARHSP1,Calcium-regulated heat-stable protein 1,22446,2110,1.00 [0.93-1.08],0.9487077731252934
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CASC3,Protein CASC3,19370,1843,1.12 [1.01-1.24],0.0328562262147409
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CASP1,Caspase-1,22446,2110,1.08 [1.02-1.13],0.0054106334012177
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CASP10,Caspase-10,22446,2110,1.05 [1.00-1.11],0.0647749260535131
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CASP2,Caspase-2,22920,2165,1.05 [1.00-1.11],0.0584951059769099
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CASP3,Caspase-3,23232,2193,1.02 [0.97-1.06],0.4504528475333227
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CASP4,Caspase-4,19560,1852,1.01 [0.98-1.04],0.4119423793154234
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CASP7,Caspase-7,19860,1881,1.03 [0.98-1.09],0.2150109612704055
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CASP8,Caspase-8,23084,2173,0.96 [0.91-1.02],0.2150371085838268
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CASP9,Caspase-9,19320,1836,1.00 [0.93-1.08],0.9219327964321476
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CASQ2,Calsequestrin-2,19234,1836,0.94 [0.85-1.04],0.2515008424312283
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CAT,Catalase,19648,1866,0.99 [0.91-1.07],0.7568076760699484
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CBLIF,Cobalamin binding intrinsic factor,22913,2159,1.25 [1.19-1.31],1.3862525774124418e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CBLN1,Cerebellin-1,19272,1835,0.94 [0.89-0.99],0.030336346436081
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CBLN4,Cerebellin-4,23146,2176,1.48 [1.33-1.64],9.897806852727862e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CBS,Cystathionine beta-synthase,19360,1834,1.49 [1.39-1.60],2.132593003249537e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CBX2,Chromobox protein homolog 2,19234,1836,1.00 [0.89-1.12],0.973087601387875
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,22750,2153,1.10 [1.04-1.16],0.0003108336624921
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCAR2,Cell cycle and apoptosis regulator protein 2,19860,1881,1.07 [0.99-1.16],0.0765997506593449
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCDC134,Coiled-coil domain-containing protein 134,19841,1877,1.07 [0.98-1.17],0.1291200133085182
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCDC28A,Coiled-coil domain-containing protein 28A,19370,1843,0.95 [0.81-1.10],0.4760516856561599
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCDC50,Coiled-coil domain-containing protein 50,19874,1884,0.98 [0.93-1.04],0.5581616556541253
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCDC80,Coiled-coil domain-containing protein 80,22943,2160,1.28 [1.16-1.42],2.578089273740003e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,19360,1834,0.94 [0.87-1.00],0.0676442193378561
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL11,Eotaxin,23215,2189,1.56 [1.41-1.72],9.802828407695779e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL13,C-C motif chemokine 13,23183,2183,1.06 [1.00-1.11],0.049670266035759
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL14,C-C motif chemokine 14,22909,2156,0.95 [0.87-1.05],0.3179104633344706
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL15,C-C motif chemokine 15,23232,2193,1.75 [1.62-1.89],1.293660167899205e-44
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL16,C-C motif chemokine 16,23232,2193,1.37 [1.27-1.47],3.113237760695006e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL17,C-C motif chemokine 17,22867,2158,1.03 [0.99-1.07],0.1479168525511075
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL18,C-C motif chemokine 18,22656,2133,1.05 [1.00-1.11],0.0571496057444125
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL19,C-C motif chemokine 19,23155,2176,1.07 [1.04-1.10],2.8054130173188604e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL2,C-C motif chemokine 2,22707,2149,1.01 [0.94-1.09],0.7391107350583027
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL20,C-C motif chemokine 20,23215,2189,1.26 [1.22-1.31],9.461946239794349e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL21,C-C motif chemokine 21,23025,2168,1.45 [1.34-1.57],3.133553037401896e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL22,C-C motif chemokine 22,22681,2144,1.19 [1.11-1.28],7.721075043318674e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL23,C-C motif chemokine 23,23025,2168,0.97 [0.89-1.06],0.534059107432079
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL24,C-C motif chemokine 24,22989,2166,1.05 [1.01-1.10],0.0290232052371264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL25,C-C motif chemokine 25,23215,2189,1.29 [1.19-1.39],1.2803937341014903e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL26,C-C motif chemokine 26,22920,2165,0.98 [0.94-1.03],0.4376584728966622
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL27,C-C motif chemokine 27,22943,2160,1.01 [0.95-1.07],0.7916095510859933
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL28,C-C motif chemokine 28,22840,2159,1.11 [1.04-1.18],0.0018381905249806
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL3,C-C motif chemokine 3,22920,2165,1.16 [1.11-1.21],2.1517718486246992e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL4,C-C motif chemokine 4,22949,2163,1.08 [1.02-1.14],0.0064880560947422
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL5,C-C motif chemokine 5,23056,2165,1.06 [1.02-1.10],0.0012678368424835
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL7,C-C motif chemokine 7,22920,2165,1.24 [1.17-1.32],4.833724484513586e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL8,C-C motif chemokine 8,23111,2175,0.98 [0.92-1.04],0.5278351337955931
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCN1,CCN family member 1,22798,2138,1.13 [1.07-1.19],1.0881536528277137e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCN2,CCN family member 2,22911,2155,1.04 [0.97-1.11],0.2532013523424525
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCN3,CCN family member 3,23187,2187,1.16 [1.04-1.29],0.0069434343823529
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCN4,CCN family member 4,23146,2176,1.49 [1.36-1.62],6.454416021706846e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCN5,CCN family member 5,22954,2166,1.14 [1.04-1.26],0.0081137381493688
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCND2,G1/S-specific cyclin-D2,19560,1852,0.91 [0.81-1.03],0.124761297137305
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCNE1,G1/S-specific cyclin-E1,19320,1836,0.99 [0.94-1.05],0.7749718904266052
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCS,Copper chaperone for superoxide dismutase,22750,2153,0.91 [0.84-0.98],0.0181372576627957
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCT5,T-complex protein 1 subunit epsilon,22405,2098,1.07 [0.98-1.16],0.1439865369091489
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD101,Immunoglobulin superfamily member 2,19848,1888,1.39 [1.25-1.54],9.839868461647383e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD109,CD109 antigen,22954,2166,1.70 [1.52-1.91],1.7447135620594102e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD14,Monocyte differentiation antigen CD14,22519,2123,1.35 [1.23-1.48],2.0732055220962718e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD160,CD160 antigen,23215,2189,1.18 [1.09-1.27],4.444226821221792e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD163,Scavenger receptor cysteine-rich type 1 protein M130,23056,2165,1.81 [1.67-1.96],2.6881199813975543e-47
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD164,Sialomucin core protein 24,22954,2166,1.40 [1.28-1.54],6.654012376062219e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD164L2,CD164 sialomucin-like 2 protein,19370,1843,0.97 [0.85-1.09],0.5805871708068251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD177,CD177 antigen,22916,2163,1.03 [1.00-1.06],0.0861957202269723
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD1C,T-cell surface glycoprotein CD1c,23005,2159,0.64 [0.55-0.75],1.2107113340175005e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD2,T-cell surface antigen CD2,19234,1836,1.24 [1.13-1.36],1.0916453391500786e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD200,OX-2 membrane glycoprotein,22920,2165,0.91 [0.79-1.05],0.1834015295225972
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD200R1,Cell surface glycoprotein CD200 receptor 1,22842,2156,1.30 [1.17-1.45],9.28868172354788e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD207,C-type lectin domain family 4 member K,22426,2099,1.32 [1.20-1.46],3.484677469348871e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD209,CD209 antigen,23011,2177,0.89 [0.81-0.99],0.0251114588705662
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD22,B-cell receptor CD22,23215,2189,1.54 [1.42-1.67],2.51428184128462e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD226,CD226 antigen,19320,1836,1.10 [0.99-1.22],0.0711940217800467
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD244,Natural killer cell receptor 2B4,23215,2189,1.67 [1.46-1.91],5.01746879833127e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD248,Endosialin,19921,1897,0.61 [0.54-0.68],4.009618135066874e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD27,CD27 antigen,23005,2159,1.48 [1.36-1.61],1.0683613705209936e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD274,Programmed cell death 1 ligand 1,22750,2153,1.43 [1.29-1.59],1.898532400839164e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD276,CD276 antigen,22907,2158,1.67 [1.49-1.86],3.7594244313774323e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD28,T-cell-specific surface glycoprotein CD28,22405,2098,1.58 [1.45-1.73],9.061888885142364e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD2AP,CD2-associated protein,22943,2160,1.09 [1.03-1.16],0.0036557862708478
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD300A,CMRF35-like molecule 8,19456,1848,1.46 [1.26-1.68],3.213306866344364e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD300C,CMRF35-like molecule 6,23155,2176,1.45 [1.31-1.61],1.20230582901507e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD300E,CMRF35-like molecule 2,23085,2171,1.31 [1.20-1.43],2.1182889857813164e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD300LF,CMRF35-like molecule 1,23146,2176,1.12 [1.05-1.19],0.0004380679209823
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD300LG,CMRF35-like molecule 9,22954,2166,0.60 [0.54-0.67],1.5482696081011865e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD302,CD302 antigen,22833,2139,1.43 [1.27-1.61],2.4111190237502483e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD33,Myeloid cell surface antigen CD33,23005,2159,1.07 [1.02-1.12],0.0072960442541475
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD34,Hematopoietic progenitor cell antigen CD34,23086,2170,0.53 [0.46-0.63],7.35535247140947e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD36,Platelet glycoprotein 4,19320,1836,1.25 [1.14-1.37],1.6110916937791733e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,22833,2139,1.33 [1.18-1.49],1.369639916612381e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD3D,T-cell surface glycoprotein CD3 delta chain,19272,1835,1.02 [0.90-1.17],0.7352621584984648
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD3E,T-cell surface glycoprotein CD3 epsilon chain,19560,1852,1.04 [0.93-1.18],0.4734751657269735
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD3G,T-cell surface glycoprotein CD3 gamma chain,19320,1836,1.00 [0.95-1.05],0.9099045364137868
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD4,T-cell surface glycoprotein CD4,22882,2163,1.54 [1.38-1.73],8.459459436872179e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD40,Tumor necrosis factor receptor superfamily member 5,22913,2161,1.19 [1.11-1.28],2.9648245594295992e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD40LG,CD40 ligand,23215,2189,1.02 [0.98-1.07],0.3509689259827491
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD46,Membrane cofactor protein,22840,2146,1.32 [1.16-1.50],2.777333332434016e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD48,CD48 antigen,22989,2166,1.78 [1.58-2.01],1.5001622663850615e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD5,T-cell surface glycoprotein CD5,23111,2175,1.57 [1.45-1.71],3.78015500858911e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD55,Complement decay-accelerating factor,22161,2084,0.96 [0.83-1.12],0.6327384175854901
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD58,Lymphocyte function-associated antigen 3,22863,2153,0.79 [0.64-0.97],0.0281490755161287
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD59,CD59 glycoprotein,22147,2078,1.38 [1.17-1.62],9.260840937565652e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD5L,CD5 antigen-like,19832,1878,1.06 [0.97-1.17],0.1820384931493507
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD6,T-cell differentiation antigen CD6,23178,2185,1.24 [1.16-1.34],2.127507142384765e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD63,CD63 antigen,22707,2149,1.29 [1.19-1.39],1.0809365182318475e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD69,Early activation antigen CD69,22826,2149,1.04 [1.00-1.09],0.0487952834424294
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD7,T-cell antigen CD7,19287,1830,1.22 [1.11-1.35],8.279925736627492e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD70,CD70 antigen,22920,2165,1.05 [0.97-1.15],0.2297202691629977
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD72,B-cell differentiation antigen CD72,19456,1848,1.41 [1.27-1.56],1.8101099671923085e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD74,HLA class II histocompatibility antigen gamma chain,23155,2176,1.72 [1.55-1.91],2.0322899920615475e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD79B,B-cell antigen receptor complex-associated protein beta chain,23215,2189,1.25 [1.16-1.36],2.1305362554036443e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD80,T-lymphocyte activation antigen CD80,19913,1888,2.50 [2.26-2.77],1.747416979426068e-68
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD82,CD82 antigen,19560,1852,1.09 [0.98-1.21],0.1016001432555366
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD83,CD83 antigen,22920,2165,1.70 [1.54-1.89],7.308235834264112e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD84,SLAM family member 5,22920,2165,0.99 [0.88-1.12],0.8880181842419687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD86,T-lymphocyte activation antigen CD86,19848,1888,1.04 [0.90-1.20],0.5919180571265623
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD8A,T-cell surface glycoprotein CD8 alpha chain,23155,2176,1.39 [1.30-1.50],1.64646278780613e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD93,Complement component C1q receptor,22100,2095,0.86 [0.76-0.98],0.0218842989300031
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD99,CD99 antigen,22954,2166,0.91 [0.75-1.10],0.336724308611281
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD99L2,CD99 antigen-like protein 2,22954,2166,0.99 [0.85-1.16],0.933349337098888
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDA,Cytidine deaminase,19877,1883,1.16 [1.06-1.27],0.0008966872746949
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDAN1,Codanin-1,19860,1881,0.94 [0.78-1.14],0.5256561986872581
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDC123,Cell division cycle protein 123 homolog,19204,1817,1.05 [0.98-1.12],0.163550395188076
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDC25A,M-phase inducer phosphatase 1,19204,1817,1.06 [0.94-1.18],0.3603609460049993
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDC26,Anaphase-promoting complex subunit CDC26,19805,1883,1.05 [0.98-1.12],0.1520482058644654
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDC27,Cell division cycle protein 27 homolog,22405,2098,1.11 [1.05-1.19],0.0005851164695052
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDC37,Hsp90 co-chaperone Cdc37,23005,2159,1.03 [0.98-1.08],0.1946573886351398
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDC42BPB,Serine/threonine-protein kinase MRCK beta,19848,1888,1.06 [1.01-1.10],0.0084440421754827
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDCP1,CUB domain-containing protein 1,22750,2153,1.61 [1.52-1.71],3.746969542205199e-58
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDH1,Cadherin-1,22194,2081,1.61 [1.50-1.72],6.411315692615421e-43
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDH15,Cadherin-15,23123,2171,1.41 [1.35-1.47],2.391434300176425e-53
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDH17,Cadherin-17,22943,2160,1.41 [1.34-1.49],1.336851204032275e-40
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDH2,Cadherin-2,22943,2160,2.75 [2.49-3.03],4.455965972986575e-92
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDH22,Cadherin-22,19560,1852,1.01 [0.86-1.19],0.8772913390743245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDH23,Cadherin-23,19860,1881,0.95 [0.80-1.13],0.559536096916239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDH3,Cadherin-3,23155,2176,0.99 [0.89-1.10],0.848329905125621
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDH4,Cadherin-4,19272,1835,0.95 [0.86-1.05],0.3230790389612347
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDH5,Cadherin-5,23232,2193,1.01 [0.89-1.15],0.852049512545026
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDH6,Cadherin-6,22943,2160,1.44 [1.31-1.58],8.456159993327337e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDHR1,Cadherin-related family member 1,22446,2110,1.14 [1.05-1.24],0.0017999815712563
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDHR2,Cadherin-related family member 2,22833,2139,1.56 [1.46-1.66],1.4524280480988093e-43
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDHR5,Cadherin-related family member 5,22943,2160,1.20 [1.08-1.33],0.0005311963600731
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDK1,Cyclin-dependent kinase 1,19204,1817,1.28 [1.13-1.45],8.476148181684831e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,19874,1884,1.04 [0.97-1.12],0.2750057193119516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDKL5,Cyclin-dependent kinase-like 5,19272,1835,0.94 [0.86-1.03],0.1774835223149402
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDKN1A,Cyclin-dependent kinase inhibitor 1,22833,2139,1.08 [1.04-1.11],5.332435582966341e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,22833,2139,1.02 [0.98-1.06],0.3600852652795813
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDNF,Cerebral dopamine neurotrophic factor,22833,2139,0.87 [0.77-0.98],0.0190690005362358
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,22943,2163,1.53 [1.32-1.77],1.2784291560220424e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDSN,Corneodesmosin,23148,2179,0.84 [0.77-0.92],0.0001341343070587
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,22972,2157,1.93 [1.64-2.26],4.779102858241197e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,19848,1888,1.08 [1.03-1.14],0.0029743717657081
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,19560,1852,1.04 [0.98-1.11],0.1884460809633557
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,19848,1888,1.00 [0.90-1.12],0.9750304491560516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,19560,1852,1.26 [1.16-1.38],1.7482490003052684e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,22920,2165,1.06 [1.01-1.10],0.0128158109190137
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,22405,2098,1.03 [0.95-1.12],0.5019324153128308
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,22121,2077,1.23 [1.16-1.31],2.638534599256399e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,19921,1897,1.40 [1.29-1.53],2.011801717611757e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,22530,2127,1.21 [1.13-1.30],2.804166965949667e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEBPA,CCAAT/enhancer-binding protein alpha,19320,1836,1.17 [1.04-1.31],0.006991384054211
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEBPB,CCAAT/enhancer-binding protein beta,22530,2127,1.13 [1.03-1.25],0.0089873923188953
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CELA2A,Chymotrypsin-like elastase family member 2A,19921,1897,0.95 [0.89-1.02],0.1871088738924936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CELA3A,Chymotrypsin-like elastase family member 3A,23196,2190,1.01 [0.95-1.07],0.790848704431202
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,19456,1848,0.96 [0.82-1.12],0.5893756598342197
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEMIP2,Cell surface hyaluronidase,19320,1836,1.59 [1.46-1.74],1.5174686238307986e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEND1,Cell cycle exit and neuronal differentiation protein 1,19272,1835,0.97 [0.90-1.05],0.4776060489306517
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CENPF,Centromere protein F,19560,1852,1.00 [0.93-1.08],0.9591710714318264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CENPJ,Centromere protein J,19560,1852,1.06 [0.99-1.12],0.0865525051430072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEP112,Centrosomal protein of 112 kDa,19234,1836,0.99 [0.90-1.09],0.8387965839851831
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEP152,Centrosomal protein of 152 kDa,19204,1817,1.07 [0.97-1.18],0.2058841431584402
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEP164,Centrosomal protein of 164 kDa,22537,2110,1.02 [0.96-1.08],0.4989691202005432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEP170,Centrosomal protein of 170 kDa,19360,1834,1.06 [1.00-1.12],0.0421073744577068
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEP20,Centrosomal protein 20,22405,2098,1.10 [1.05-1.16],0.0001886055753887
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEP290,Centrosomal protein of 290 kDa,19560,1852,1.00 [0.92-1.10],0.9207939547430106
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEP350,Centrosome-associated protein 350,19204,1817,1.05 [0.93-1.18],0.4207726736484162
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEP43,Centrosomal protein 43,22357,2114,1.11 [1.05-1.17],0.0002281817941828
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEP85,Centrosomal protein of 85 kDa,22405,2098,1.09 [1.02-1.15],0.005597273754347
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CERT,Ceramide transfer protein,22446,2110,1.03 [0.97-1.10],0.3854240473658848
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CES1,Liver carboxylesterase 1,23009,2171,1.40 [1.35-1.46],8.717499292604117e-70
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CES2,Cocaine esterase,22833,2139,1.34 [1.26-1.43],8.117310387266799e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CES3,Carboxylesterase 3,22833,2139,1.14 [1.08-1.19],3.093024248432209e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CETN2,Centrin-2,22446,2110,1.10 [1.04-1.16],0.0011338592133263
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CETN3,Centrin-3,19848,1888,1.05 [0.99-1.11],0.0949482445922714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CFB,Complement factor B,19585,1855,2.17 [1.89-2.50],3.355981855464956e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CFC1,Cryptic protein,22405,2098,1.32 [1.22-1.42],3.286750708768593e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CFD,Complement factor D,19935,1892,0.79 [0.63-0.99],0.038722138041971
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CFH,Complement factor H,18782,1780,3.21 [2.65-3.88],2.247582618952524e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CFHR2,Complement factor H-related protein 2,19794,1876,1.04 [0.96-1.13],0.2982874114817113
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CFHR4,Complement factor H-related protein 4,19893,1890,0.83 [0.78-0.88],6.35797797939686e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CFHR5,Complement factor H-related protein 5,19681,1857,0.82 [0.74-0.90],0.0001119262899535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CFI,Complement factor I,19935,1892,4.07 [3.26-5.08],2.64275941546479e-35
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CFP,Properdin,19935,1892,1.08 [0.89-1.31],0.4269615765050191
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CGA,Glycoprotein hormones alpha chain,22954,2166,1.27 [1.20-1.35],5.995893323160069e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,19935,1893,1.03 [0.92-1.16],0.5781431567214055
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CGN,Cingulin,19370,1843,1.12 [1.00-1.24],0.0430325520147193
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CGREF1,Cell growth regulator with EF hand domain protein 1,22943,2160,1.43 [1.31-1.56],9.026750029087875e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,22405,2098,1.01 [0.94-1.08],0.8010946669268499
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHAD,Chondroadherin,19456,1848,0.48 [0.44-0.53],7.9641483584106095e-53
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",19860,1881,1.70 [1.57-1.85],2.7676260059311364e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHCHD6,MICOS complex subunit MIC25,19841,1877,1.51 [1.36-1.68],3.764669887879481e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHEK2,Serine/threonine-protein kinase Chk2,22530,2127,0.91 [0.80-1.02],0.1092041575315474
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHGA,Chromogranin-A,19921,1897,1.14 [1.09-1.19],2.9128893635951484e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHGB,Secretogranin-1,23090,2163,0.97 [0.88-1.06],0.4872276172338462
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHI3L1,Chitinase-3-like protein 1,22469,2108,1.30 [1.25-1.35],5.873477480540028e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHIT1,Chitotriosidase-1,23048,2180,1.00 [0.98-1.02],0.872249385261322
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHL1,Neural cell adhesion molecule L1-like protein,23023,2163,0.74 [0.65-0.84],7.505511271418095e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHM,Rab proteins geranylgeranyltransferase component A 1,19370,1843,1.07 [0.99-1.15],0.0712448497121153
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHMP1A,Charged multivesicular body protein 1a,22750,2153,1.01 [0.96-1.06],0.6223484553754608
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHMP6,Charged multivesicular body protein 6,19913,1888,1.11 [1.03-1.19],0.0085927510825322
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHP1,Calcineurin B homologous protein 1,19272,1835,1.00 [0.94-1.06],0.9311195980782278
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHRDL1,Chordin-like protein 1,22989,2166,1.16 [1.03-1.31],0.0124711707400303
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHRDL2,Chordin-like protein 2,22943,2160,1.35 [1.24-1.46],4.677002587694687e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHRM1,Muscarinic acetylcholine receptor M1,19370,1843,1.05 [0.93-1.18],0.4695662847260535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CIAPIN1,Anamorsin,23005,2159,1.07 [1.00-1.14],0.037466824927046
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CILP,Cartilage intermediate layer protein 1,19921,1897,1.70 [1.57-1.85],2.4056729797906717e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CINP,Cyclin-dependent kinase 2-interacting protein,19560,1852,1.01 [0.91-1.11],0.90342808276542
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CIRBP,Cold-inducible RNA-binding protein,19848,1888,1.03 [0.99-1.08],0.153824523526448
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CIT,Citron Rho-interacting kinase,19370,1843,1.10 [1.00-1.21],0.0512751130633789
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CKAP4,Cytoskeleton-associated protein 4,23102,2180,1.46 [1.29-1.65],3.038872642361522e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CKB,Creatine kinase B-type,19921,1897,0.59 [0.55-0.64],3.816641301849615e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",22833,2151,1.13 [1.06-1.20],6.586367245620402e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLASP1,CLIP-associating protein 1,19204,1817,1.06 [0.99-1.12],0.0766439892251691
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLC,Galectin-10,22907,2156,1.03 [0.97-1.08],0.3468244360467647
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC10A,C-type lectin domain family 10 member A,22750,2153,1.02 [0.92-1.13],0.6988282178258587
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC11A,C-type lectin domain family 11 member A,22922,2161,1.01 [0.93-1.09],0.8661657871582531
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC12A,C-type lectin domain family 12 member A,19320,1836,1.42 [1.16-1.75],0.0008562268867775
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC14A,C-type lectin domain family 14 member A,22954,2166,1.19 [1.05-1.33],0.0045349860674612
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC1A,C-type lectin domain family 1 member A,22530,2127,0.90 [0.80-1.01],0.0751106640165561
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC1B,C-type lectin domain family 1 member B,23155,2176,1.06 [1.02-1.10],0.0038578445150155
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC2L,C-type lectin domain family 2 member L,19370,1843,1.00 [0.91-1.09],0.9445914214008152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC3B,Tetranectin,19481,1844,0.44 [0.35-0.55],5.358127726214002e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC4A,C-type lectin domain family 4 member A,22920,2165,0.67 [0.60-0.74],2.6079359173219563e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC4C,C-type lectin domain family 4 member C,22920,2165,1.03 [0.96-1.12],0.4083438081883026
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC4D,C-type lectin domain family 4 member D,22920,2165,1.26 [1.19-1.34],1.9123269223697936e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC4G,C-type lectin domain family 4 member G,22920,2165,1.05 [0.94-1.18],0.3897388306222142
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC4M,C-type lectin domain family 4 member M,19891,1895,0.79 [0.72-0.86],2.43712761050544e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC5A,C-type lectin domain family 5 member A,22866,2155,1.35 [1.19-1.52],1.3437230101073805e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC6A,C-type lectin domain family 6 member A,22405,2098,1.33 [1.23-1.44],1.90706725393908e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC7A,C-type lectin domain family 7 member A,23215,2189,1.02 [0.95-1.08],0.6211363996069565
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLGN,Calmegin,19370,1843,1.14 [1.04-1.25],0.0056513933916651
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLIC5,Chloride intracellular channel protein 5,19370,1843,0.95 [0.83-1.09],0.4899561971514469
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLINT1,Clathrin interactor 1,19204,1817,0.95 [0.86-1.05],0.3465120839127519
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLIP2,CAP-Gly domain-containing linker protein 2,22920,2165,1.05 [1.02-1.09],0.0035292938764358
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLMP,CXADR-like membrane protein,23146,2176,1.15 [0.97-1.37],0.1067023274752267
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLNS1A,Methylosome subunit pICln,19370,1843,1.00 [0.88-1.13],0.9877515019902328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",22718,2148,1.07 [1.03-1.11],0.0009750330974254
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLPS,Colipase,22910,2160,0.99 [0.94-1.04],0.6831263778330208
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLSPN,Claspin,22414,2105,1.07 [0.97-1.19],0.1726050155565805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLSTN1,Calsyntenin-1,22446,2110,1.10 [1.02-1.18],0.0121345072903575
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLSTN2,Calsyntenin-2,23215,2189,1.56 [1.44-1.70],6.975345754955944e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLSTN3,Calsyntenin-3,19860,1881,1.75 [1.53-2.00],6.84535416826635e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLTA,Clathrin light chain A,22530,2127,1.06 [0.98-1.15],0.153738584369477
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLU,Clusterin,19935,1892,1.08 [0.94-1.25],0.2747570651092941
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLUL1,Clusterin-like protein 1,22901,2157,0.74 [0.68-0.81],6.546091738926307e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CMC1,COX assembly mitochondrial protein homolog,19913,1888,1.05 [1.00-1.10],0.0461091235930217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CMIP,C-Maf-inducing protein,19841,1877,1.06 [1.01-1.12],0.0242426104579354
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CNDP1,Beta-Ala-His dipeptidase,23056,2165,1.05 [0.96-1.14],0.2745930079572467
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CNGB3,Cyclic nucleotide-gated cation channel beta-3,19272,1835,1.01 [0.93-1.10],0.8408101628331099
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",19326,1831,1.09 [1.03-1.16],0.0020072167107156
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CNPY2,Protein canopy homolog 2,22530,2127,0.98 [0.92-1.05],0.5536173535798422
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CNPY4,Protein canopy homolog 4,22833,2139,1.05 [1.00-1.11],0.0590291691267428
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CNST,Consortin,22943,2160,1.05 [1.01-1.09],0.0057867533162359
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CNTF,Ciliary neurotrophic factor,19272,1835,1.05 [0.92-1.20],0.4664834784604013
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CNTN1,Contactin-1,23232,2193,1.27 [1.10-1.46],0.0009774076093448
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CNTN2,Contactin-2,23146,2176,1.44 [1.32-1.57],1.9802082048228666e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CNTN3,Contactin-3,22954,2166,2.45 [2.14-2.81],5.1295250127609216e-39
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CNTN4,Contactin-4,22954,2166,1.87 [1.60-2.19],1.1053982787310216e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CNTN5,Contactin-5,23008,2163,0.83 [0.75-0.92],0.0004021238138308
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CNTNAP2,Contactin-associated protein-like 2,22920,2165,1.26 [1.16-1.37],3.3458537431985734e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CNTNAP4,Contactin-associated protein-like 4,19370,1843,1.02 [0.98-1.06],0.371885895724096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COCH,Cochlin,19913,1888,1.14 [1.04-1.25],0.005690323642389
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL15A1,Collagen alpha-1(XV) chain,19921,1897,0.53 [0.45-0.62],2.7640886652176867e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL18A1,Collagen alpha-1(XVIII) chain,23045,2175,1.64 [1.40-1.92],7.578352137925855e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL1A1,Collagen alpha-1(I) chain,23232,2193,0.68 [0.58-0.80],4.620613856445876e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL24A1,Collagen alpha-1(XXIV) chain,19848,1888,1.04 [0.97-1.12],0.2911488884198989
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL28A1,Collagen alpha-1(XXVIII) chain,19370,1843,1.02 [0.96-1.07],0.5789834545759167
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL2A1,Collagen alpha-1(II) chain,19360,1834,1.07 [1.02-1.14],0.011099949322977
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL3A1,Collagen alpha-1(III) chain,19921,1897,2.10 [1.77-2.50],3.8746190957833626e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL4A1,Collagen alpha-1(IV) chain,22943,2160,1.38 [1.26-1.52],3.183521369982536e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL4A4,Collagen alpha-4(IV) chain,19529,1847,0.95 [0.88-1.04],0.2508990223950798
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL5A1,Collagen alpha-1(V) chain,19456,1848,1.71 [1.56-1.87],8.452251479224095e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL6A3,Collagen alpha-3(VI) chain,23232,2193,1.50 [1.36-1.66],1.3599724992089116e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL9A1,Collagen alpha-1(IX) chain,22920,2165,0.79 [0.72-0.86],1.1694383472895637e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL9A2,Collagen alpha-2(IX) chain,19560,1852,0.91 [0.82-1.01],0.0674174110318078
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COLEC12,Collectin-12,22907,2158,1.62 [1.41-1.85],5.182043105995853e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COMMD1,COMM domain-containing protein 1,19360,1834,1.09 [1.01-1.17],0.028079943097541
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COMMD9,COMM domain-containing protein 9,19841,1877,0.97 [0.87-1.09],0.6127854840633268
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COMP,Cartilage oligomeric matrix protein,22721,2137,0.81 [0.72-0.90],0.0002355543007268
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COMT,Catechol O-methyltransferase,22279,2106,1.05 [1.00-1.10],0.0497978111225506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COPB2,Coatomer subunit beta',19234,1836,1.05 [0.95-1.16],0.355604805267411
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COPE,Coatomer subunit epsilon,22446,2110,0.98 [0.90-1.06],0.6054328502364098
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",19360,1834,0.96 [0.86-1.08],0.4880993122084184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CORO1A,Coronin-1A,22510,2125,1.06 [1.02-1.11],0.0044733434141655
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CORO6,Coronin-6,19272,1835,1.05 [0.95-1.16],0.3232257328298198
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",22833,2139,1.10 [1.04-1.16],0.0004160211747131
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COX6B1,Cytochrome c oxidase subunit 6B1,19913,1888,1.20 [1.06-1.36],0.0048635932124292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CPA1,Carboxypeptidase A1,23232,2193,1.00 [0.94-1.06],0.969980097510544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CPA2,Carboxypeptidase A2,23087,2168,1.40 [1.33-1.48],2.890796063492236e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CPA4,Carboxypeptidase A4,19075,1803,0.79 [0.71-0.87],7.238887950237552e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CPB1,Carboxypeptidase B,23232,2193,1.01 [0.95-1.07],0.8052200296521232
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CPB2,Carboxypeptidase B2,19902,1887,1.05 [0.86-1.27],0.6527356435031014
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CPE,Carboxypeptidase E,22955,2155,0.78 [0.71-0.85],4.887756336836122e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CPLX2,Complexin-2,19204,1817,1.00 [0.86-1.15],0.9600350939458872
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CPM,Carboxypeptidase M,23038,2161,3.16 [2.86-3.49],2.136210846342379e-112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",19320,1836,1.02 [0.87-1.21],0.7759612136862699
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CPPED1,Serine/threonine-protein phosphatase CPPED1,23155,2176,1.06 [1.00-1.12],0.0474508217375017
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CPQ,Carboxypeptidase Q,19887,1895,1.45 [1.29-1.63],1.1612462007971622e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CPTP,Ceramide-1-phosphate transfer protein,19234,1836,0.99 [0.89-1.11],0.9161563409155288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CPVL,Probable serine carboxypeptidase CPVL,23099,2172,1.34 [1.21-1.47],3.266821132225077e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CPXM1,Probable carboxypeptidase X1,23005,2159,1.05 [1.00-1.11],0.052780545327646
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CPXM2,Inactive carboxypeptidase-like protein X2,19913,1888,1.66 [1.41-1.96],1.4656786362031287e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CR1,Complement receptor type 1,19860,1883,1.49 [1.32-1.68],2.3509968757596496e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CR2,Complement receptor type 2,23056,2165,1.47 [1.36-1.60],1.4068937685976278e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,22405,2098,1.05 [1.01-1.10],0.0199862717186709
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRADD,Death domain-containing protein CRADD,22718,2148,1.02 [0.97-1.08],0.3697389338131208
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CREB3,Cyclic AMP-responsive element-binding protein 3,19204,1817,0.99 [0.92-1.08],0.8998132017776206
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CREBZF,CREB/ATF bZIP transcription factor,19204,1817,1.06 [0.90-1.27],0.4779067696765756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CREG1,Protein CREG1,22639,2127,1.07 [0.98-1.18],0.1427012040509009
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRELD1,Protein disulfide isomerase CRELD1,19456,1848,2.11 [1.88-2.37],1.0219820674189309e-35
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRELD2,Protein disulfide isomerase CRELD2,22989,2166,1.18 [1.10-1.26],6.382075271201262e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRH,Corticoliberin,22369,2095,0.80 [0.76-0.84],8.62479003335169e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRHBP,Corticotropin-releasing factor-binding protein,22907,2158,2.45 [2.14-2.81],1.473776858476933e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRHR1,Corticotropin-releasing factor receptor 1,22530,2127,0.98 [0.91-1.04],0.4839891847355144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRIM1,Cysteine-rich motor neuron 1 protein,23025,2168,1.44 [1.20-1.74],0.0001075799000668
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRIP2,Cysteine-rich protein 2,22750,2153,1.47 [1.35-1.60],2.026610108196639e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRISP2,Cysteine-rich secretory protein 2,23146,2176,0.85 [0.79-0.91],1.6771558630807488e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRISP3,Cysteine-rich secretory protein 3,19747,1874,0.65 [0.55-0.76],8.894454500565071e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRKL,Crk-like protein,22945,2161,1.03 [0.99-1.07],0.1169754987667626
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRLF1,Cytokine receptor-like factor 1,23025,2168,1.74 [1.50-2.02],7.597618560206716e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRNN,Cornulin,22298,2085,0.81 [0.77-0.86],1.2893749020592437e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRTAC1,Cartilage acidic protein 1,23232,2193,0.63 [0.56-0.71],2.3737667888370848e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRTAM,Cytotoxic and regulatory T-cell molecule,22750,2153,1.05 [0.98-1.14],0.1719738625132643
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRTAP,Cartilage-associated protein,19370,1843,0.96 [0.88-1.06],0.4541380830997721
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRX,Cone-rod homeobox protein,22530,2127,0.98 [0.95-1.02],0.412300734256797
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRYBB1,Beta-crystallin B1,19913,1888,1.05 [0.98-1.12],0.1358392811029351
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRYBB2,Beta-crystallin B2,19860,1881,1.04 [0.98-1.10],0.1553836335254787
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRYGD,Gamma-crystallin D,19860,1881,0.99 [0.95-1.04],0.8141082671553872
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRYM,Ketimine reductase mu-crystallin,19272,1835,1.06 [1.00-1.13],0.036438800607997
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRYZL1,Quinone oxidoreductase-like protein 1,19360,1834,1.02 [0.97-1.08],0.3594210074806063
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CSDE1,Cold shock domain-containing protein E1,19234,1836,1.04 [1.00-1.08],0.0558101915052074
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CSF1,Macrophage colony-stimulating factor 1,23025,2168,1.85 [1.62-2.12],5.208994532576414e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CSF1R,Macrophage colony-stimulating factor 1 receptor,19935,1893,1.79 [1.62-1.97],1.4655196265364393e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CSF2,Granulocyte-macrophage colony-stimulating factor,19234,1836,1.34 [1.21-1.49],2.067063530377484e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,22750,2153,1.20 [1.13-1.27],2.1420180800835793e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CSF2RB,Cytokine receptor common subunit beta,19320,1836,1.06 [0.95-1.18],0.2761498951188349
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CSF3,Granulocyte colony-stimulating factor,22537,2110,1.11 [1.03-1.20],0.0079684237517225
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CSF3R,Granulocyte colony-stimulating factor receptor,19320,1836,1.25 [1.10-1.43],0.0007218621604648
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CSH1,Chorionic somatomammotropin hormone 1,19935,1893,1.13 [0.97-1.32],0.1083550463521681
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CSNK1D,Casein kinase I isoform delta,19320,1836,1.01 [0.94-1.08],0.7850055738914554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CSNK2A1,Casein kinase II subunit alpha,19874,1884,0.91 [0.83-1.01],0.0713109894927077
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CSPG4,Chondroitin sulfate proteoglycan 4,19921,1897,0.89 [0.78-1.02],0.0992678641805479
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CSPG5,Chondroitin sulfate proteoglycan 5,19272,1835,0.91 [0.82-1.00],0.0446407044307082
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CSRP3,Cysteine and glycine-rich protein 3,19234,1836,1.05 [1.00-1.09],0.0370820648276379
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CST1,Cystatin-SN,17293,1627,1.00 [0.96-1.05],0.8477091607480851
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CST3,Cystatin-C,23014,2158,1.49 [1.31-1.69],1.039344469616637e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CST5,Cystatin-D,22464,2136,1.02 [0.95-1.10],0.5345701803793035
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CST6,Cystatin-M,22351,2102,0.81 [0.75-0.87],1.07282725862619e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CST7,Cystatin-F,22949,2163,1.11 [1.07-1.15],9.556409648046178e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CSTB,Cystatin-B,22636,2137,1.18 [1.08-1.28],0.0001963363041428
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTAG1A_CTAG1B,Cancer/testis antigen 1,19524,1849,0.96 [0.88-1.05],0.4080081194576922
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTBS,Di-N-acetylchitobiase,19652,1861,2.30 [1.97-2.68],5.389965245689848e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTF1,Cardiotrophin-1,22530,2127,1.04 [0.99-1.09],0.0854546052435288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTHRC1,Collagen triple helix repeat-containing protein 1,19921,1897,1.43 [1.24-1.66],2.102355902560569e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTLA4,Cytotoxic T-lymphocyte protein 4,19921,1897,1.06 [0.92-1.23],0.4069142824421859
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTNNA1,Catenin alpha-1,19272,1835,0.96 [0.84-1.10],0.5651540832251298
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTRB1,Chymotrypsinogen B,22954,2166,1.02 [0.95-1.09],0.6146568505755947
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTRC,Chymotrypsin-C,22907,2162,0.88 [0.83-0.93],1.3698165021668588e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTRL,Chymotrypsin-like protease CTRL-1,19860,1881,0.92 [0.87-0.98],0.009781957546239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSB,Cathepsin B,22968,2165,0.77 [0.71-0.83],8.322979692173337e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSC,Dipeptidyl peptidase 1,22859,2150,1.28 [1.18-1.39],5.170842953243108e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSD,Cathepsin D,21471,2021,2.00 [1.87-2.14],1.204022906390091e-89
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSE,Cathepsin E,19456,1848,1.33 [1.22-1.45],2.6082264503531887e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSF,Cathepsin F,23005,2159,1.11 [1.01-1.22],0.0325705771670161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSH,Pro-cathepsin H,22444,2125,1.12 [1.06-1.18],2.2718278128366853e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSL,Cathepsin L1,22943,2160,1.62 [1.39-1.88],2.9419735601576376e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSO,Cathepsin O,23215,2189,2.56 [2.31-2.84],6.086097127963912e-72
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSS,Cathepsin S,18054,1705,2.80 [2.32-3.38],1.8356289384190936e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSV,Cathepsin L2,23059,2165,1.14 [1.05-1.25],0.0029590499830572
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSZ,Cathepsin Z,22985,2157,1.87 [1.66-2.09],1.3095124790484996e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CUZD1,CUB and zona pellucida-like domain-containing protein 1,19370,1843,1.14 [1.03-1.27],0.0134438686114706
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CWC15,Spliceosome-associated protein CWC15 homolog,19735,1876,1.13 [1.06-1.20],0.0003049622466708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CX3CL1,Fractalkine,22750,2153,0.83 [0.74-0.93],0.001589634860989
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CXADR,Coxsackievirus and adenovirus receptor,22920,2165,1.19 [1.10-1.28],9.361383774838066e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CXCL1,Growth-regulated alpha protein,22877,2157,1.01 [0.97-1.05],0.5636109213281157
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CXCL10,C-X-C motif chemokine 10,23025,2168,1.07 [1.01-1.13],0.0144049541439587
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CXCL11,C-X-C motif chemokine 11,23155,2176,1.06 [1.02-1.11],0.0082963176850127
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CXCL12,Stromal cell-derived factor 1,22537,2110,0.93 [0.84-1.03],0.1569354407535605
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CXCL13,C-X-C motif chemokine 13,23155,2176,1.20 [1.14-1.27],1.2045004547087249e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CXCL14,C-X-C motif chemokine 14,22537,2110,1.02 [0.96-1.09],0.5147553236573781
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CXCL16,C-X-C motif chemokine 16,23195,2192,1.53 [1.30-1.79],2.158321443408197e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CXCL17,C-X-C motif chemokine 17,23215,2189,1.38 [1.28-1.49],1.2184165594422188e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CXCL3,C-X-C motif chemokine 3,22913,2161,0.99 [0.95-1.03],0.6781323255316026
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CXCL5,C-X-C motif chemokine 5,22867,2154,1.06 [1.02-1.09],0.0013358558933293
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CXCL6,C-X-C motif chemokine 6,23215,2189,1.14 [1.09-1.20],1.747145280558266e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CXCL8,Interleukin-8,22789,2139,1.19 [1.14-1.25],7.49660142620247e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CXCL9,C-X-C motif chemokine 9,23025,2168,1.07 [1.01-1.14],0.0191430549370839
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CYB5A,Cytochrome b5,19204,1817,1.08 [1.01-1.14],0.0149969727301188
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CYB5R2,NADH-cytochrome b5 reductase 2,19643,1867,1.07 [0.99-1.15],0.1030013464780817
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",19234,1836,1.03 [0.98-1.09],0.2177603060419663
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CYTH3,Cytohesin-3,19204,1817,1.00 [0.94-1.07],0.9071927844616086
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CYTL1,Cytokine-like protein 1,19921,1897,0.53 [0.44-0.63],2.9542572796391177e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DAAM1,Disheveled-associated activator of morphogenesis 1,19456,1848,1.09 [1.03-1.15],0.001731111709087
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DAB2,Disabled homolog 2,23146,2176,1.04 [1.00-1.08],0.0269476397384989
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DAG1,Dystroglycan,23025,2168,1.49 [1.38-1.62],2.2634436702959808e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DAND5,DAN domain family member 5,19320,1836,1.03 [0.96-1.11],0.4161136882494374
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DAPK2,Death-associated protein kinase 2,19320,1836,1.13 [1.05-1.22],0.0007785993892017
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,22920,2165,1.00 [0.97-1.03],0.9405075010598126
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DARS1,"Aspartate--tRNA ligase, cytoplasmic",22718,2148,0.97 [0.92-1.02],0.2348437237847229
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DBH,Dopamine beta-hydroxylase,19899,1888,1.03 [0.99-1.07],0.1200977977176577
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DBI,Acyl-CoA-binding protein,22848,2156,1.07 [1.02-1.13],0.0056587842231548
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DBN1,Drebrin,19320,1836,1.03 [0.94-1.13],0.4992053567034756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DBNL,Drebrin-like protein,23025,2168,1.03 [0.99-1.08],0.1230585990174033
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",23005,2159,1.87 [1.69-2.08],3.047729831455617e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DCC,Netrin receptor DCC,19370,1843,0.81 [0.66-1.00],0.0525088850014415
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DCDC2C,Doublecortin domain-containing protein 2C,19204,1817,1.02 [0.95-1.10],0.5410000718197405
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DCLRE1C,Protein artemis,19204,1817,1.06 [0.91-1.22],0.4662979663536072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DCN,Decorin,22530,2127,1.14 [0.97-1.35],0.1130578692788633
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DCTD,Deoxycytidylate deaminase,19456,1848,1.02 [0.98-1.07],0.3327824137251503
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DCTN1,Dynactin subunit 1,23146,2176,1.08 [1.01-1.14],0.0146186460271256
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DCTN2,Dynactin subunit 2,22833,2139,0.99 [0.95-1.03],0.6456459950354679
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DCTN6,Dynactin subunit 6,22446,2110,1.03 [0.98-1.09],0.2164187729265378
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DCTPP1,dCTP pyrophosphatase 1,22943,2160,0.99 [0.88-1.11],0.838922370257576
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DCUN1D1,DCN1-like protein 1,19272,1835,1.02 [0.96-1.09],0.5340732354401351
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DCUN1D2,DCN1-like protein 2,19204,1817,0.96 [0.91-1.02],0.2448353024438542
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DCXR,L-xylulose reductase,23005,2159,1.47 [1.37-1.57],2.759813906761913e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DDA1,DET1- and DDB1-associated protein 1,19234,1836,1.05 [0.94-1.17],0.4041699841837097
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",22833,2139,1.51 [1.40-1.63],5.195875281185611e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DDC,Aromatic-L-amino-acid decarboxylase,22913,2159,1.20 [1.11-1.29],7.332314988511127e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DDHD2,Phospholipase DDHD2,19874,1884,1.09 [1.02-1.17],0.0116163900930115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DDI2,Protein DDI1 homolog 2,19456,1848,0.94 [0.89-1.00],0.0488952004233139
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DDR1,Epithelial discoidin domain-containing receptor 1,23155,2176,2.10 [1.80-2.45],2.147697709083308e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DDT,D-dopachrome decarboxylase,19921,1897,1.21 [1.10-1.33],0.0001360679330611
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DDX1,ATP-dependent RNA helicase DDX1,19848,1888,0.97 [0.89-1.06],0.5387207312950653
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DDX25,ATP-dependent RNA helicase DDX25,19370,1843,0.96 [0.85-1.10],0.5757937888346899
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DDX39A,ATP-dependent RNA helicase DDX39A,19320,1836,0.95 [0.78-1.16],0.5894242483082914
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DDX4,Probable ATP-dependent RNA helicase DDX4,19320,1836,1.03 [0.95-1.11],0.525884684909182
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DDX53,Probable ATP-dependent RNA helicase DDX53,19370,1843,0.90 [0.79-1.02],0.1005370192307296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DDX58,Antiviral innate immune response receptor RIG-I,22405,2098,1.07 [1.00-1.14],0.0416104657126101
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",22920,2165,1.08 [1.04-1.12],0.0001840401889576
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DEFA1_DEFA1B,Neutrophil defensin 1,22493,2124,1.06 [0.99-1.14],0.0992609284160518
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DEFB103A_DEFB103B,Beta-defensin 103,19174,1819,1.31 [1.21-1.43],2.375869106314293e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DEFB104A_DEFB104B,Beta-defensin 104,19272,1835,0.90 [0.83-0.98],0.0188077059549807
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DEFB116,Beta-defensin 116,19272,1835,0.98 [0.92-1.05],0.5835127596186644
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DEFB118,Beta-defensin 118,19272,1835,1.10 [1.02-1.19],0.0095842442076162
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DEFB4A_DEFB4B,Beta-defensin 4A,22602,2124,1.04 [1.02-1.07],0.0012564529384903
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DENND2B,DENN domain-containing protein 2B,19234,1836,1.06 [0.97-1.16],0.1631720670994617
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DENR,Density-regulated protein,19320,1836,1.08 [1.01-1.17],0.0365031731507915
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DFFA,DNA fragmentation factor subunit alpha,23215,2189,1.07 [1.01-1.13],0.0169562029238519
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DGCR6,Protein DGCR6,19272,1835,1.12 [1.01-1.24],0.0275960583251473
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DGKA,Diacylglycerol kinase alpha,19320,1836,1.15 [1.06-1.24],0.0006956506936192
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DGKZ,Diacylglycerol kinase zeta,22537,2110,1.06 [0.95-1.18],0.273130780675019
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DHODH,Dihydroorotate dehydrogenase,19234,1836,1.02 [0.92-1.12],0.7560130710843196
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DHPS,Deoxyhypusine synthase,19841,1877,1.41 [1.28-1.54],4.656820939815143e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,19860,1881,1.06 [0.97-1.16],0.2162946215779443
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DIABLO,"Diablo homolog, mitochondrial",22866,2155,1.02 [0.98-1.05],0.35536637908635
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DIPK1C,Divergent protein kinase domain 1C,19370,1843,0.94 [0.84-1.05],0.2467898429111001
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DIPK2B,Divergent protein kinase domain 2B,19456,1848,0.69 [0.59-0.80],2.266826764367038e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DKK1,Dickkopf-related protein 1,23155,2176,1.11 [1.04-1.18],0.0009901300253082
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DKK3,Dickkopf-related protein 3,23232,2193,0.95 [0.84-1.08],0.4385638337529686
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DKK4,Dickkopf-related protein 4,22707,2148,1.46 [1.35-1.58],7.172701567829065e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DKKL1,Dickkopf-like protein 1,22833,2139,1.02 [0.97-1.06],0.474206661536818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DLG4,Disks large homolog 4,19860,1881,1.05 [0.99-1.12],0.0928105345234583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DLGAP5,Disks large-associated protein 5,19874,1884,0.98 [0.89-1.08],0.6870594050454639
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DLK1,Protein delta homolog 1,23232,2193,1.14 [1.07-1.21],6.57022429772039e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DLL1,Delta-like protein 1,23005,2159,1.58 [1.40-1.78],1.4160753008660142e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DLL4,Delta-like protein 4,19360,1834,1.00 [0.95-1.05],0.9656545504454952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DMD,Dystrophin,19360,1834,1.21 [1.11-1.31],7.672177504018112e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DMP1,Dentin matrix acidic phosphoprotein 1,19360,1834,0.60 [0.56-0.64],2.281393416530557e-57
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DNAJA1,DnaJ homolog subfamily A member 1,19204,1817,0.91 [0.82-1.01],0.0674790866161194
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DNAJA2,DnaJ homolog subfamily A member 2,23139,2184,1.08 [1.03-1.13],0.0016546138822722
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DNAJA4,DnaJ homolog subfamily A member 4,19860,1881,0.99 [0.93-1.05],0.6284997238484107
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DNAJB1,DnaJ homolog subfamily B member 1,22833,2139,1.05 [1.01-1.10],0.01882307977728
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DNAJB14,DnaJ homolog subfamily B member 14,19848,1888,1.09 [1.02-1.17],0.0085303851036092
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DNAJB2,DnaJ homolog subfamily B member 2,19456,1848,1.03 [0.95-1.11],0.4987926117246888
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DNAJB6,DnaJ homolog subfamily B member 6,19278,1827,1.07 [1.01-1.13],0.0165030388397039
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DNAJB8,DnaJ homolog subfamily B member 8,22530,2127,0.99 [0.92-1.07],0.8363825976073032
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DNAJC21,DnaJ homolog subfamily C member 21,19860,1881,1.11 [1.00-1.25],0.0608479403309999
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DNAJC6,Putative tyrosine-protein phosphatase auxilin,19360,1834,1.08 [1.02-1.13],0.0059322317924719
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DNAJC9,DnaJ homolog subfamily C member 9,19848,1888,1.02 [0.96-1.08],0.5170359127725898
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DNER,Delta and Notch-like epidermal growth factor-related receptor,22874,2158,0.87 [0.76-1.01],0.0596931695908252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DNLZ,DNL-type zinc finger protein,19272,1835,0.96 [0.91-1.02],0.2039389065084972
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DNM1,Dynamin-1,19848,1888,0.99 [0.96-1.03],0.7933616762558114
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DNM3,Dynamin-3,19874,1884,1.15 [1.07-1.24],0.0001523666261856
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DNMBP,Dynamin-binding protein,22750,2153,1.12 [1.05-1.19],0.0002949354891763
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DNPEP,Aspartyl aminopeptidase,19860,1881,1.24 [1.14-1.34],1.0878823992442169e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,22981,2163,1.07 [0.99-1.15],0.0745896742690029
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DOC2B,Double C2-like domain-containing protein beta,19370,1843,1.04 [0.93-1.17],0.4811031077837014
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DOCK9,Dedicator of cytokinesis protein 9,19272,1835,0.99 [0.96-1.03],0.7791308280538884
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DOK1,Docking protein 1,19860,1881,1.02 [0.98-1.05],0.3110589790257831
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DOK2,Docking protein 2,22943,2160,1.04 [1.01-1.07],0.0153306323418024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DPEP1,Dipeptidase 1,22718,2148,1.05 [0.97-1.14],0.265338058221357
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DPEP2,Dipeptidase 2,22833,2139,0.95 [0.84-1.08],0.4122036358507929
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DPP10,Inactive dipeptidyl peptidase 10,22920,2165,1.70 [1.56-1.85],7.470534697366658e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DPP4,Dipeptidyl peptidase 4,22534,2120,1.27 [1.11-1.46],0.0004982916440492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DPP6,Dipeptidyl aminopeptidase-like protein 6,22833,2139,2.16 [1.95-2.40],3.212896010682169e-48
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DPP7,Dipeptidyl peptidase 2,22768,2143,1.19 [1.12-1.26],3.5139042034614565e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DPT,Dermatopontin,23232,2193,1.20 [1.03-1.40],0.0216280052585385
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DPY30,Protein dpy-30 homolog,23084,2173,1.35 [1.28-1.43],2.7174336204346497e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DRAXIN,Draxin,22750,2153,1.12 [1.02-1.22],0.0148779869160002
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DRG2,Developmentally-regulated GTP-binding protein 2,22833,2139,1.04 [0.97-1.11],0.2442590436361775
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DSC2,Desmocollin-2,22679,2140,1.61 [1.45-1.78],1.2391575879447373e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DSCAM,Down syndrome cell adhesion molecule,19874,1884,2.10 [1.87-2.36],2.9667429084209825e-35
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DSG2,Desmoglein-2,22954,2166,0.71 [0.61-0.81],1.2299231046226931e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DSG3,Desmoglein-3,23070,2172,0.84 [0.75-0.94],0.0016306809821076
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DSG4,Desmoglein-4,22759,2131,0.82 [0.76-0.88],4.1328178126883545e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DTD1,D-aminoacyl-tRNA deacylase 1,19456,1848,1.05 [0.99-1.10],0.0837712883210946
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DTNB,Dystrobrevin beta,19798,1872,1.59 [1.46-1.73],2.1349302409007595e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DTX2,Probable E3 ubiquitin-protein ligase DTX2,19370,1843,0.92 [0.85-0.99],0.0338641293210215
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DTX3,Probable E3 ubiquitin-protein ligase DTX3,22833,2139,0.92 [0.79-1.08],0.3078673983857293
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DTYMK,Thymidylate kinase,19913,1888,1.09 [1.02-1.16],0.0095624562895998
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DUOX2,Dual oxidase 2,22530,2127,0.93 [0.88-0.99],0.0235712342351694
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DUSP13,Dual specificity protein phosphatase 13 isoform A,19841,1877,1.00 [0.91-1.11],0.9325270659892558
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DUSP29,Dual specificity phosphatase 29,19370,1843,1.06 [0.99-1.13],0.0837359006952747
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DUSP3,Dual specificity protein phosphatase 3,22446,2110,0.93 [0.89-0.98],0.0042372481761592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",19848,1888,1.09 [1.04-1.13],9.772082643238572e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DXO,Decapping and exoribonuclease protein,19860,1881,1.11 [1.01-1.22],0.0313451514017987
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,19841,1877,0.94 [0.85-1.04],0.2268258651524174
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DYNLT1,Dynein light chain Tctex-type 1,19370,1843,1.12 [1.06-1.18],3.261844839638486e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DYNLT3,Dynein light chain Tctex-type 3,19841,1877,1.07 [0.97-1.18],0.1755640885632813
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,22750,2153,1.07 [1.03-1.11],0.000862038436026
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EBI3_IL27,Interleukin-27,23119,2174,1.33 [1.18-1.51],5.824791059226238e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ECE1,Endothelin-converting enzyme 1,22446,2110,0.95 [0.85-1.06],0.3456387780527933
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",19913,1888,1.34 [1.27-1.41],2.8700214427666415e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ECHS1,"Enoyl-CoA hydratase, mitochondrial",19360,1834,1.18 [1.13-1.23],6.737553978089804e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ECI2,Enoyl-CoA delta isomerase 2,19234,1836,1.14 [1.07-1.22],7.515812622308172e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ECM1,Extracellular matrix protein 1,19412,1838,1.11 [0.98-1.26],0.0998358524218445
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ECSCR,Endothelial cell-specific chemotaxis regulator,19272,1835,1.08 [0.99-1.18],0.0787219297620987
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EDA2R,Tumor necrosis factor receptor superfamily member 27,23146,2176,1.45 [1.32-1.60],6.149145670750421e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EDAR,Tumor necrosis factor receptor superfamily member EDAR,22920,2165,0.96 [0.92-1.00],0.0509687823953756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EDDM3B,Epididymal secretory protein E3-beta,19841,1877,0.82 [0.76-0.88],3.7798207187337307e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,19234,1836,1.05 [0.93-1.19],0.4310240398736614
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EDF1,Endothelial differentiation-related factor 1,19874,1884,1.12 [1.06-1.19],0.000146635620083
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,22530,2127,1.32 [1.19-1.47],2.308073451634386e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EDN1,Endothelin-1,19360,1834,1.44 [1.24-1.67],1.6054590843352848e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EDNRB,Endothelin receptor type B,19320,1836,1.08 [0.98-1.20],0.1280842362431548
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EEF1D,Elongation factor 1-delta,19913,1888,1.12 [1.07-1.18],1.140602723925665e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EFCAB14,EF-hand calcium-binding domain-containing protein 14,19848,1888,1.12 [0.97-1.29],0.132131724478084
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EFCAB2,Dynein regulatory complex protein 8,19560,1852,1.09 [0.96-1.24],0.1696311788979418
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,23020,2164,1.37 [1.22-1.54],1.2319618158226573e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EFHD1,EF-hand domain-containing protein D1,19874,1884,0.99 [0.87-1.12],0.8505543350142961
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EFNA1,Ephrin-A1,22912,2163,1.45 [1.28-1.65],5.712325603487627e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EFNA4,Ephrin-A4,22707,2149,2.09 [1.89-2.31],1.577104736132369e-46
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EFNB2,Ephrin-B2,19370,1843,1.10 [1.02-1.18],0.012265536459042
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EGF,Pro-epidermal growth factor,22876,2160,1.01 [0.98-1.05],0.4719678008528937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EGFL7,Epidermal growth factor-like protein 7,22405,2098,1.27 [1.15-1.39],1.3383578332031403e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EGFLAM,Pikachurin,19848,1888,1.34 [1.17-1.53],3.0438657373809043e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EGFR,Epidermal growth factor receptor,23232,2193,0.79 [0.62-1.00],0.0456564420435355
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EGLN1,Egl nine homolog 1,22920,2165,1.22 [1.16-1.29],3.2381097074594423e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EHBP1,EH domain-binding protein 1,19913,1888,1.10 [1.04-1.16],0.0017638011915684
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EHD3,EH domain-containing protein 3,19360,1834,1.00 [0.96-1.04],0.9424310472498268
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",19860,1881,1.02 [0.94-1.11],0.5721675321796069
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",19774,1879,1.06 [1.02-1.10],0.003667856327746
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,19234,1836,1.07 [1.00-1.15],0.0363122149449922
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,19360,1834,1.06 [0.95-1.18],0.2973195419633496
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EIF4B,Eukaryotic translation initiation factor 4B,22750,2153,1.08 [1.01-1.16],0.0287650329240117
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EIF4E,Eukaryotic translation initiation factor 4E,19320,1836,1.05 [1.00-1.11],0.0476765763625419
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,22943,2160,1.10 [1.04-1.16],0.000963649354288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,23215,2189,1.10 [1.06-1.15],1.7165459502073969e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,19874,1884,1.09 [1.02-1.17],0.0077075669398303
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EIF5,Eukaryotic translation initiation factor 5,19234,1836,1.12 [1.02-1.24],0.0214325915436285
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EIF5A,Eukaryotic translation initiation factor 5A-1,22537,2110,1.02 [0.90-1.15],0.8042894021094608
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ELAC1,Zinc phosphodiesterase ELAC protein 1,19874,1884,1.04 [0.99-1.09],0.1475081018678051
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ELAVL4,ELAV-like protein 4,19272,1835,1.05 [0.99-1.11],0.0787449026728526
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ELN,Elastin,19913,1888,0.99 [0.87-1.13],0.895629018511189
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ELOA,Elongin-A,22833,2139,1.19 [1.12-1.26],2.277509860546757e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ELOB,Elongin-B,19234,1836,1.11 [0.99-1.24],0.0737922937991489
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENAH,Protein enabled homolog,22537,2110,1.19 [1.10-1.28],1.6159005961629298e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENDOU,Poly(U)-specific endoribonuclease,18379,1755,0.95 [0.87-1.03],0.2119696880090892
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENG,Endoglin,23232,2193,1.76 [1.43-2.18],1.1907980948029373e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENO1,Alpha-enolase,22938,2164,1.07 [1.02-1.12],0.0083043356110038
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENO2,Gamma-enolase,23155,2176,1.03 [0.97-1.09],0.2979807385575174
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENO3,Beta-enolase,19360,1834,1.24 [1.16-1.32],2.7741286577284107e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENOPH1,Enolase-phosphatase E1,19841,1877,0.95 [0.87-1.04],0.3051732564789655
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,19234,1836,1.17 [1.01-1.36],0.0318442356145929
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENPEP,Glutamyl aminopeptidase,19234,1836,1.01 [0.91-1.12],0.8858732058651996
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,23232,2193,1.76 [1.53-2.03],9.945338976905756e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,23025,2168,0.96 [0.88-1.04],0.3395521780608372
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,19360,1834,1.12 [0.99-1.28],0.069668378638342
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,22247,2090,1.31 [1.25-1.37],2.5476613436755596e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENSA,Alpha-endosulfine,19841,1877,0.97 [0.90-1.06],0.537827673407935
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,22405,2098,1.51 [1.39-1.65],2.0452296387678e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,22530,2127,0.50 [0.43-0.59],3.078143907578925e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,22530,2127,1.53 [1.31-1.78],4.435862728807895e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENTR1,Endosome-associated-trafficking regulator 1,19360,1834,1.24 [1.16-1.32],4.509598579145557e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EP300,Histone acetyltransferase p300,19320,1836,1.21 [1.06-1.38],0.0050790897067804
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPB41L5,Band 4.1-like protein 5,19370,1843,1.05 [0.98-1.12],0.1390942959032732
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPCAM,Epithelial cell adhesion molecule,22904,2158,0.96 [0.92-1.00],0.0669426267590025
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPGN,Epigen,19841,1877,0.93 [0.83-1.03],0.1370963995287589
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPHA1,Ephrin type-A receptor 1,22981,2163,1.25 [1.11-1.40],0.0003039742872055
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPHA10,Ephrin type-A receptor 10,22446,2110,0.98 [0.92-1.04],0.5252342263848695
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPHA2,Ephrin type-A receptor 2,22088,2068,1.64 [1.46-1.84],2.9850806381458854e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPHA4,Ephrin type-A receptor 4,19456,1848,1.36 [1.17-1.58],7.668534829101426e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPHB4,Ephrin type-B receptor 4,23232,2193,1.17 [1.01-1.36],0.0334228689675089
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPHB6,Ephrin type-B receptor 6,22718,2148,1.04 [0.93-1.17],0.510177772041311
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPHX2,Bifunctional epoxide hydrolase 2,22530,2127,1.07 [1.01-1.13],0.0314628748459096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPN1,Epsin-1,19560,1852,1.01 [0.90-1.12],0.9212601454360412
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPO,Erythropoietin,22920,2165,1.16 [1.11-1.21],2.1655502628921208e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPPK1,Epiplakin,19360,1834,1.05 [0.99-1.11],0.1136925912094026
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,23111,2175,1.92 [1.73-2.14],3.922476989153708e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ERBB2,Receptor tyrosine-protein kinase erbB-2,23005,2159,2.39 [2.06-2.78],1.1798536313308972e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ERBB3,Receptor tyrosine-protein kinase erbB-3,22823,2153,1.25 [1.03-1.52],0.0215207550306877
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ERBB4,Receptor tyrosine-protein kinase erbB-4,23005,2159,2.37 [2.03-2.77],5.5645028005764135e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ERBIN,Erbin,22833,2139,1.06 [1.02-1.10],0.0033198977452275
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ERC2,ERC protein 2,19370,1843,1.01 [0.95-1.08],0.6502542852316744
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ERCC1,DNA excision repair protein ERCC-1,19204,1817,0.93 [0.80-1.07],0.2924390009202774
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EREG,Proepiregulin,22718,2148,1.04 [0.99-1.09],0.1253850006484592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ERI1,3'-5' exoribonuclease 1,19560,1852,1.16 [1.03-1.32],0.0171315584378823
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ERMAP,Erythroid membrane-associated protein,19320,1836,1.32 [1.20-1.46],3.4259854416188226e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,19841,1877,1.35 [1.21-1.51],1.82242335004179e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ERP29,Endoplasmic reticulum resident protein 29,19456,1848,1.05 [1.01-1.09],0.0077137374455459
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ERP44,Endoplasmic reticulum resident protein 44,22798,2138,1.25 [1.08-1.44],0.0033871551396025
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,19234,1836,0.99 [0.90-1.10],0.9150026582366126
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ESAM,Endothelial cell-selective adhesion molecule,23232,2193,1.20 [1.08-1.35],0.0012450564080922
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ESM1,Endothelial cell-specific molecule 1,22907,2158,0.68 [0.61-0.76],1.4385993788247102e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ESPL1,Separin,19204,1817,1.08 [1.00-1.17],0.0583775570437059
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ESR1,Estrogen receptor,19320,1836,0.98 [0.90-1.07],0.7016823159204709
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ESYT2,Extended synaptotagmin-2,19860,1881,1.11 [1.05-1.17],9.337408106622824e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EVI2B,Protein EVI2B,19204,1817,0.97 [0.87-1.09],0.6552899839253519
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EVI5,Ecotropic viral integration site 5 protein homolog,19320,1836,1.08 [1.02-1.13],0.003939494625347
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EVPL,Envoplakin,19560,1852,0.95 [0.82-1.10],0.4804078296825483
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EXOSC10,Exosome component 10,19234,1836,0.97 [0.90-1.05],0.4874944350765566
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EXTL1,Exostosin-like 1,19234,1836,0.91 [0.83-1.01],0.0826765247076927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EZR,Ezrin,23155,2176,1.68 [1.46-1.93],4.993478803189487e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,F10,Coagulation factor X,19935,1893,1.11 [0.96-1.29],0.150589787698425
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,F11,Coagulation factor XI,19644,1865,1.32 [1.18-1.48],1.2520380903651048e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,F11R,Junctional adhesion molecule A,22954,2166,1.22 [1.14-1.30],3.5929816673093046e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,F12,Coagulation factor XII,19935,1892,1.05 [0.94-1.17],0.3718108787496412
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,F13B,Coagulation factor XIII B chain,19832,1878,0.65 [0.55-0.77],4.111673577510737e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,F2,Prothrombin,19935,1892,0.78 [0.58-1.04],0.0935490152070263
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,F2R,Proteinase-activated receptor 1,22989,2166,1.12 [1.05-1.20],0.0009325420427017
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,F3,Tissue factor,22997,2163,0.90 [0.78-1.04],0.1713172562830439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,F7,Coagulation factor VII,23015,2161,1.33 [1.17-1.50],7.053501412977222e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,F9,Coagulation factor IX,23022,2164,2.73 [2.22-3.35],1.0683377238690222e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FABP1,"Fatty acid-binding protein, liver",22907,2158,1.44 [1.38-1.49],1.5996510803808104e-85
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FABP2,"Fatty acid-binding protein, intestinal",22943,2160,1.13 [1.08-1.18],8.181958853574413e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FABP3,"Fatty acid-binding protein, heart",19913,1888,1.44 [1.34-1.55],2.857338128991318e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FABP4,"Fatty acid-binding protein, adipocyte",23232,2193,1.54 [1.44-1.65],4.4572499887072624e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FABP5,Fatty acid-binding protein 5,23079,2170,1.18 [1.12-1.25],6.038516432429002e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FABP6,Gastrotropin,22497,2125,1.10 [1.03-1.17],0.004679695273395
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FABP9,Fatty acid-binding protein 9,22920,2165,0.89 [0.83-0.95],0.0006101438127284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FADD,FAS-associated death domain protein,22943,2160,1.00 [0.95-1.05],0.9900838855881782
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FAM13A,Protein FAM13A,19848,1888,1.08 [1.02-1.16],0.0127474302719479
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FAM171A2,Protein FAM171A2,19874,1884,0.99 [0.97-1.02],0.6140120619385216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FAM171B,Protein FAM171B,19841,1877,1.11 [0.95-1.30],0.1784470032189339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FAM172A,Cotranscriptional regulator FAM172A,19360,1834,0.99 [0.92-1.07],0.8117296414791862
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FAM20A,Pseudokinase FAM20A,19913,1888,2.02 [1.77-2.30],6.181797007025295e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FAM3B,Protein FAM3B,22833,2139,1.66 [1.49-1.85],5.3880301006421744e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FAM3C,Protein FAM3C,22913,2159,2.02 [1.79-2.27],3.1961807569277825e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FAM3D,Protein FAM3D,19848,1888,1.25 [1.19-1.32],3.8361423181288594e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FAP,Prolyl endopeptidase FAP,23232,2193,1.18 [1.03-1.35],0.0176677620671023
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FARSA,Phenylalanine--tRNA ligase alpha subunit,19370,1843,1.09 [1.03-1.16],0.0038482520453007
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FAS,Tumor necrosis factor receptor superfamily member 6,23154,2188,1.38 [1.27-1.49],1.1971207075375152e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FASLG,Tumor necrosis factor ligand superfamily member 6,23215,2189,0.63 [0.57-0.70],4.961662094511595e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FBLN2,Fibulin-2,19921,1897,1.06 [0.93-1.22],0.3762837156805695
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FBN2,Fibrillin-2,19370,1843,1.09 [1.01-1.17],0.0351831024004139
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FBP1,"Fructose-1,6-bisphosphatase 1",22943,2160,1.27 [1.21-1.33],1.0950213032440522e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,19913,1888,1.60 [1.51-1.69],4.5621195400640514e-57
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCAR,Immunoglobulin alpha Fc receptor,22920,2165,1.42 [1.31-1.53],2.764432389007737e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,19874,1884,1.28 [1.07-1.54],0.0063293339557682
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCER2,Low affinity immunoglobulin epsilon Fc receptor,22954,2166,1.21 [1.13-1.30],1.5888983791928003e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,22865,2153,1.09 [1.02-1.17],0.0116891470063578
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,22405,2098,1.08 [1.01-1.15],0.0221107023605171
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,22980,2159,1.04 [0.97-1.13],0.2796033474884554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCN1,Ficolin-1,19899,1888,1.27 [1.17-1.38],3.2080459416154246e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCN2,Ficolin-2,22865,2148,0.93 [0.85-1.02],0.1136931816159734
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCRL1,Fc receptor-like protein 1,22943,2160,1.20 [1.11-1.30],6.195286887974601e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCRL2,Fc receptor-like protein 2,23105,2182,1.13 [1.05-1.22],0.000948984616236
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCRL3,Fc receptor-like protein 3,22537,2110,1.08 [1.00-1.15],0.0433152958025261
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCRL5,Fc receptor-like protein 5,22954,2166,1.18 [1.11-1.26],2.848455154467212e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCRL6,Fc receptor-like protein 6,22920,2165,1.16 [1.10-1.23],1.8089129821149e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCRLB,Fc receptor-like B,22405,2098,1.18 [1.12-1.24],2.7460439859952195e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FDX1,"Adrenodoxin, mitochondrial",19234,1836,1.14 [1.07-1.22],5.122944266864624e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FDX2,"Ferredoxin-2, mitochondrial",19234,1836,1.09 [1.00-1.17],0.0408929095374465
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FEN1,Flap endonuclease 1,22405,2098,1.10 [1.04-1.15],0.00036153367245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FES,Tyrosine-protein kinase Fes/Fps,22405,2098,1.08 [1.00-1.18],0.0524955837617146
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FETUB,Fetuin-B,23022,2164,1.39 [1.23-1.58],2.5375712458514414e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGA,Fibrinogen alpha chain,19471,1846,1.29 [1.12-1.49],0.0005625858403153
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",19874,1884,1.08 [1.02-1.14],0.0059697019184035
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGF12,Fibroblast growth factor 12,19320,1836,0.92 [0.83-1.03],0.157199378169171
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGF16,Fibroblast growth factor 16,19320,1836,1.09 [0.99-1.20],0.0898297417408066
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGF19,Fibroblast growth factor 19,23025,2168,0.89 [0.85-0.93],1.4078575130007857e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGF2,Fibroblast growth factor 2,22920,2165,1.07 [1.01-1.13],0.0173427686105607
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGF20,Fibroblast growth factor 20,19320,1836,1.08 [0.97-1.19],0.1491861143597677
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGF21,Fibroblast growth factor 21,23119,2174,1.23 [1.20-1.27],1.7428122059578445e-44
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGF23,Fibroblast growth factor 23,23107,2168,1.27 [1.19-1.35],1.1382914183710494e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGF3,Fibroblast growth factor 3,19320,1836,0.96 [0.83-1.12],0.609432029792405
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGF5,Fibroblast growth factor 5,22537,2110,1.29 [1.15-1.43],7.658500953502544e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGF6,Fibroblast growth factor 6,19320,1836,1.02 [0.91-1.14],0.7835194942135594
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGF7,Fibroblast growth factor 7,19204,1817,1.02 [0.97-1.08],0.4050257692920314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGF9,Fibroblast growth factor 9,19169,1814,0.96 [0.86-1.07],0.4291135796377449
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGFBP1,Fibroblast growth factor-binding protein 1,23005,2159,0.37 [0.33-0.41],1.2671323891595564e-73
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGFBP2,Fibroblast growth factor-binding protein 2,19921,1897,0.85 [0.78-0.93],0.0004179684317651
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGFBP3,Fibroblast growth factor-binding protein 3,19860,1881,0.67 [0.59-0.75],2.503866948910605e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGFR2,Fibroblast growth factor receptor 2,23005,2159,3.55 [3.09-4.08],6.14385084148131e-71
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGFR4,Fibroblast growth factor receptor 4,19456,1848,0.88 [0.81-0.96],0.0035890477541318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGL1,Fibrinogen-like protein 1,19935,1893,1.20 [1.13-1.29],5.220821722093401e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGR,Tyrosine-protein kinase Fgr,22446,2110,1.15 [1.09-1.22],1.6441045891765813e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FH,"Fumarate hydratase, mitochondrial",19272,1835,1.06 [1.00-1.11],0.0340324218179751
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FHIP2A,FHF complex subunit HOOK interacting protein 2A,19234,1836,1.01 [0.92-1.10],0.8987405815179637
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FHIT,Bis(5'-adenosyl)-triphosphatase,22446,2110,1.00 [0.95-1.06],0.8603070219253841
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FIS1,Mitochondrial fission 1 protein,22905,2158,1.04 [0.99-1.10],0.0804419054815382
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,19874,1884,1.05 [1.01-1.10],0.0219486316527122
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,23032,2169,1.01 [0.98-1.04],0.540333916901055
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,22750,2153,1.33 [1.21-1.45],1.0493884110047595e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,22750,2153,1.06 [1.02-1.10],0.007321364548778
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,22414,2105,1.06 [0.97-1.14],0.1867724490650251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FKBPL,FK506-binding protein-like,19848,1888,1.07 [0.99-1.15],0.0725532162425037
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FLI1,Friend leukemia integration 1 transcription factor,22405,2098,1.04 [1.01-1.08],0.0155059796084439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,22750,2153,1.49 [1.31-1.70],1.709844788894396e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FLT1,Vascular endothelial growth factor receptor 1,22793,2138,1.03 [0.87-1.23],0.711494282881467
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FLT3,Receptor-type tyrosine-protein kinase FLT3,22405,2098,0.92 [0.81-1.04],0.1784723988068794
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FLT3LG,Fms-related tyrosine kinase 3 ligand,23215,2189,1.45 [1.30-1.61],1.4423850815979076e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FLT4,Vascular endothelial growth factor receptor 3,23005,2159,1.09 [0.97-1.22],0.1432430881245001
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FMNL1,Formin-like protein 1,22446,2110,1.13 [1.08-1.19],9.79649355949309e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FMR1,Synaptic functional regulator FMR1,22405,2098,0.99 [0.89-1.11],0.9213486436598246
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FN1,Fibronectin,19935,1892,1.11 [0.94-1.30],0.2238810475347872
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FNDC1,Fibronectin type III domain-containing protein 1,19860,1881,1.03 [0.94-1.13],0.4997309819391817
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,19841,1877,1.20 [1.07-1.35],0.0022283182297666
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FOLH1,Glutamate carboxypeptidase 2,19320,1836,1.00 [0.96-1.05],0.8988515394256134
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FOLR1,Folate receptor alpha,22907,2149,1.32 [1.16-1.49],1.4082243406313202e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FOLR2,Folate receptor beta,23155,2176,1.19 [1.05-1.36],0.0071643696532249
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FOLR3,Folate receptor gamma,22934,2156,1.00 [0.98-1.02],0.917294975346476
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FOS,Proto-oncogene c-Fos,19169,1814,1.11 [0.98-1.25],0.103808991532139
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FOSB,Protein fosB,22446,2110,0.99 [0.89-1.09],0.8310815456576107
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FOXJ3,Forkhead box protein J3,19320,1836,1.16 [1.06-1.28],0.0013816662407778
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FOXO1,Forkhead box protein O1,22920,2165,1.04 [0.99-1.08],0.1069878990355261
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FOXO3,Forkhead box protein O3,22405,2098,1.01 [0.97-1.06],0.5203629481471636
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FRMD4B,FERM domain-containing protein 4B,19234,1836,1.04 [0.97-1.10],0.2802765982138343
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FRMD7,FERM domain-containing protein 7,19370,1843,0.97 [0.85-1.11],0.6567436764652181
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FRZB,Secreted frizzled-related protein 3,22678,2148,1.06 [0.91-1.23],0.4281718252141783
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FSHB,Follitropin subunit beta,19360,1834,1.30 [1.18-1.43],1.123930114763409e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FST,Follistatin,22989,2166,0.82 [0.75-0.88],8.969899834767342e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FSTL1,Follistatin-related protein 1,19360,1834,1.86 [1.53-2.26],4.370107729260976e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FSTL3,Follistatin-related protein 3,22875,2157,1.55 [1.39-1.74],1.0358632828572316e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FTCD,Formimidoyltransferase-cyclodeaminase,19817,1876,1.46 [1.40-1.53],2.8073916942500858e-61
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FUCA1,Tissue alpha-L-fucosidase,23073,2181,1.10 [1.05-1.15],8.111371402947764e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FUOM,Fucose mutarotase,19456,1848,1.58 [1.48-1.68],1.6078950707346728e-46
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FURIN,Furin,23005,2159,2.12 [1.89-2.38],4.355745845504675e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FUS,RNA-binding protein FUS,22366,2090,1.15 [1.04-1.26],0.0050655171465742
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",19528,1850,1.05 [0.98-1.13],0.1734298867010784
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,23155,2176,1.26 [1.17-1.37],6.922153265208327e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FUT8,"Alpha-(1,6)-fucosyltransferase",22750,2153,1.00 [0.94-1.07],0.9163710808865676
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FXN,"Frataxin, mitochondrial",23146,2176,1.05 [1.00-1.11],0.0460809106303866
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FXYD5,FXYD domain-containing ion transport regulator 5,22537,2110,1.05 [0.99-1.12],0.0861978868959997
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FYB1,FYN-binding protein 1,22910,2160,1.07 [1.03-1.12],0.0006191310248846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FZD10,Frizzled-10,19370,1843,1.04 [0.96-1.12],0.3155278376764256
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FZD8,Frizzled-8,19272,1835,1.01 [0.91-1.12],0.7865490260028853
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GABARAP,Gamma-aminobutyric acid receptor-associated protein,19841,1877,1.05 [0.96-1.15],0.3117233464598294
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,19560,1852,0.98 [0.92-1.05],0.5935770595028558
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,19272,1835,0.94 [0.87-1.01],0.0748039845518475
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GAD1,Glutamate decarboxylase 1,19204,1817,0.99 [0.83-1.17],0.8876932995551641
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GAD2,Glutamate decarboxylase 2,19320,1836,1.01 [0.92-1.11],0.8704432018500042
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,19560,1852,1.03 [0.94-1.13],0.5810482767797012
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,19360,1834,1.09 [1.01-1.18],0.0322006745622424
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GAGE2A,G antigen 2A,19204,1817,1.08 [1.01-1.15],0.0162936493974711
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GAL,Galanin peptides,23025,2168,0.79 [0.75-0.84],1.1550860104259225e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,22833,2139,2.21 [1.94-2.52],1.1278107052083563e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,23146,2176,0.74 [0.65-0.86],3.9215388962791896e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,22537,2110,1.47 [1.35-1.60],6.398487914332815e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,19913,1888,1.34 [1.16-1.54],5.329815475116685e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GALNT7,N-acetylgalactosaminyltransferase 7,22833,2139,1.92 [1.59-2.31],9.382422094831346e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GAMT,Guanidinoacetate N-methyltransferase,19234,1836,1.06 [0.94-1.20],0.3640141850075369
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,19027,1799,1.62 [1.37-1.91],1.3398727966275998e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GART,Trifunctional purine biosynthetic protein adenosine-3,19874,1884,1.02 [0.86-1.20],0.8275958520703136
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GAS2,Growth arrest-specific protein 2,19560,1852,1.23 [1.15-1.32],8.835024409148564e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GAS6,Growth arrest-specific protein 6,23090,2181,1.69 [1.45-1.96],8.375346284843944e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GASK1A,Golgi-associated kinase 1A,19234,1836,1.02 [0.92-1.13],0.6936699174951007
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GAST,Gastrin,19860,1881,1.13 [1.09-1.16],1.617483132065712e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,19204,1817,1.01 [0.85-1.20],0.8974502668283081
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",19360,1834,1.05 [0.99-1.11],0.1023132119912903
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GBA,Lysosomal acid glucosylceramidase,19370,1843,1.06 [0.98-1.15],0.1393547772430209
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GBP1,Guanylate-binding protein 1,19822,1879,1.16 [1.08-1.24],2.433594136567197e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GBP2,Guanylate-binding protein 2,22537,2110,1.07 [1.00-1.14],0.0360152909629657
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GBP4,Guanylate-binding protein 4,22446,2110,0.95 [0.87-1.03],0.1771488715580874
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GBP6,Guanylate-binding protein 6,19234,1836,1.01 [0.91-1.12],0.7966333520672912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GC,Vitamin D-binding protein,19935,1892,0.88 [0.74-1.05],0.155407531808481
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GCC1,GRIP and coiled-coil domain-containing protein 1,19860,1881,1.07 [1.02-1.11],0.002201459822505
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GCG,Pro-glucagon,22405,2098,1.27 [1.23-1.31],4.7197059861296974e-48
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,18964,1792,1.25 [1.15-1.36],1.0678530601925789e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GCLM,Glutamate--cysteine ligase regulatory subunit,19234,1836,1.06 [0.96-1.16],0.2545846657470305
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",22833,2139,1.51 [1.36-1.69],1.258959061213514e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GDF15,Growth/differentiation factor 15,23232,2193,2.58 [2.44-2.73],4.753166638942941e-247
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GDF2,Growth/differentiation factor 2,22943,2160,1.47 [1.33-1.64],3.899399061192081e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GDNF,Glial cell line-derived neurotrophic factor,22446,2110,1.51 [1.37-1.66],2.216954589354568e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GET3,ATPase GET3,19913,1888,1.14 [1.05-1.23],0.0010942779023194
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GFAP,Glial fibrillary acidic protein,22367,2095,0.99 [0.91-1.08],0.8564875872649902
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GFER,FAD-linked sulfhydryl oxidase ALR,22405,2098,1.20 [1.13-1.28],7.61919341939748e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,22405,2098,0.99 [0.96-1.02],0.5596423257514044
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GFRA1,GDNF family receptor alpha-1,23119,2174,2.29 [2.02-2.59],1.5239205895033493e-39
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GFRA2,GDNF family receptor alpha-2,22833,2139,1.15 [0.96-1.38],0.1213157316545048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GFRA3,GDNF family receptor alpha-3,22678,2149,1.15 [1.00-1.32],0.0426615116449713
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GFRAL,GDNF family receptor alpha-like,19286,1824,0.84 [0.78-0.90],2.7773390984301164e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GGA1,ADP-ribosylation factor-binding protein GGA1,22446,2110,0.98 [0.93-1.04],0.5766427998957833
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GGACT,Gamma-glutamylaminecyclotransferase,19913,1888,0.99 [0.93-1.06],0.8474588331439413
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GGCT,Gamma-glutamylcyclotransferase,19879,1886,1.04 [0.95-1.13],0.4540759125528054
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GGH,Gamma-glutamyl hydrolase,22569,2123,1.60 [1.44-1.78],1.2383438207423519e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GGT1,Glutathione hydrolase 1 proenzyme,22912,2163,1.65 [1.55-1.76],1.0207943774442672e-54
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GGT5,Glutathione hydrolase 5 proenzyme,22750,2153,2.45 [2.13-2.81],2.8289954507980503e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GH1,Somatotropin,22913,2159,0.99 [0.97-1.01],0.2832504030806608
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GH2,Growth hormone variant,22405,2098,0.99 [0.96-1.01],0.3025499382562123
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GHR,Growth hormone receptor,19456,1848,1.87 [1.59-2.21],1.1129782099274777e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GHRHR,Growth hormone-releasing hormone receptor,22446,2110,0.98 [0.91-1.06],0.6595275095439115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GHRL,Appetite-regulating hormone,22943,2160,0.83 [0.80-0.87],1.994420802731996e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GID8,Glucose-induced degradation protein 8 homolog,19874,1884,0.92 [0.80-1.06],0.2450772955713696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GIGYF2,GRB10-interacting GYF protein 2,19874,1884,1.14 [1.08-1.21],5.5112768232365335e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GIMAP7,GTPase IMAP family member 7,19456,1848,0.75 [0.64-0.87],0.000168239436471
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GIMAP8,GTPase IMAP family member 8,19204,1817,1.14 [1.05-1.24],0.0020089698447202
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GIP,Gastric inhibitory polypeptide,19360,1834,1.23 [1.13-1.33],7.473542570951583e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GIPC2,PDZ domain-containing protein GIPC2,19860,1881,1.58 [1.39-1.80],4.587840466554561e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GIPC3,PDZ domain-containing protein GIPC3,19848,1888,1.02 [0.98-1.07],0.3048191900798343
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GIPR,Gastric inhibitory polypeptide receptor,19320,1836,0.97 [0.87-1.08],0.5657562051437692
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GIT1,ARF GTPase-activating protein GIT1,19320,1836,1.03 [0.99-1.08],0.1654488361033067
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GJA8,Gap junction alpha-8 protein,19204,1817,0.99 [0.92-1.07],0.8481155600832093
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GKN1,Gastrokine-1,22028,2075,1.29 [1.12-1.48],0.0003208239266467
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GLA,Alpha-galactosidase A,19425,1846,1.96 [1.76-2.18],3.254871711313429e-35
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GLB1,Beta-galactosidase,22750,2153,1.47 [1.35-1.61],7.2516434030926455e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GLI2,Zinc finger protein GLI2,19320,1836,1.01 [0.87-1.16],0.9349776104014154
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GLO1,Lactoylglutathione lyase,22530,2127,1.16 [1.08-1.24],1.555693288296377e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GLOD4,Glyoxalase domain-containing protein 4,22869,2156,1.07 [0.96-1.20],0.2008172361765101
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GLP1R,Glucagon-like peptide 1 receptor,19272,1835,0.93 [0.82-1.06],0.2671277838834433
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GLRX,Glutaredoxin-1,22797,2148,1.01 [0.95-1.08],0.6578514482564519
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",19456,1848,1.06 [1.01-1.12],0.016308175947517
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,22446,2110,1.00 [0.92-1.09],0.9648646494958174
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GLYR1,Putative oxidoreductase GLYR1,19841,1877,1.01 [0.94-1.09],0.7459412328461201
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GM2A,Ganglioside GM2 activator,19432,1853,1.06 [0.94-1.18],0.3319888769780306
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GMFG,Glia maturation factor gamma,19913,1888,1.04 [0.98-1.10],0.2164428480973327
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GMPR,GMP reductase 1,23215,2189,0.98 [0.91-1.06],0.5862547839098168
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GMPR2,GMP reductase 2,19456,1848,1.08 [1.01-1.16],0.0181628080365797
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GNAS,Neuroendocrine secretory protein 55,19874,1884,1.02 [0.97-1.07],0.382330541292238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,22405,2098,1.02 [0.96-1.08],0.537098490409915
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,19370,1843,1.02 [0.94-1.11],0.6715197619312882
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GNLY,Granulysin,22954,2166,1.01 [0.94-1.08],0.8840266743420399
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GNPDA1,Glucosamine-6-phosphate isomerase 1,19360,1834,0.98 [0.85-1.12],0.7302981352392519
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GNPDA2,Glucosamine-6-phosphate isomerase 2,19456,1848,0.88 [0.78-0.99],0.0326641945260481
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GOLGA3,Golgin subfamily A member 3,19874,1884,1.07 [1.01-1.13],0.0213939522050641
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GOLM2,Protein GOLM2,23155,2176,2.56 [2.28-2.87],2.774436987261753e-58
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,22920,2165,1.04 [1.00-1.08],0.0400080004345737
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GORASP2,Golgi reassembly-stacking protein 2,19848,1888,1.11 [1.02-1.22],0.0205984811503272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GOT1,"Aspartate aminotransferase, cytoplasmic",19921,1897,1.20 [1.10-1.32],8.310826238994054e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GP1BA,Platelet glycoprotein Ib alpha chain,22868,2149,0.82 [0.73-0.92],0.0006275678506091
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GP1BB,Platelet glycoprotein Ib beta chain,19234,1836,1.05 [0.98-1.12],0.1464158512272243
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,22237,2103,1.11 [1.06-1.16],9.686275323154209e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GP5,Platelet glycoprotein V,19456,1848,1.11 [0.98-1.26],0.1006624754366742
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GP6,Platelet glycoprotein VI,22910,2160,1.01 [0.97-1.06],0.5179022841782857
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPA33,Cell surface A33 antigen,22833,2139,0.93 [0.90-0.96],1.1553937280600865e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPC1,Glypican-1,23146,2176,1.08 [0.95-1.23],0.22548510622391
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPC5,Glypican-5,22750,2153,0.87 [0.81-0.93],3.928164719036191e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPD1,Glycerol-3-phosphate dehydrogenase,19841,1877,1.79 [1.67-1.91],2.152403416533353e-65
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPHA2,Glycoprotein hormone alpha-2,19848,1888,0.95 [0.86-1.05],0.3321806956316963
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPI,Glucose-6-phosphate isomerase,19935,1893,1.23 [1.13-1.35],2.8154342116974934e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,19848,1888,0.94 [0.89-0.99],0.0320509005318942
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPKOW,G-patch domain and KOW motifs-containing protein,22446,2110,1.32 [1.20-1.46],8.160156015772738e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPNMB,Transmembrane glycoprotein NMB,22323,2106,1.94 [1.70-2.22],6.61699432127365e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPR101,Probable G-protein coupled receptor 101,19272,1835,0.99 [0.91-1.07],0.7288828398728795
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPR158,Probable G-protein coupled receptor 158,19874,1884,0.86 [0.75-0.99],0.0374798980561239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPR15L,Protein GPR15L,19848,1888,1.06 [0.99-1.14],0.0949086830524492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPR37,Prosaposin receptor GPR37,22530,2127,1.28 [1.21-1.36],2.750634665428263e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPRC5C,G-protein coupled receptor family C group 5 member C,19841,1877,1.41 [1.32-1.49],8.901889570222524e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GRAP2,GRB2-related adapter protein 2,22943,2160,1.02 [0.99-1.05],0.2073658577551048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,19913,1888,1.26 [1.18-1.35],6.285075038951427e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GRIK2,"Glutamate receptor ionotropic, kainate 2",19874,1884,0.99 [0.89-1.10],0.8661645042839374
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",19272,1835,0.96 [0.88-1.05],0.4043936383641642
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GRK5,G protein-coupled receptor kinase 5,22530,2127,1.03 [0.96-1.11],0.3597747783518127
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GRN,Progranulin,22832,2156,1.87 [1.62-2.16],4.486708731555644e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GRP,Gastrin-releasing peptide,19360,1834,0.86 [0.79-0.94],0.0006046146001295
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GRPEL1,"GrpE protein homolog 1, mitochondrial",22833,2139,1.40 [1.32-1.48],2.191444481784104e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GRSF1,G-rich sequence factor 1,19096,1805,1.05 [0.99-1.11],0.083096050675778
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GSAP,Gamma-secretase-activating protein,22405,2098,1.00 [0.95-1.05],0.9742559909878812
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GSN,Gelsolin,19849,1887,0.28 [0.23-0.33],5.410242335301871e-46
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GSR,"Glutathione reductase, mitochondrial",19825,1878,1.16 [0.95-1.40],0.1450246227727805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GSTA1,Glutathione S-transferase A1,22907,2156,1.42 [1.36-1.48],1.728569906032955e-62
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GSTA3,Glutathione S-transferase A3,22405,2098,1.39 [1.33-1.45],2.4148857860763342e-48
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GSTM4,Glutathione S-transferase Mu 4,19234,1836,1.06 [1.00-1.12],0.0460438577109266
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GSTP1,Glutathione S-transferase P,22304,2097,0.93 [0.87-0.98],0.0127459208461479
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GSTT2B,Glutathione S-transferase theta-2B,19860,1881,1.00 [0.99-1.02],0.6473831810335979
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,19560,1852,0.96 [0.89-1.03],0.2163498208335562
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GTPBP2,GTP-binding protein 2,19370,1843,1.01 [0.96-1.07],0.6573970212235688
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GUCA2A,Guanylin,22829,2155,1.03 [0.92-1.15],0.6220340337177941
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GUCY2C,Heat-stable enterotoxin receptor,19560,1852,0.98 [0.93-1.04],0.5188669715376234
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GUK1,Guanylate kinase,19234,1836,1.09 [0.98-1.22],0.0973447916929229
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GUSB,Beta-glucuronidase,23040,2178,1.64 [1.55-1.73],4.206343215586659e-65
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GYS1,"Glycogen [starch] synthase, muscle",22530,2127,0.96 [0.92-1.00],0.0370165538448026
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GZMA,Granzyme A,23215,2189,1.41 [1.27-1.57],2.96140390066972e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GZMB,Granzyme B,22920,2165,0.93 [0.87-0.98],0.0113415272551161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GZMH,Granzyme H,22530,2127,1.06 [1.01-1.11],0.0143044274226408
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,H2AP,Huntingtin-interacting protein M,19204,1817,1.00 [0.91-1.09],0.9405015659971264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",19234,1836,0.96 [0.90-1.03],0.2998589734694403
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",23084,2173,0.97 [0.92-1.02],0.1920931596971886
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HAO1,Hydroxyacid oxidase 1,23146,2176,1.28 [1.24-1.32],7.213511453734938e-61
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HARS1,"Histidine--tRNA ligase, cytoplasmic",22954,2166,1.06 [1.01-1.11],0.0213167082185223
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HAVCR1,Hepatitis A virus cellular receptor 1,23111,2175,1.73 [1.64-1.81],7.901361639370411e-106
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HAVCR2,Hepatitis A virus cellular receptor 2,22954,2166,1.63 [1.48-1.81],5.1802056812583885e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HBEGF,Proheparin-binding EGF-like growth factor,23084,2173,1.06 [1.00-1.11],0.0387455665677796
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HBQ1,Hemoglobin subunit theta-1,23146,2176,0.88 [0.83-0.94],0.0001070975975809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HBZ,Hemoglobin subunit zeta,19913,1888,0.96 [0.92-1.00],0.0573558192207745
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HCG22,Protein PBMUCL2,19234,1836,1.06 [0.99-1.14],0.0991884955889386
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HCLS1,Hematopoietic lineage cell-specific protein,23215,2189,1.09 [1.02-1.17],0.0111073653906219
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HDAC8,Histone deacetylase 8,19320,1836,0.97 [0.90-1.05],0.413617765327264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HDAC9,Histone deacetylase 9,19272,1835,0.95 [0.88-1.02],0.1518950776022
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HDDC2,5'-deoxynucleotidase HDDC2,19848,1888,0.94 [0.85-1.04],0.231494317471831
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HDGF,Hepatoma-derived growth factor,23106,2171,1.03 [0.99-1.07],0.2009117503214512
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HDGFL2,Hepatoma-derived growth factor-related protein 2,19860,1881,1.15 [1.08-1.23],3.539521802464229e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HEBP1,Heme-binding protein 1,22530,2127,0.95 [0.88-1.02],0.1562348705849625
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HEG1,Protein HEG homolog 1,19456,1848,3.32 [2.85-3.86],2.197988382150096e-54
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HEPACAM2,HEPACAM family member 2,19860,1881,0.93 [0.84-1.03],0.144020802875005
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HEPH,Hephaestin,19913,1888,3.21 [2.69-3.84],2.3785539450200312e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HEXIM1,Protein HEXIM1,22920,2165,1.08 [1.03-1.14],0.0010190942897692
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HGF,Hepatocyte growth factor,23215,2189,2.57 [2.35-2.81],1.7701224764828662e-95
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HGFAC,Hepatocyte growth factor activator,19753,1870,1.15 [0.98-1.35],0.0941789416462055
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,22405,2098,1.02 [0.97-1.07],0.3924032179629083
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HHEX,Hematopoietically-expressed homeobox protein HHEX,19860,1881,1.15 [1.09-1.22],1.5019960393252006e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HIF1A,Hypoxia-inducible factor 1-alpha,19320,1836,1.07 [1.00-1.15],0.0438555033166985
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HIP1,Huntingtin-interacting protein 1,19234,1836,1.11 [0.98-1.26],0.116120952568268
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HIP1R,Huntingtin-interacting protein 1-related protein,19819,1877,1.46 [1.37-1.55],7.995914442716745e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HJV,Hemojuvelin,19874,1884,1.49 [1.37-1.62],4.9526065170792974e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HK2,Hexokinase-2,22530,2127,0.94 [0.82-1.08],0.3901230289414109
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HLA-A,"HLA class I histocompatibility antigen, A alpha chain",19874,1884,1.17 [1.02-1.33],0.0225661435132223
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",22847,2160,1.39 [1.25-1.53],2.005194578527868e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",22920,2165,1.22 [1.08-1.39],0.0018460037600217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HMBS,Porphobilinogen deaminase,23146,2176,1.05 [0.95-1.15],0.3387054773206456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HMCN2,Hemicentin-2,19420,1845,1.33 [1.23-1.44],1.1661725008740053e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",19360,1834,1.09 [1.00-1.19],0.0540152126232581
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",19234,1836,0.98 [0.88-1.08],0.6419146173328343
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HMMR,Hyaluronan mediated motility receptor,19161,1812,0.95 [0.86-1.05],0.3275412454665306
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HMOX1,Heme oxygenase 1,22690,2138,0.84 [0.77-0.91],1.2166552104116202e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HMOX2,Heme oxygenase 2,22446,2110,1.13 [1.04-1.22],0.0031571049077405
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HNF1A,Hepatocyte nuclear factor 1-alpha,19370,1843,0.99 [0.93-1.05],0.7413827233275794
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HNMT,Histamine N-methyltransferase,22645,2142,1.45 [1.35-1.57],2.3297509120259216e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,22451,2121,1.06 [1.01-1.11],0.0175119922816007
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,19874,1884,1.21 [1.12-1.31],1.2644363231143266e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HPCAL1,Hippocalcin-like protein 1,23215,2189,1.03 [0.98-1.08],0.3014816794007043
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HPGDS,Hematopoietic prostaglandin D synthase,22405,2098,0.74 [0.66-0.82],1.5918402430456244e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HPSE,Heparanase,19670,1875,1.10 [1.05-1.15],0.0001376552102102
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HRAS,GTPase Hras,19527,1848,1.00 [0.96-1.05],0.9685345822745822
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,19360,1834,0.70 [0.60-0.81],3.8939036138367055e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HRG,Histidine-rich glycoprotein,19832,1878,1.39 [1.21-1.59],2.7356224501296863e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HS1BP3,HCLS1-binding protein 3,19360,1834,1.02 [0.97-1.08],0.3779984287662223
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,22833,2139,1.20 [1.08-1.33],0.0005220147156754
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,23146,2176,1.14 [1.03-1.27],0.0158312227608917
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,19320,1836,1.46 [1.30-1.63],6.96158345302818e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HSBP1,Heat shock factor-binding protein 1,19360,1834,1.08 [1.03-1.13],0.0028630783991186
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,22920,2165,0.46 [0.42-0.51],1.5283147326483668e-60
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,19860,1881,1.29 [1.20-1.38],6.382463431621927e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HSD17B3,Testosterone 17-beta-dehydrogenase 3,19234,1836,1.06 [0.97-1.16],0.1941707354302082
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,19360,1834,1.12 [1.02-1.23],0.0126237577736789
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HSP90B1,Endoplasmin,22340,2100,1.00 [0.94-1.06],0.9568911583444566
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HSPA1A,Heat shock 70 kDa protein 1A,22981,2163,1.09 [1.04-1.15],0.0009665245216684
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HSPA2,Heat shock-related 70 kDa protein 2,19841,1877,1.21 [1.08-1.35],0.00084811162892
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HSPB1,Heat shock protein beta-1,22586,2124,1.06 [1.00-1.12],0.0630826680730357
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HSPB6,Heat shock protein beta-6,23146,2176,1.25 [1.14-1.37],2.042672491794421e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,22796,2143,1.10 [0.95-1.27],0.2060183612196144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HTR1A,5-hydroxytryptamine receptor 1A,19272,1835,1.05 [0.99-1.11],0.1281349213424127
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HTR1B,5-hydroxytryptamine receptor 1B,19272,1835,1.02 [0.92-1.14],0.6942204418141308
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HTRA2,"Serine protease HTRA2, mitochondrial",23005,2159,1.10 [1.03-1.17],0.0030881000900302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HYAL1,Hyaluronidase-1,22846,2141,2.12 [1.81-2.47],4.802903844926621e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HYOU1,Hypoxia up-regulated protein 1,23232,2193,0.82 [0.70-0.96],0.0148540627786698
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ICA1,Islet cell autoantigen 1,22537,2110,1.04 [0.99-1.09],0.1587683897638626
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ICAM1,Intercellular adhesion molecule 1,22864,2150,2.44 [2.16-2.75],7.553556353282268e-48
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ICAM2,Intercellular adhesion molecule 2,23232,2193,1.17 [1.04-1.32],0.0086078620833399
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ICAM3,Intercellular adhesion molecule 3,23232,2193,1.28 [1.11-1.47],0.0005134177087117
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ICAM4,Intercellular adhesion molecule 4,22920,2165,0.79 [0.73-0.85],5.8031444505195957e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ICAM5,Intercellular adhesion molecule 5,22943,2160,1.29 [1.19-1.40],4.4943890240247047e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ICOSLG,ICOS ligand,22833,2139,0.88 [0.72-1.08],0.2236726363571132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ID4,DNA-binding protein inhibitor ID-4,19560,1852,1.07 [0.97-1.19],0.1570560213267211
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IDI2,Isopentenyl-diphosphate delta-isomerase 2,22446,2110,1.12 [1.04-1.21],0.0033709706007137
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IDO1,"Indoleamine 2,3-dioxygenase 1",19360,1834,1.12 [1.04-1.20],0.001445884533301
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IDS,Iduronate 2-sulfatase,23215,2189,0.60 [0.40-0.90],0.0142573649871837
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IDUA,Alpha-L-iduronidase,23146,2176,1.66 [1.53-1.80],3.8667562055156665e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,19384,1842,1.75 [1.58-1.94],8.020968564844103e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,19560,1852,1.01 [0.92-1.10],0.849638633653008
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,19560,1852,1.11 [0.99-1.24],0.0653910265878043
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IFNAR1,Interferon alpha/beta receptor 1,19848,1888,1.18 [0.99-1.40],0.0571816855138224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IFNG,Interferon gamma,22537,2110,1.03 [1.00-1.07],0.0901666109582963
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IFNGR1,Interferon gamma receptor 1,23025,2168,1.14 [0.96-1.36],0.130813393351741
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IFNGR2,Interferon gamma receptor 2,22750,2153,1.49 [1.39-1.59],7.262933023154249e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IFNL1,Interferon lambda-1,22446,2110,1.16 [1.07-1.26],0.0005212552395057
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IFNL2,Interferon lambda-2,19272,1835,1.01 [0.94-1.09],0.7594928116295986
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IFNLR1,Interferon lambda receptor 1,22920,2165,1.34 [1.22-1.47],2.996313188983005e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IFNW1,Interferon omega-1,19234,1836,1.01 [0.89-1.14],0.9235185224004788
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IFT20,Intraflagellar transport protein 20 homolog,19370,1843,1.05 [0.95-1.16],0.3753272007215259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGBP1,Immunoglobulin-binding protein 1,19874,1884,1.05 [0.98-1.12],0.1979353995839975
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,19272,1835,0.98 [0.90-1.08],0.719783451455926
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,19921,1897,0.65 [0.55-0.76],6.189959230852821e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGF1R,Insulin-like growth factor 1 receptor,22833,2139,1.36 [1.14-1.61],0.0005011685092396
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,19234,1836,0.99 [0.89-1.10],0.8607154577695578
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGF2R,Cation-independent mannose-6-phosphate receptor,22954,2166,2.26 [1.94-2.63],1.1874791309327167e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGFBP1,Insulin-like growth factor-binding protein 1,23201,2191,0.80 [0.78-0.83],2.1496707347810297e-44
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGFBP2,Insulin-like growth factor-binding protein 2,23198,2189,0.66 [0.62-0.71],1.5820192816375187e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGFBP3,Insulin-like growth factor-binding protein 3,23056,2165,0.72 [0.65-0.80],2.6312219619514526e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGFBP4,Insulin-like growth factor-binding protein 4,22682,2144,1.39 [1.28-1.50],6.821332849811657e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGFBP6,Insulin-like growth factor-binding protein 6,22868,2152,0.94 [0.83-1.07],0.3429152962251686
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGFBP7,Insulin-like growth factor-binding protein 7,23232,2193,1.80 [1.64-1.98],3.8887506894504455e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGFBPL1,Insulin-like growth factor-binding protein-like 1,22943,2160,1.83 [1.66-2.02],1.57972805521976e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGFL4,Insulin growth factor-like family member 4,19320,1836,1.00 [0.94-1.06],0.9317714608952852
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGHMBP2,DNA-binding protein SMUBP-2,19234,1836,1.05 [0.97-1.14],0.2337077681984614
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGLC2,Immunoglobulin lambda constant 2,19909,1888,1.42 [1.24-1.63],5.24299613619299e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGLON5,IgLON family member 5,19204,1817,0.94 [0.89-0.99],0.0218704481859779
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGSF21,Immunoglobulin superfamily member 21,19360,1834,1.02 [0.91-1.14],0.7545196773744478
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGSF3,Immunoglobulin superfamily member 3,22833,2139,2.27 [2.14-2.41],1.0274023938274142e-164
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGSF8,Immunoglobulin superfamily member 8,22943,2160,1.75 [1.56-1.96],2.524238347695952e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGSF9,Protein turtle homolog A,19913,1888,1.72 [1.65-1.80],4.015480571368805e-122
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IKBKG,NF-kappa-B essential modulator,22920,2165,1.05 [1.01-1.10],0.0164957663918092
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IKZF2,Zinc finger protein Helios,22405,2098,1.00 [0.95-1.05],0.955609067034221
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL10,Interleukin-10,22537,2110,1.11 [1.06-1.16],2.389905651593237e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL10RA,Interleukin-10 receptor subunit alpha,22537,2110,1.01 [0.95-1.08],0.6748447067192745
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL10RB,Interleukin-10 receptor subunit beta,23025,2168,1.88 [1.69-2.09],2.646612900107833e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL11,Interleukin-11,22537,2110,0.96 [0.90-1.03],0.2569124954125497
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL12A_IL12B,Interleukin-12,22833,2139,1.21 [1.15-1.27],7.157235145390456e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL12B,Interleukin-12 subunit beta,23215,2189,1.31 [1.22-1.40],1.16467783019231e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL12RB1,Interleukin-12 receptor subunit beta-1,22537,2110,1.61 [1.45-1.78],5.117356352278132e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL12RB2,Interleukin-12 receptor subunit beta-2,19320,1836,1.09 [0.98-1.22],0.1073521498061683
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL13,Interleukin-13,22537,2110,0.96 [0.89-1.05],0.3851561288591741
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL13RA1,Interleukin-13 receptor subunit alpha-1,22655,2125,1.68 [1.43-1.97],2.508218876341963e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL13RA2,Interleukin-13 receptor subunit alpha-2,19272,1835,1.02 [0.88-1.19],0.77525731367819
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL15,Interleukin-15,22920,2165,1.13 [1.01-1.27],0.0357436603826298
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL15RA,Interleukin-15 receptor subunit alpha,22537,2110,1.24 [1.11-1.38],0.0001396247987562
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL16,Pro-interleukin-16,23215,2189,1.22 [1.12-1.32],2.2751747521501943e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL17A,Interleukin-17A,22490,2105,1.15 [1.06-1.24],0.0007479169059776
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL17C,Interleukin-17C,22537,2110,1.17 [1.11-1.23],1.2238401012009643e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL17D,Interleukin-17D,22537,2110,0.92 [0.81-1.04],0.1690354256172683
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL17F,Interleukin-17F,22537,2110,0.99 [0.94-1.05],0.829447086990909
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL17RA,Interleukin-17 receptor A,22954,2166,1.22 [1.12-1.32],3.680405019299217e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL17RB,Interleukin-17 receptor B,22636,2144,0.73 [0.68-0.79],1.3568789193313293e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL18,Interleukin-18,22828,2152,1.45 [1.34-1.57],3.225121206302803e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL18BP,Interleukin-18-binding protein,23056,2165,1.75 [1.56-1.96],2.988556103473825e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL18R1,Interleukin-18 receptor 1,23215,2189,3.35 [3.02-3.72],8.986594133164359e-114
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL18RAP,Interleukin-18 receptor accessory protein,22601,2137,0.99 [0.97-1.01],0.4820280151751933
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL19,Interleukin-19,22370,2112,1.14 [1.09-1.20],9.308138737972585e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL1A,Interleukin-1 alpha,22537,2110,1.04 [0.98-1.10],0.2130703266348816
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL1B,Interleukin-1 beta,22434,2100,1.04 [0.98-1.11],0.1971576941402772
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL1R1,Interleukin-1 receptor type 1,22912,2163,2.82 [2.46-3.24],3.487564206375427e-48
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL1R2,Interleukin-1 receptor type 2,22866,2154,3.45 [2.86-4.16],3.812916936949984e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL1RAP,Interleukin-1 receptor accessory protein,22954,2166,0.92 [0.85-1.01],0.0683996252210747
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL1RL1,Interleukin-1 receptor-like 1,23154,2188,1.39 [1.28-1.51],9.978143346230267e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL1RL2,Interleukin-1 receptor-like 2,22537,2110,1.11 [1.00-1.23],0.0517710651810472
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL1RN,Interleukin-1 receptor antagonist protein,22872,2154,1.59 [1.51-1.67],4.917940129941231e-66
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL2,Interleukin-2,22537,2110,0.97 [0.86-1.09],0.6085768669383778
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL20,Interleukin-20,22537,2110,1.00 [0.92-1.09],0.9936132952819614
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL20RA,Interleukin-20 receptor subunit alpha,22537,2110,1.01 [0.93-1.11],0.7663255535854003
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL20RB,Interleukin-20 receptor subunit beta,19320,1836,1.03 [0.92-1.14],0.638191563606379
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL21R,Interleukin-21 receptor,19320,1836,1.04 [0.97-1.12],0.2795965543219075
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL22,Interleukin-22,19841,1877,1.10 [1.04-1.17],0.0017621955625278
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL22RA1,Interleukin-22 receptor subunit alpha-1,22537,2110,1.03 [0.95-1.13],0.4694301898323813
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL24,Interleukin-24,22537,2110,0.96 [0.89-1.04],0.3236147535210916
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL25,Interleukin-25,19132,1809,0.99 [0.86-1.13],0.8562344479176751
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL2RA,Interleukin-2 receptor subunit alpha,22806,2152,1.25 [1.14-1.37],1.1511165500286545e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL2RB,Interleukin-2 receptor subunit beta,22537,2110,1.05 [0.95-1.17],0.3415789582550808
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL2RG,Cytokine receptor common subunit gamma,19841,1877,1.08 [0.96-1.22],0.1888084857115834
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL3,Interleukin-3,19204,1817,1.00 [0.93-1.08],0.9475883342889284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL31,Interleukin-31,19320,1836,1.08 [1.00-1.17],0.0504705221918902
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL31RA,Interleukin-31 receptor subunit alpha,19252,1829,1.29 [1.15-1.46],1.5117835962268978e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL32,Interleukin-32,22920,2165,1.04 [0.96-1.14],0.3378915111689951
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL33,Interleukin-33,22537,2110,1.01 [0.92-1.11],0.8311313553664081
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL34,Interleukin-34,22405,2105,1.11 [1.00-1.24],0.0603815785163349
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL36A,Interleukin-36 alpha,19320,1836,0.98 [0.90-1.06],0.587427879180046
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL36G,Interleukin-36 gamma,19251,1828,1.02 [0.96-1.09],0.4626439417365965
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL3RA,Interleukin-3 receptor subunit alpha,22537,2110,1.29 [1.15-1.45],2.5493599664181875e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL4,Interleukin-4,22537,2110,1.03 [0.98-1.07],0.2732314331323771
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL4R,Interleukin-4 receptor subunit alpha,22920,2165,1.30 [1.17-1.43],3.3704332414710325e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL5,Interleukin-5,22537,2110,0.99 [0.96-1.02],0.3625280892436395
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL5RA,Interleukin-5 receptor subunit alpha,22920,2165,1.15 [1.07-1.22],3.0237539095737264e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL6,Interleukin-6,22833,2139,1.26 [1.21-1.31],1.0198504037233075e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL6R,Interleukin-6 receptor subunit alpha,22832,2147,1.14 [1.02-1.27],0.0256835905300329
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL6ST,Interleukin-6 receptor subunit beta,22943,2160,2.65 [2.16-3.24],2.8320013649242745e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL7,Interleukin-7,22920,2165,1.01 [0.95-1.07],0.683167104108352
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL7R,Interleukin-7 receptor subunit alpha,22954,2166,0.87 [0.81-0.94],0.000228651492039
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL9,Interleukin-9,19560,1852,0.99 [0.92-1.08],0.872479584605587
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,22406,2107,1.10 [1.03-1.18],0.0027402111977572
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IMMT,MICOS complex subunit MIC60,19841,1877,1.60 [1.49-1.73],2.597153270605508e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IMPA1,Inositol monophosphatase 1,22750,2153,0.99 [0.93-1.05],0.7221913315369508
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IMPACT,Protein IMPACT,19860,1881,1.05 [0.97-1.14],0.2159780532953482
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IMPG1,Interphotoreceptor matrix proteoglycan 1,19272,1835,0.95 [0.81-1.10],0.4905896262691513
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ING1,Inhibitor of growth protein 1,22414,2105,1.07 [1.00-1.16],0.0649787831734468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,INHBB,Inhibin beta B chain,19456,1848,1.16 [1.07-1.26],0.0005737167976701
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,INHBC,Inhibin beta C chain,22954,2166,2.06 [1.85-2.29],1.4459606113153618e-41
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,INPP1,Inositol polyphosphate 1-phosphatase,22833,2139,1.05 [0.98-1.13],0.181092314576076
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",19360,1834,1.19 [1.11-1.29],5.129335167269754e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",19874,1884,1.06 [0.95-1.18],0.2875607435283049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",22833,2139,1.06 [1.02-1.11],0.0021304374481064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,INSL3,Insulin-like 3,19860,1881,0.84 [0.80-0.88],1.9609198892903093e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,INSL4,Early placenta insulin-like peptide,19841,1877,1.09 [1.00-1.18],0.0596731132913174
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,INSL5,Insulin-like peptide INSL5,19848,1888,1.12 [1.08-1.17],6.49292502691691e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,INSR,Insulin receptor,19320,1836,1.75 [1.37-2.24],9.664263044498502e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IPCEF1,Interactor protein for cytohesin exchange factors 1,22707,2149,1.09 [1.04-1.14],7.925239116801198e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IQGAP2,Ras GTPase-activating-like protein IQGAP2,22833,2139,1.24 [1.16-1.33],8.41857133245662e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",22530,2127,1.05 [1.00-1.09],0.0297070214788634
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IRAK1,Interleukin-1 receptor-associated kinase 1,22537,2110,1.06 [1.00-1.12],0.0381829431789573
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IRAK4,Interleukin-1 receptor-associated kinase 4,22920,2165,1.03 [0.99-1.07],0.1024957211130453
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,22118,2079,1.07 [0.97-1.19],0.1622306222903976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ISM1,Isthmin-1,22920,2165,1.25 [1.13-1.37],7.311107975795117e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ISM2,Isthmin-2,19921,1897,1.12 [1.01-1.23],0.0247858648256749
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IST1,IST1 homolog,19697,1874,1.05 [1.00-1.10],0.0481607428017228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGA11,Integrin alpha-11,22920,2165,0.69 [0.62-0.77],5.815315235908274e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGA2,Integrin alpha-2,19456,1848,0.80 [0.70-0.91],0.0005819076164297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGA5,Integrin alpha-5,22954,2166,2.98 [2.58-3.44],1.484533744207841e-50
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGA6,Integrin alpha-6,22920,2165,0.95 [0.88-1.03],0.2292317911816904
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGAL,Integrin alpha-L,19320,1836,1.44 [1.30-1.60],2.059182602339666e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGAM,Integrin alpha-M,22954,2166,1.65 [1.47-1.85],8.670600773822462e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGAV,Integrin alpha-V,23146,2176,0.50 [0.40-0.63],1.0975886598457556e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGAX,Integrin alpha-X,19560,1852,1.08 [1.00-1.17],0.0582995805141579
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGB1,Integrin beta-1,22943,2157,1.24 [1.04-1.48],0.0161966129355921
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGB1BP1,Integrin beta-1-binding protein 1,22405,2098,1.11 [1.01-1.22],0.0303841059955156
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGB1BP2,Integrin beta-1-binding protein 2,22530,2127,1.02 [0.98-1.05],0.3005711508181949
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGB2,Integrin beta-2,22828,2164,2.13 [1.89-2.40],2.3802645336298608e-35
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGB5,Integrin beta-5,23005,2159,1.02 [0.93-1.13],0.6303690898251009
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGB6,Integrin beta-6,22537,2110,1.56 [1.37-1.77],6.042807915156029e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGB7,Integrin beta-7,23146,2176,1.38 [1.28-1.49],4.441782336609991e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGBL1,Integrin beta-like protein 1,19921,1897,1.96 [1.79-2.14],1.726540341939141e-49
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,19935,1892,1.12 [0.89-1.41],0.3414134831618575
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,23056,2165,1.13 [1.03-1.25],0.0135301221177624
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,19935,1892,0.97 [0.81-1.16],0.7632173874187238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,19841,1877,1.06 [0.96-1.16],0.249910982139126
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITM2A,Integral membrane protein 2A,22920,2165,0.93 [0.87-0.99],0.0221535529241971
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITPA,Inosine triphosphate pyrophosphatase,19234,1836,1.03 [0.97-1.10],0.3117899012583492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",19360,1834,1.10 [1.03-1.17],0.0031292316836732
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",19272,1835,0.91 [0.82-1.01],0.0732913400075376
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",22446,2110,0.99 [0.92-1.07],0.8050311659650166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IZUMO1,Izumo sperm-egg fusion protein 1,19204,1817,1.02 [0.92-1.12],0.7525265100243225
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,JAM2,Junctional adhesion molecule B,23155,2176,1.26 [1.09-1.44],0.0012209723113217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,JAM3,Junctional adhesion molecule C,19456,1848,1.12 [1.03-1.22],0.0076566603481583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,JCHAIN,Immunoglobulin J chain,22537,2110,1.05 [0.99-1.12],0.1075260644962956
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,19204,1817,1.01 [0.93-1.09],0.8658986008483629
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,JPT2,Jupiter microtubule associated homolog 2,19848,1888,1.03 [0.98-1.09],0.2091055886779107
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,JUN,Transcription factor AP-1,22537,2110,1.08 [1.00-1.17],0.0417708027421293
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,22833,2139,1.07 [0.98-1.16],0.1406973556382185
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KAZN,Kazrin,19848,1888,1.06 [1.02-1.11],0.0058453996902656
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KCNC4,Potassium voltage-gated channel subfamily C member 4,19272,1835,0.98 [0.90-1.07],0.6823772494516024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KCNH2,Potassium voltage-gated channel subfamily H member 2,19370,1843,1.03 [0.97-1.09],0.3633531606221797
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KCNIP4,Kv channel-interacting protein 4,22446,2110,1.02 [0.95-1.10],0.5262131375018059
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KCTD5,BTB/POZ domain-containing protein KCTD5,19476,1846,1.32 [1.21-1.44],4.1306744897051036e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KDM3A,Lysine-specific demethylase 3A,19320,1836,0.99 [0.94-1.05],0.8391873619807406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KDR,Vascular endothelial growth factor receptor 2,23005,2159,1.10 [0.94-1.29],0.2146432831921005
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KEL,Kell blood group glycoprotein,22446,2110,1.21 [1.09-1.34],0.0003541215419194
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KHDC3L,KH domain-containing protein 3,19204,1817,0.97 [0.90-1.04],0.3649580252816029
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KHK,Ketohexokinase,19360,1834,1.61 [1.50-1.73],1.505094565012285e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KIAA0319,Dyslexia-associated protein KIAA0319,19860,1881,0.68 [0.59-0.79],5.386895213213217e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KIAA1549,UPF0606 protein KIAA1549,19560,1852,1.02 [0.95-1.09],0.6295715550916383
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KIAA1549L,UPF0606 protein KIAA1549L,19560,1852,1.00 [0.85-1.17],0.9752909670992598
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KIAA2013,Uncharacterized protein KIAA2013,19841,1877,1.03 [0.95-1.12],0.4221968115276772
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KIF1C,Kinesin-like protein KIF1C,19234,1836,1.15 [1.02-1.30],0.0229274061875522
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KIF20B,Kinesin-like protein KIF20B,19272,1835,1.01 [0.95-1.07],0.7412386949884552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KIF22,Kinesin-like protein KIF22,19234,1836,1.11 [1.07-1.16],1.2219726351809169e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KIFBP,KIF-binding protein,22833,2139,1.07 [1.02-1.12],0.0036730424387986
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,19841,1877,1.06 [1.01-1.11],0.0203624764310826
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,22405,2098,1.04 [0.99-1.10],0.0812883632070626
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,19848,1888,0.98 [0.96-1.01],0.1308652098280546
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,22405,2098,1.00 [0.97-1.03],0.7811994461729839
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,19204,1817,0.97 [0.92-1.03],0.3348161162235412
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KIRREL1,Kin of IRRE-like protein 1,19272,1835,0.97 [0.90-1.06],0.5192460089478298
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KIRREL2,Kin of IRRE-like protein 2,22446,2110,0.94 [0.86-1.03],0.2055996689247818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KIT,Mast/stem cell growth factor receptor Kit,23022,2164,0.70 [0.62-0.80],4.718950418625232e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KITLG,Kit ligand,22943,2160,0.55 [0.50-0.61],5.838307400724052e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLB,Beta-klotho,22446,2110,0.90 [0.85-0.95],5.070329972274968e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLF4,Krueppel-like factor 4,19272,1835,1.17 [1.06-1.30],0.0019288375199208
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLHL41,Kelch-like protein 41,19874,1884,0.98 [0.90-1.07],0.6180493260561631
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLK1,Kallikrein-1,22730,2138,1.00 [0.97-1.03],0.8405532056206066
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLK10,Kallikrein-10,22942,2155,0.92 [0.84-1.01],0.0903022956654656
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLK11,Kallikrein-11,22785,2139,1.11 [0.98-1.25],0.0963871012168212
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLK12,Kallikrein-12,22405,2098,1.01 [0.98-1.04],0.3858812894399342
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLK13,Kallikrein-13,22418,2099,0.89 [0.82-0.97],0.0073253257214437
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLK14,Kallikrein-14,23146,2176,0.79 [0.72-0.85],7.152651007892575e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLK15,Kallikrein-15,19802,1873,1.07 [0.98-1.17],0.1394982706789856
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLK3,Prostate-specific antigen,19921,1897,0.93 [0.90-0.97],0.0005031526362532
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLK4,Kallikrein-4,23146,2176,1.21 [1.14-1.28],2.629744448842904e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLK6,Kallikrein-6,22961,2156,0.91 [0.80-1.03],0.1361575520137857
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLK7,Kallikrein-7,18976,1799,0.74 [0.65-0.83],9.708842869162178e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLK8,Kallikrein-8,22167,2084,0.87 [0.78-0.97],0.0104125960527386
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLKB1,Plasma kallikrein,19521,1849,1.15 [0.96-1.38],0.1300752580786011
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLRB1,Killer cell lectin-like receptor subfamily B member 1,23215,2189,1.83 [1.67-2.01],2.395924754333422e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,19272,1835,1.01 [0.93-1.09],0.8143247504264474
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLRD1,Natural killer cells antigen CD94,23215,2189,1.22 [1.12-1.32],1.3901906316018955e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLRF1,Killer cell lectin-like receptor subfamily F member 1,19320,1836,1.26 [1.17-1.36],1.766500783996184e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLRK1,NKG2-D type II integral membrane protein,19860,1881,1.28 [1.16-1.40],2.705082227501334e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KRT14,"Keratin, type I cytoskeletal 14",21763,2048,0.85 [0.74-0.98],0.0205878208218721
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KRT17,"Keratin, type I cytoskeletal 17",19234,1836,0.92 [0.82-1.03],0.1512285969877994
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KRT18,"Keratin, type I cytoskeletal 18",22833,2139,1.45 [1.40-1.50],2.381064768777477e-85
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KRT19,"Keratin, type I cytoskeletal 19",22878,2161,1.32 [1.25-1.39],1.1965362905448863e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KRT5,"Keratin, type II cytoskeletal 5",22446,2110,0.82 [0.76-0.88],3.183908893774046e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KRT6C,"Keratin, type II cytoskeletal 6C",19234,1836,1.05 [0.93-1.19],0.3972310010554424
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KRT8,"Keratin, type II cytoskeletal 8",19272,1835,1.30 [1.26-1.35],9.86576004146957e-61
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KYAT1,Kynurenine--oxoglutarate transaminase 1,22906,2159,1.09 [1.02-1.16],0.0156236825781773
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KYNU,Kynureninase,23215,2189,1.60 [1.48-1.73],2.1684523323071124e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,L1CAM,Neural cell adhesion molecule L1,23005,2159,1.26 [1.11-1.44],0.0003273871299868
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,19913,1888,1.08 [1.03-1.13],0.0017537651111617
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LACRT,Extracellular glycoprotein lacritin,19805,1869,0.93 [0.84-1.03],0.187663710876228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LACTB2,Endoribonuclease LACTB2,22943,2160,1.04 [0.99-1.11],0.1370549992146576
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAG3,Lymphocyte activation gene 3 protein,22833,2139,1.39 [1.28-1.51],1.2724602336454488e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,22907,2158,1.39 [1.28-1.50],9.676291739185487e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,22750,2153,1.05 [1.01-1.09],0.0085707915685507
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAMA1,Laminin subunit alpha-1,19234,1836,1.03 [0.94-1.12],0.5287247991952074
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAMA4,Laminin subunit alpha-4,23025,2168,1.02 [0.91-1.14],0.7444923983350504
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAMB1,Laminin subunit beta-1,19360,1834,2.31 [2.00-2.68],6.144100048934958e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAMP1,Lysosome-associated membrane glycoprotein 1,19368,1850,1.43 [1.31-1.55],4.701918208537009e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAMP2,Lysosome-associated membrane glycoprotein 2,22244,2097,2.69 [2.23-3.25],8.335674665623596e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAMP3,Lysosome-associated membrane glycoprotein 3,23178,2185,1.16 [1.08-1.25],2.437946542883575e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAMTOR5,Ragulator complex protein LAMTOR5,19841,1877,0.92 [0.82-1.02],0.1250993551644584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAP3,Cytosol aminopeptidase,22537,2110,1.20 [1.11-1.29],3.2218477290317e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LARP1,La-related protein 1,19841,1877,1.10 [1.02-1.17],0.0080394964205394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAT,Linker for activation of T-cells family member 1,23215,2189,1.09 [1.04-1.15],0.0005043700611236
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAT2,Linker for activation of T-cells family member 2,22833,2139,1.06 [1.03-1.10],4.559328334095992e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LATS1,Serine/threonine-protein kinase LATS1,19320,1836,1.11 [1.05-1.16],0.0001249683521568
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAYN,Layilin,22718,2148,1.47 [1.32-1.63],2.1720200874208091e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LBP,Lipopolysaccharide-binding protein,23056,2165,1.28 [1.20-1.36],7.982396819956098e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LBR,Delta(14)-sterol reductase LBR,23155,2176,1.18 [1.12-1.24],1.25157982576838e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LCAT,Phosphatidylcholine-sterol acyltransferase,19935,1893,1.70 [1.38-2.10],5.482235966605532e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LCN15,Lipocalin-15,19874,1884,1.18 [1.11-1.26],1.5172051859529958e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LCN2,Neutrophil gelatinase-associated lipocalin,22265,2090,1.14 [1.03-1.25],0.0081781950741358
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LCP1,Plastin-2,19921,1897,0.87 [0.79-0.96],0.003549030524144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LDLR,Low-density lipoprotein receptor,23008,2173,1.26 [1.18-1.36],2.520046459463795e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LDLRAP1,Low density lipoprotein receptor adapter protein 1,19874,1884,1.05 [1.01-1.10],0.0233854489080745
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LECT2,Leukocyte cell-derived chemotaxin-2,19913,1888,1.22 [1.14-1.30],2.8411673242019142e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LEFTY2,Left-right determination factor 2,23119,2174,1.09 [1.01-1.17],0.0237456792651805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LEG1,Protein LEG1 homolog,18814,1776,0.96 [0.90-1.02],0.1754202201798542
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LELP1,Late cornified envelope-like proline-rich protein 1,19272,1835,1.04 [0.98-1.11],0.1865690719757422
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LEO1,RNA polymerase-associated protein LEO1,19874,1884,1.37 [1.22-1.54],5.9045717166115374e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LEP,Leptin,22943,2160,1.35 [1.27-1.43],1.0553457676942122e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LEPR,Leptin receptor,22943,2160,0.93 [0.82-1.05],0.2196986566194343
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LETM1,Mitochondrial proton/calcium exchanger protein,19874,1884,1.29 [1.20-1.39],2.0139816597692552e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LGALS1,Galectin-1,22943,2160,1.21 [1.09-1.34],0.0004008734854785
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LGALS3,Galectin-3,23018,2170,1.12 [0.98-1.27],0.0864649466739606
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LGALS3BP,Galectin-3-binding protein,19935,1892,2.01 [1.81-2.24],1.7592297281730818e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LGALS4,Galectin-4,22907,2158,2.16 [2.04-2.29],2.473889975367121e-153
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LGALS7_LGALS7B,Galectin-7,22887,2151,0.83 [0.76-0.91],6.305056783595882e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LGALS8,Galectin-8,23155,2176,1.11 [1.05-1.18],0.0005634356377488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LGALS9,Galectin-9,22913,2161,1.65 [1.47-1.85],3.527401900945158e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LGMN,Legumain,23025,2168,1.49 [1.35-1.66],1.0462310096117527e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LHB,Lutropin subunit beta,22405,2098,1.00 [0.96-1.04],0.9933718212209556
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,22948,2159,0.98 [0.92-1.04],0.5436380391617894
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LIF,Leukemia inhibitory factor,22446,2110,1.17 [1.10-1.25],1.406580205766207e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LIFR,Leukemia inhibitory factor receptor,22920,2165,2.82 [2.46-3.23],5.305293423982616e-50
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,22954,2166,1.37 [1.23-1.52],7.831155802097646e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,19921,1897,1.03 [1.00-1.06],0.0941239199593264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,19234,1836,0.99 [0.90-1.08],0.7952083026010166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,22913,2159,1.67 [1.49-1.87],2.388079228463288e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,19913,1888,1.09 [1.03-1.16],0.0027653113516771
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,23232,2193,1.88 [1.64-2.15],3.936505545595348e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,23120,2184,1.46 [1.31-1.63],3.6936994039591365e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,22537,2110,1.26 [1.15-1.37],1.3900758327198558e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,23232,2193,1.01 [0.96-1.07],0.6655054655293431
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LIPF,Gastric triacylglycerol lipase,19360,1834,1.15 [1.07-1.23],0.0001392793657726
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LMNB1,Lamin-B1,19812,1885,1.06 [0.99-1.13],0.1226949863495284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LMNB2,Lamin-B2,19860,1881,1.36 [1.17-1.58],7.966015555569997e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LMOD1,Leiomodin-1,19874,1884,0.96 [0.85-1.09],0.5459988467996391
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LMOD2,Leiomodin-2,19272,1835,1.01 [0.94-1.09],0.7650429820502077
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LONP1,"Lon protease homolog, mitochondrial",19360,1834,1.12 [1.06-1.17],1.569189297641054e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LPA,Apolipoprotein(a),19481,1848,0.97 [0.95-1.00],0.0293545642865919
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LPCAT2,Lysophosphatidylcholine acyltransferase 2,22833,2139,1.15 [1.07-1.23],0.0001256991423709
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LPL,Lipoprotein lipase,22943,2160,0.56 [0.53-0.60],2.2209695874863606e-76
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LPO,Lactoperoxidase,22139,2105,1.43 [1.35-1.52],1.4273325683380984e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LPP,Lipoma-preferred partner,19234,1836,1.03 [0.96-1.10],0.4089957038344824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,19234,1836,1.21 [1.14-1.29],1.258046363628797e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,19370,1843,1.01 [0.92-1.12],0.8063131731284576
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRG1,Leucine-rich alpha-2-glycoprotein,19935,1892,1.01 [0.86-1.19],0.8942877759692557
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,23084,2173,1.21 [1.09-1.34],0.0004927628087042
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,19260,1830,1.61 [1.40-1.86],3.1799184832017277e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRP1,Prolow-density lipoprotein receptor-related protein 1,22833,2139,0.95 [0.83-1.10],0.5262503630827431
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRP11,Low-density lipoprotein receptor-related protein 11,22943,2160,1.33 [1.21-1.48],2.203885333113118e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRP2,Low-density lipoprotein receptor-related protein 2,19370,1843,0.96 [0.85-1.09],0.5562080451989152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRP2BP,LRP2-binding protein,19370,1843,0.99 [0.94-1.05],0.7849281788759828
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,23155,2176,1.04 [0.97-1.11],0.3042694514138551
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRRC25,Leucine-rich repeat-containing protein 25,22833,2139,1.27 [1.15-1.39],1.1155252722117931e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRRC37A2,Leucine-rich repeat-containing protein 37A2,19848,1888,1.28 [1.16-1.42],1.5039201546943372e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRRC38,Leucine-rich repeat-containing protein 38,19370,1843,1.15 [1.05-1.26],0.0022800763653034
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRRC59,Leucine-rich repeat-containing protein 59,19913,1888,1.15 [1.06-1.26],0.0008066949615047
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,19841,1877,1.17 [1.07-1.27],0.0005937881482664
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRRN1,Leucine-rich repeat neuronal protein 1,22537,2110,0.82 [0.75-0.91],8.106252284248828e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,19370,1843,0.98 [0.88-1.10],0.7477741313998156
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,19874,1884,0.85 [0.72-1.02],0.0782934518828457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LSM1,U6 snRNA-associated Sm-like protein LSm1,22405,2098,0.98 [0.91-1.05],0.5537318565993297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LSM8,U6 snRNA-associated Sm-like protein LSm8,19560,1852,1.02 [0.97-1.08],0.472631676723013
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LSP1,Lymphocyte-specific protein 1,22920,2165,1.29 [1.18-1.41],3.876890695922292e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LTA,Lymphotoxin-alpha,22920,2165,1.11 [1.01-1.23],0.0284711519491914
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LTA4H,Leukotriene A-4 hydrolase,23146,2176,0.98 [0.91-1.04],0.4482669790466761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LTB,Lymphotoxin-beta,19841,1877,1.06 [0.94-1.20],0.3512740351567761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LTBP2,Latent-transforming growth factor beta-binding protein 2,23232,2193,1.24 [1.10-1.39],0.0005214097962261
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LTBP3,Latent-transforming growth factor beta-binding protein 3,22405,2098,1.29 [1.21-1.38],9.959566366662093e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LTBR,Tumor necrosis factor receptor superfamily member 3,22787,2148,1.20 [1.06-1.36],0.0048147610093777
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LTO1,Protein LTO1 homolog,22537,2110,0.99 [0.90-1.08],0.7721653226934918
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LUZP2,Leucine zipper protein 2,19841,1877,0.99 [0.90-1.10],0.8684002666867385
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LXN,Latexin,22638,2141,0.91 [0.86-0.97],0.0013383723399389
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LY6D,Lymphocyte antigen 6D,22799,2148,0.85 [0.77-0.94],0.0020410438084072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LY75,Lymphocyte antigen 75,22920,2165,1.13 [1.02-1.25],0.0152664938978293
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LY9,T-lymphocyte surface antigen Ly-9,22654,2130,1.57 [1.39-1.78],1.2572929320066324e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LY96,Lymphocyte antigen 96,22750,2153,1.43 [1.29-1.57],6.359601097281522e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LYAR,Cell growth-regulating nucleolar protein,22405,2098,1.07 [1.00-1.14],0.0447523924935397
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LYN,Tyrosine-protein kinase Lyn,22833,2139,1.08 [1.03-1.13],0.0017258855539139
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LYPD1,Ly6/PLAUR domain-containing protein 1,22446,2110,1.00 [0.94-1.06],0.9593471838904548
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LYPD3,Ly6/PLAUR domain-containing protein 3,22833,2147,1.60 [1.43-1.79],5.0922588378713653e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LYPD8,Ly6/PLAUR domain-containing protein 8,22405,2098,1.20 [1.12-1.28],2.1499284350577725e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LYPLA2,Acyl-protein thioesterase 2,19272,1835,1.00 [0.96-1.04],0.8495283958550368
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,19370,1843,1.00 [0.96-1.05],0.8656035780535859
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,19935,1892,1.67 [1.33-2.09],7.808414058802963e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LYZL2,Lysozyme-like protein 2,19204,1817,1.09 [0.97-1.23],0.1399074060803752
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LZTFL1,Leucine zipper transcription factor-like protein 1,19456,1848,1.08 [1.02-1.15],0.0142350661854731
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,M6PR,Cation-dependent mannose-6-phosphate receptor,19360,1834,1.18 [1.06-1.31],0.0026641899633058
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,22680,2143,1.29 [1.22-1.37],8.211422882210713e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAEA,E3 ubiquitin-protein transferase MAEA,22405,2098,1.02 [0.93-1.13],0.6283904783315584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAG,Myelin-associated glycoprotein,19370,1843,0.95 [0.87-1.05],0.3008435512154477
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAGEA3,Melanoma-associated antigen 3,19560,1852,1.00 [0.95-1.06],0.8725461956463841
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAGED1,Melanoma-associated antigen D1,22405,2098,1.05 [0.97-1.14],0.2047639473929535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAMDC2,MAM domain-containing protein 2,19913,1888,1.29 [1.14-1.45],7.278040247526726e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAMDC4,Apical endosomal glycoprotein,19841,1877,1.42 [1.32-1.52],1.1535647424473404e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",19360,1834,1.03 [0.87-1.23],0.7112347762085218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAN2B2,Epididymis-specific alpha-mannosidase,19913,1888,1.38 [1.28-1.48],5.78608676470929e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",19204,1817,0.95 [0.87-1.03],0.2216728972315596
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MANF,Mesencephalic astrocyte-derived neurotrophic factor,23025,2168,1.02 [0.99-1.06],0.1326370203577318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MANSC1,MANSC domain-containing protein 1,23005,2159,0.97 [0.85-1.12],0.7095389896251787
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MANSC4,MANSC domain-containing protein 4,19234,1836,1.11 [1.04-1.18],0.0019015810937178
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,19272,1835,0.96 [0.84-1.11],0.5906283372030221
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,19234,1836,1.06 [0.99-1.13],0.0962963429396512
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAP2,Microtubule-associated protein 2,19860,1881,1.23 [1.13-1.33],2.2885644612440024e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,19848,1888,1.05 [0.98-1.12],0.1910694941715456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,22920,2165,1.00 [0.96-1.04],0.9919096363619178
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,22405,2098,1.02 [0.98-1.06],0.3325022040122575
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,22718,2148,1.04 [1.00-1.07],0.0389187089365453
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAPK13,Mitogen-activated protein kinase 13,19204,1817,1.15 [1.05-1.26],0.0039252098488232
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAPK9,Mitogen-activated protein kinase 9,22920,2165,1.06 [0.97-1.15],0.2343671059306795
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAPKAPK2,MAP kinase-activated protein kinase 2,19560,1852,1.06 [1.00-1.13],0.0428932470737302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAPRE3,Microtubule-associated protein RP/EB family member 3,19204,1817,1.01 [0.98-1.04],0.5730566062976179
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAPT,Microtubule-associated protein tau,22446,2110,1.02 [0.95-1.10],0.5737343447546255
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MARCO,Macrophage receptor MARCO,22943,2160,1.58 [1.37-1.83],1.12433518405017e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MARS1,"Methionine--tRNA ligase, cytoplasmic",19425,1846,1.07 [1.02-1.13],0.0071344819670935
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MASP1,Mannan-binding lectin serine protease 1,22718,2148,2.08 [1.77-2.45],1.1715439464203865e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MATN2,Matrilin-2,22943,2163,1.19 [1.04-1.35],0.0086717567772175
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MATN3,Matrilin-3,22707,2149,0.51 [0.45-0.57],8.404157452510515e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAVS,Mitochondrial antiviral-signaling protein,22405,2098,1.03 [0.99-1.08],0.1428384703270987
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAX,Protein max,22446,2110,1.03 [1.00-1.07],0.0758151132928475
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MB,Myoglobin,23232,2193,1.08 [1.01-1.15],0.0248473940637786
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MBL2,Mannose-binding protein C,19654,1859,1.00 [0.96-1.04],0.9803147734139872
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MCAM,Cell surface glycoprotein MUC18,23056,2165,0.80 [0.71-0.90],0.0002603209079286
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",19874,1884,0.97 [0.87-1.08],0.568433696471183
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MCEMP1,Mast cell-expressed membrane protein 1,19320,1836,1.09 [1.04-1.15],0.0004208001042258
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MCFD2,Multiple coagulation factor deficiency protein 2,22824,2149,1.11 [1.02-1.21],0.0136557894257812
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MCTS1,Malignant T-cell-amplified sequence 1,19848,1888,0.93 [0.79-1.10],0.4133675328575492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,22750,2153,1.18 [1.12-1.25],1.4144931674150602e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MDH1,"Malate dehydrogenase, cytoplasmic",19830,1878,1.08 [0.97-1.20],0.1789244691258552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MDK,Midkine,22929,2152,1.25 [1.17-1.34],1.4249399921783727e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MDM1,Nuclear protein MDM1,19370,1843,1.00 [0.86-1.15],0.9488293511319884
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",19360,1834,1.08 [1.03-1.13],0.0011224615057295
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MED18,Mediator of RNA polymerase II transcription subunit 18,22405,2098,1.02 [0.97-1.07],0.439685798872759
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MED21,Mediator of RNA polymerase II transcription subunit 21,19234,1836,1.04 [0.94-1.14],0.4494488994534149
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MEGF10,Multiple epidermal growth factor-like domains protein 10,22907,2158,0.95 [0.86-1.04],0.2634734371356415
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MEGF11,Multiple epidermal growth factor-like domains protein 11,19234,1836,1.07 [0.94-1.23],0.3083866920724118
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MEGF9,Multiple epidermal growth factor-like domains protein 9,23154,2188,1.67 [1.41-1.97],1.6021851424428384e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MELTF,Melanotransferrin,19913,1888,0.99 [0.85-1.14],0.8392890052324424
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MENT,Protein MENT,19456,1848,0.31 [0.26-0.37],2.488051464183614e-39
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MEP1A,Meprin A subunit alpha,19848,1888,1.30 [1.23-1.38],1.4665849619539601e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MEP1B,Meprin A subunit beta,22943,2160,0.99 [0.96-1.03],0.6383839478936284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MEPE,Matrix extracellular phosphoglycoprotein,22907,2158,0.66 [0.57-0.76],3.9512791130492666e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MERTK,Tyrosine-protein kinase Mer,23215,2189,1.39 [1.20-1.61],1.4965111937056922e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MESD,LRP chaperone MESD,22954,2166,1.03 [1.00-1.06],0.0776174217063091
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MET,Hepatocyte growth factor receptor,23006,2177,0.36 [0.29-0.43],1.9715159174815635e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,METAP1,Methionine aminopeptidase 1,22446,2110,1.04 [0.91-1.19],0.5430410558744829
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",22920,2165,1.08 [1.03-1.13],0.0006187915708458
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,METAP2,Methionine aminopeptidase 2,23119,2174,1.14 [1.07-1.23],0.0001380080547314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MFAP3,Microfibril-associated glycoprotein 3,22530,2127,1.04 [0.96-1.13],0.3521861858013828
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MFAP3L,Microfibrillar-associated protein 3-like,19370,1843,0.98 [0.91-1.05],0.5434362447144613
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MFAP4,Microfibril-associated glycoprotein 4,19456,1848,1.84 [1.60-2.10],1.1643213688475222e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MFAP5,Microfibrillar-associated protein 5,23232,2193,1.09 [0.99-1.19],0.0790153663068103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MFGE8,Lactadherin,22954,2166,1.82 [1.69-1.97],7.239671285987035e-53
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MGLL,Monoglyceride lipase,22989,2166,1.03 [0.99-1.08],0.1650815046977235
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MGMT,Methylated-DNA--protein-cysteine methyltransferase,22920,2165,1.03 [0.99-1.06],0.1050905122623999
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MIA,Melanoma-derived growth regulatory protein,23005,2159,0.77 [0.70-0.86],2.304353338831369e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MICALL2,MICAL-like protein 2,19370,1843,1.07 [1.00-1.14],0.0435461665207854
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,22920,2165,1.07 [1.04-1.10],9.402859865030948e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MIF,Macrophage migration inhibitory factor,22908,2159,1.06 [1.00-1.12],0.0596703739266331
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MILR1,Allergin-1,22537,2110,1.37 [1.28-1.48],4.3403158173325866e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,19841,1877,1.04 [1.00-1.08],0.0714208271251748
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MINK1,Misshapen-like kinase 1,19860,1881,1.08 [1.03-1.14],0.0009176402058976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MITD1,MIT domain-containing protein 1,22750,2153,1.04 [1.00-1.08],0.0718918100613343
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MKI67,Proliferation marker protein Ki-67,19320,1836,1.12 [1.01-1.24],0.0286616910587089
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MLLT1,Protein ENL,19204,1817,0.99 [0.92-1.06],0.6673392243239866
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MLN,Promotilin,22920,2165,1.14 [1.10-1.19],8.78319548246298e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MME,Neprilysin,22833,2139,1.40 [1.33-1.46],4.146129800746769e-47
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MMP1,Interstitial collagenase,22176,2100,1.06 [1.01-1.10],0.0100437413349489
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MMP10,Stromelysin-2,22865,2152,1.14 [1.07-1.22],7.079811660155463e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MMP12,Macrophage metalloelastase,22978,2166,1.51 [1.41-1.61],8.824180516442024e-35
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MMP13,Collagenase 3,22446,2110,0.86 [0.76-0.97],0.0144881770862012
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MMP15,Matrix metalloproteinase-15,19913,1888,1.03 [0.94-1.12],0.541875949680646
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MMP3,Stromelysin-1,22954,2166,0.87 [0.81-0.95],0.0007753277915736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MMP7,Matrilysin,22499,2125,1.71 [1.57-1.85],1.6245113587398166e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MMP8,Neutrophil collagenase,23118,2173,1.23 [1.17-1.29],9.376399158951556e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MMP9,Matrix metalloproteinase-9,22919,2161,1.26 [1.18-1.34],1.9260838984746568e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",19234,1836,1.08 [0.99-1.18],0.0716577535622542
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MN1,Transcriptional activator MN1,19370,1843,1.02 [0.95-1.10],0.5810737181350811
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MNAT1,CDK-activating kinase assembly factor MAT1,19560,1852,1.01 [0.91-1.11],0.8586237867733751
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MNDA,Myeloid cell nuclear differentiation antigen,22907,2156,1.07 [1.03-1.11],0.0002650765419749
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MOCS2,Molybdopterin synthase catalytic subunit,19456,1848,1.14 [1.06-1.21],0.0001502008456311
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MOG,Myelin-oligodendrocyte glycoprotein,23146,2176,0.88 [0.78-0.98],0.0211070926286548
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MORC3,MORC family CW-type zinc finger protein 3,19860,1881,1.16 [0.99-1.35],0.064091495345234
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MORF4L1,Mortality factor 4-like protein 1,19560,1852,1.05 [0.95-1.17],0.3484416368420524
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MORF4L2,Mortality factor 4-like protein 2,19204,1817,1.07 [0.94-1.20],0.3023855768295058
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MORN4,MORN repeat-containing protein 4,19204,1817,1.04 [0.99-1.10],0.1565243801640396
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MPHOSPH8,M-phase phosphoprotein 8,22530,2127,1.06 [1.01-1.11],0.0253700081252305
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MPI,Mannose-6-phosphate isomerase,22833,2139,1.06 [1.01-1.11],0.0140050560056948
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,22989,2166,1.01 [0.96-1.07],0.6033331690014216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MPO,Myeloperoxidase,22954,2166,1.26 [1.16-1.36],5.284467277692562e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MPRIP,Myosin phosphatase Rho-interacting protein,19809,1875,1.11 [1.01-1.22],0.0379258115433856
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MRC1,Macrophage mannose receptor 1,19935,1893,2.15 [1.85-2.49],7.07442301621787e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MRI1,Methylthioribose-1-phosphate isomerase,19370,1843,0.97 [0.90-1.03],0.3175420440762634
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MRPL24,"39S ribosomal protein L24, mitochondrial",19234,1836,1.11 [1.00-1.24],0.0552055733338648
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MRPL28,"39S ribosomal protein L28, mitochondrial",19874,1884,1.07 [0.96-1.20],0.1965733975714445
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MRPL46,"39S ribosomal protein L46, mitochondrial",22446,2110,1.16 [1.01-1.32],0.0290049312374973
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MRPL52,"39S ribosomal protein L52, mitochondrial",19161,1812,0.86 [0.72-1.03],0.0999789834020234
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",19874,1884,1.08 [1.02-1.14],0.0121350538817805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MRPS16,"28S ribosomal protein S16, mitochondrial",19320,1836,1.00 [0.84-1.18],0.9577331801216372
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MSLN,Mesothelin,22794,2133,1.12 [1.05-1.19],0.000344819116509
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MSLNL,Mesothelin-like protein,19370,1843,0.94 [0.83-1.06],0.3217171578658132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MSMB,Beta-microseminoprotein,22925,2168,1.03 [0.98-1.09],0.2874883303011333
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MSR1,Macrophage scavenger receptor types I and II,23155,2176,1.80 [1.67-1.94],1.3859788749873477e-50
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MSRA,Mitochondrial peptide methionine sulfoxide reductase,23005,2159,1.05 [1.00-1.11],0.0532803221617109
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MST1,Hepatocyte growth factor-like protein,19637,1859,1.01 [0.94-1.08],0.851067149661906
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MSTN,Growth/differentiation factor 8,22530,2127,1.13 [1.06-1.22],0.0004322496277527
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MTDH,Protein LYRIC,19320,1836,1.12 [1.07-1.17],4.029977189208126e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",19860,1881,1.16 [0.98-1.36],0.0835625966223511
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,19560,1852,1.06 [1.02-1.10],0.0046877034154146
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MTIF3,"Translation initiation factor IF-3, mitochondrial",19848,1888,1.06 [1.01-1.11],0.0249635220912357
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MTPN,Myotrophin,22530,2127,0.93 [0.82-1.05],0.255697641514113
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MTR,Methionine synthase,19234,1836,1.06 [0.99-1.14],0.0819495788176901
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MTSS1,Protein MTSS 1,19848,1888,1.07 [1.03-1.11],0.0008653932255489
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MTSS2,Protein MTSS 2,19841,1877,1.07 [1.03-1.12],0.0019565867010587
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MTUS1,Microtubule-associated tumor suppressor 1,19560,1852,1.39 [1.30-1.49],1.5824418045844429e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MUC13,Mucin-13,22446,2110,2.04 [1.91-2.17],2.219556191181234e-103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MUC16,Mucin-16,22833,2139,1.03 [1.00-1.05],0.0188416091324399
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MUC2,Mucin-2,19921,1897,1.11 [1.06-1.16],1.6813809613418417e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MUCL3,Mucin-like protein 3,19204,1817,1.10 [0.99-1.21],0.07244159181132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MVK,Mevalonate kinase,22537,2110,1.44 [1.38-1.50],8.126358149596543e-67
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MXRA8,Matrix remodeling-associated protein 8,19456,1848,0.31 [0.27-0.36],3.0565336696704478e-59
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MYBPC1,"Myosin-binding protein C, slow-type",19913,1888,1.15 [1.09-1.21],8.759630337453656e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MYBPC2,"Myosin-binding protein C, fast-type",19360,1834,1.07 [1.02-1.13],0.0043016561202237
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,19874,1884,1.14 [1.07-1.22],6.206152639009326e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MYDGF,Myeloid-derived growth factor,19913,1888,1.08 [1.03-1.13],0.000489529615161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MYH4,Myosin-4,19234,1836,0.98 [0.89-1.08],0.7333236896458273
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MYH7B,Myosin-7B,19204,1817,1.01 [0.91-1.12],0.8585444251269307
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MYH9,Myosin-9,19921,1897,1.06 [1.02-1.11],0.0014366563268824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",19234,1836,1.22 [1.10-1.36],0.0001806782876797
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MYL3,Myosin light chain 3,19360,1834,1.13 [1.06-1.19],3.164865483166163e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MYL4,Myosin light chain 4,19360,1834,1.07 [0.99-1.16],0.0778370492220661
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MYL6B,Myosin light chain 6B,19370,1843,0.96 [0.91-1.01],0.0920542883886234
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",19370,1843,1.13 [1.05-1.22],0.0008281258062717
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MYO6,Unconventional myosin-VI,19874,1884,1.14 [1.03-1.27],0.0156426710775419
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MYO9B,Unconventional myosin-IXb,22537,2110,1.05 [0.99-1.12],0.075097784207215
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MYOC,Myocilin,22954,2166,0.81 [0.74-0.88],1.0207741854316906e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MYOM1,Myomesin-1,19272,1835,1.05 [0.96-1.15],0.3129994913669061
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MYOM2,Myomesin-2,19234,1836,1.10 [1.02-1.19],0.013475742643109
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MYOM3,Myomesin-3,19456,1848,1.04 [0.99-1.09],0.0844702626459152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MZB1,Marginal zone B- and B1-cell-specific protein,22979,2165,1.19 [1.10-1.28],3.636919786545092e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MZT1,Mitotic-spindle organizing protein 1,22405,2098,1.02 [0.94-1.10],0.6850303913818252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NAA10,N-alpha-acetyltransferase 10,19234,1836,1.04 [0.95-1.13],0.4205946549337328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NAA80,N-alpha-acetyltransferase 80,19370,1843,1.04 [1.00-1.08],0.0407859332249725
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NAAA,N-acylethanolamine-hydrolyzing acid amidase,22647,2146,0.88 [0.83-0.94],0.000227928441095
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NACC1,Nucleus accumbens-associated protein 1,19841,1877,1.13 [1.05-1.22],0.0010611541282674
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NADK,NAD kinase,22943,2160,1.19 [1.12-1.26],2.528969362372181e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NAGA,Alpha-N-acetylgalactosaminidase,19287,1830,1.09 [1.01-1.18],0.0206923413927817
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NAGK,N-acetyl-D-glucosamine kinase,19326,1831,0.97 [0.90-1.05],0.4480821675948991
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,19456,1848,3.28 [2.69-3.99],2.355348519646211e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NAMPT,Nicotinamide phosphoribosyltransferase,22405,2098,1.14 [1.07-1.21],3.0466870831640603e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NAP1L4,Nucleosome assembly protein 1-like 4,19805,1883,1.00 [0.90-1.12],0.9418743350922032
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NAPRT,Nicotinate phosphoribosyltransferase,19860,1881,1.04 [0.92-1.18],0.4809969132814773
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NARS1,"Asparagine--tRNA ligase, cytoplasmic",19874,1884,1.11 [1.00-1.22],0.0402514211763097
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NBL1,Neuroblastoma suppressor of tumorigenicity 1,23005,2159,1.47 [1.28-1.69],8.280705812277579e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NBN,Nibrin,22537,2110,1.11 [1.05-1.18],0.0006386768118502
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NCAM1,Neural cell adhesion molecule 1,23056,2165,0.85 [0.76-0.96],0.0085176198105655
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NCAM2,Neural cell adhesion molecule 2,22954,2166,0.89 [0.77-1.02],0.0988641073429451
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NCAN,Neurocan core protein,23155,2176,0.62 [0.56-0.68],2.4245886356232222e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NCF2,Neutrophil cytosol factor 2,22874,2162,1.10 [1.05-1.14],1.7966812563066912e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NCK2,Cytoplasmic protein NCK2,23025,2168,1.03 [0.99-1.07],0.1136580551089719
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NCLN,Nicalin,22537,2110,1.01 [0.94-1.10],0.7153669072220278
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NCR1,Natural cytotoxicity triggering receptor 1,22889,2163,1.32 [1.19-1.45],4.526759319894021e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,19848,1888,1.40 [1.24-1.58],5.8845592516957865e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NCS1,Neuronal calcium sensor 1,23146,2176,1.49 [1.30-1.70],3.5084667808802766e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NDRG1,Protein NDRG1,22446,2110,1.00 [0.94-1.06],0.9479783137269484
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,19841,1877,0.96 [0.88-1.03],0.24705254324378
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,19289,1832,1.15 [1.01-1.30],0.0282079603456259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,19848,1888,1.02 [0.97-1.07],0.4306619035905045
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",22405,2098,1.05 [1.00-1.10],0.0323942721408822
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NEB,Nebulin,19234,1836,1.21 [1.09-1.34],0.0003866959231003
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NECAP2,Adaptin ear-binding coat-associated protein 2,19234,1836,1.01 [0.94-1.08],0.7934680472992909
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NECTIN1,Nectin-1,19320,1836,1.21 [1.06-1.37],0.0039391760592052
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NECTIN2,Nectin-2,22913,2159,1.87 [1.67-2.10],1.691876770390723e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NECTIN4,Nectin-4,23005,2159,1.15 [1.03-1.29],0.0141084574948248
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,19320,1836,1.04 [0.95-1.14],0.4242411559520701
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NEDD9,Enhancer of filamentation 1,19320,1836,1.15 [1.02-1.30],0.0258401474466009
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NEFL,Neurofilament light polypeptide,22380,2104,1.29 [1.21-1.38],9.503560755928826e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NEK7,Serine/threonine-protein kinase Nek7,19560,1852,1.06 [1.00-1.13],0.0371353583950312
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NELL1,Protein kinase C-binding protein NELL1,23005,2159,0.82 [0.75-0.90],2.5920902962459648e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NELL2,Protein kinase C-binding protein NELL2,23025,2168,1.35 [1.18-1.53],6.372900786058431e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NENF,Neudesin,19841,1877,1.01 [0.97-1.05],0.5205930824845646
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NEO1,Neogenin,19874,1884,0.98 [0.81-1.19],0.8383108321269905
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NEXN,Nexilin,19935,1893,1.08 [1.01-1.15],0.0193360721078977
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NFASC,Neurofascin,23215,2189,5.59 [5.01-6.24],7.472128030428126e-206
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NFAT5,Nuclear factor of activated T-cells 5,19320,1836,1.04 [0.99-1.10],0.1416355373478833
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",22920,2165,1.04 [1.00-1.08],0.0625596918419114
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",22537,2110,1.34 [1.26-1.41],1.3890037489076502e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NFE2,Transcription factor NF-E2 45 kDa subunit,19360,1834,1.10 [1.04-1.17],0.0012454466354339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NFIC,Nuclear factor 1 C-type,19874,1884,0.98 [0.88-1.08],0.6365193917107244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NFKB1,Nuclear factor NF-kappa-B p105 subunit,19234,1836,1.10 [1.04-1.17],0.0017450857452092
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NFKB2,Nuclear factor NF-kappa-B p100 subunit,19560,1852,0.97 [0.89-1.06],0.491408684349319
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NFKBIE,NF-kappa-B inhibitor epsilon,22405,2098,1.11 [1.03-1.20],0.0073676605757724
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",19848,1888,1.06 [1.01-1.10],0.0100433778085385
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NFX1,Transcriptional repressor NF-X1,19234,1836,1.13 [1.06-1.20],0.0003188831523626
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NFYA,Nuclear transcription factor Y subunit alpha,19234,1836,1.12 [1.02-1.25],0.024052911718012
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NGF,Beta-nerve growth factor,22750,2153,0.98 [0.72-1.35],0.9235665838252972
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NGFR,Tumor necrosis factor receptor superfamily member 16,19913,1888,1.09 [0.95-1.26],0.2262755759364662
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NGRN,Neugrin,19860,1881,1.35 [1.14-1.61],0.0005917412292389
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NHLRC3,NHL repeat-containing protein 3,18992,1799,2.90 [2.52-3.35],3.114160185249289e-48
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NID1,Nidogen-1,22986,2161,1.09 [0.98-1.21],0.1215778454617951
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NID2,Nidogen-2,22954,2166,1.05 [1.00-1.10],0.075650088160419
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NINJ1,Ninjurin-1,22405,2098,1.04 [0.97-1.12],0.2532524363627162
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NIT1,Deaminated glutathione amidase,19360,1834,1.03 [0.92-1.14],0.6342543920653548
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NIT2,Omega-amidase NIT2,19833,1882,1.23 [1.15-1.30],4.1493018926985796e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NLGN1,Neuroligin-1,19370,1843,1.00 [0.94-1.08],0.8954687191048101
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NLGN2,Neuroligin-2,19272,1835,0.98 [0.89-1.08],0.6983913720934318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NME1,Nucleoside diphosphate kinase A,19320,1836,1.22 [0.99-1.51],0.0584793543586317
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NME3,Nucleoside diphosphate kinase 3,22943,2163,0.62 [0.52-0.73],2.2052542504120104e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NMI,N-myc-interactor,19759,1871,1.05 [0.99-1.12],0.0799858273282673
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,22750,2153,1.13 [1.09-1.19],1.8942759594783752e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NMRK2,Nicotinamide riboside kinase 2,19204,1817,0.98 [0.87-1.10],0.7654044980972254
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,19874,1884,1.04 [0.98-1.11],0.2082771456488783
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NOMO1,Nodal modulator 1,22954,2166,2.06 [1.77-2.41],4.489715571693375e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NOP56,Nucleolar protein 56,19234,1836,1.03 [0.99-1.08],0.1020450938821861
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NOS1,"Nitric oxide synthase, brain",22446,2110,1.14 [1.07-1.21],7.678530435712352e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NOS2,"Nitric oxide synthase, inducible",19234,1836,1.05 [0.93-1.17],0.4326722852902138
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NOS3,"Nitric oxide synthase, endothelial",22446,2110,1.40 [1.32-1.48],4.915893473859193e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NOTCH1,Neurogenic locus notch homolog protein 1,23232,2193,2.19 [1.74-2.76],2.0191198839563765e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NOTCH2,Neurogenic locus notch homolog protein 2,19921,1897,0.73 [0.61-0.89],0.0013844232120491
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NOTCH3,Neurogenic locus notch homolog protein 3,23232,2193,0.65 [0.58-0.73],1.457954109537741e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NPC2,NPC intracellular cholesterol transporter 2,19582,1865,1.81 [1.63-2.02],2.5269818257542088e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NPDC1,Neural proliferation differentiation and control protein 1,22943,2160,1.19 [1.07-1.34],0.001864073619613
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NPHS1,Nephrin,19320,1836,1.13 [0.99-1.28],0.0799823665152349
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NPHS2,Podocin,19320,1836,1.05 [1.00-1.09],0.0297419529603816
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NPL,N-acetylneuraminate lyase,19913,1888,1.30 [1.19-1.42],1.5634124034496673e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NPPB,Natriuretic peptides B,22530,2127,1.05 [1.02-1.08],0.0003016569776487
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NPPC,C-type natriuretic peptide,22920,2165,1.18 [1.11-1.26],4.481316688162824e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NPR1,Atrial natriuretic peptide receptor 1,19234,1836,1.02 [0.91-1.14],0.7662790685815764
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NPTN,Neuroplastin,22405,2098,1.01 [0.96-1.06],0.6028536262941202
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NPTX1,Neuronal pentraxin-1,22954,2166,1.37 [1.25-1.49],9.34363007966496e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NPTX2,Neuronal pentraxin-2,19921,1897,1.03 [0.90-1.17],0.6931194841618276
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NPTXR,Neuronal pentraxin receptor,22943,2160,0.88 [0.78-0.98],0.0180358765918657
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NPY,Pro-neuropeptide Y,23146,2176,1.49 [1.40-1.58],1.541124414799783e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NRCAM,Neuronal cell adhesion molecule,22943,2160,2.86 [2.56-3.19],4.009419730438899e-80
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NRGN,Neurogranin,19935,1893,1.03 [0.98-1.08],0.2244126180587196
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NRN1,Neuritin,19874,1884,1.03 [0.91-1.17],0.6212976743417733
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NRP1,Neuropilin-1,23093,2169,2.04 [1.78-2.34],9.14740473212019e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NRP2,Neuropilin-2,22954,2166,1.08 [0.95-1.23],0.2586682582288672
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NRTN,Neurturin,22537,2110,1.04 [0.97-1.13],0.284460774317119
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NRXN3,Neurexin-3,19370,1843,0.93 [0.81-1.06],0.2623852586693006
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NSFL1C,NSFL1 cofactor p47,23155,2176,1.05 [0.99-1.12],0.0788093201157162
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",19913,1888,1.02 [0.97-1.09],0.4284703562132161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NT5C1A,Cytosolic 5'-nucleotidase 1A,19860,1881,1.44 [1.29-1.60],1.1288133835045762e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NT5C3A,Cytosolic 5'-nucleotidase 3A,22879,2162,0.98 [0.94-1.03],0.402052217952459
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NT5E,5'-nucleotidase,23005,2159,1.33 [1.24-1.42],1.1965983425130453e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NTF3,Neurotrophin-3,22920,2165,1.16 [1.04-1.29],0.0069699199657112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NTF4,Neurotrophin-4,22405,2098,0.90 [0.81-1.02],0.0879516752276693
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NTRK2,BDNF/NT-3 growth factors receptor,22943,2160,1.60 [1.38-1.86],3.377548895472389e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NTRK3,NT-3 growth factor receptor,23155,2176,0.45 [0.38-0.54],1.4237191868822537e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NTproBNP,N-terminal prohormone of brain natriuretic peptide,22943,2160,1.04 [1.01-1.08],0.0171454027702787
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NUB1,NEDD8 ultimate buster 1,22920,2165,1.03 [0.99-1.08],0.1700066372864971
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,19841,1877,1.01 [0.96-1.05],0.7536440318111071
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NUCB2,Nucleobindin-2,23113,2173,1.23 [1.12-1.36],3.84789075266632e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NUDC,Nuclear migration protein nudC,23215,2189,1.11 [1.04-1.18],0.0009381854628868
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,19360,1834,0.97 [0.80-1.16],0.7164724580935828
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,19234,1836,0.99 [0.90-1.08],0.8109242103437587
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NUDT16,U8 snoRNA-decapping enzyme,19816,1886,1.09 [1.04-1.15],0.0003922525188133
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],22833,2139,0.90 [0.84-0.97],0.0040236816875146
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NUDT5,ADP-sugar pyrophosphatase,22954,2166,1.17 [1.08-1.26],4.933953252566693e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NUMB,Protein numb homolog,19320,1836,1.11 [1.05-1.17],0.0002727060742909
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NUP50,Nuclear pore complex protein Nup50,19234,1836,1.02 [0.88-1.17],0.8145556252989257
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NXPE4,NXPE family member 4,19234,1836,0.98 [0.85-1.13],0.8153152381135971
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NXPH1,Neurexophilin-1,22446,2110,1.01 [0.91-1.11],0.9160218851862908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NXPH3,Neurexophilin-3,19320,1836,0.85 [0.74-0.99],0.0387873798588684
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OBP2B,Odorant-binding protein 2b,22669,2147,0.78 [0.74-0.84],6.275507165052305e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OCLN,Occludin,19874,1884,1.89 [1.74-2.06],1.5894468956612648e-50
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ODAM,Odontogenic ameloblast-associated protein,22405,2105,0.92 [0.86-0.99],0.0297200615046476
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OFD1,Oral-facial-digital syndrome 1 protein,19560,1852,0.97 [0.90-1.04],0.4225505262889503
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OGA,Protein O-GlcNAcase,19848,1888,1.07 [1.01-1.14],0.0228392203880593
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OGFR,Opioid growth factor receptor,22833,2139,0.98 [0.87-1.10],0.6819366679775238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OGN,Mimecan,22954,2166,1.14 [1.04-1.24],0.0048920172871079
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,19560,1852,0.96 [0.89-1.03],0.2308960857847944
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OLFM4,Olfactomedin-4,18731,1771,1.20 [1.15-1.24],4.037473216104562e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OLR1,Oxidized low-density lipoprotein receptor 1,22716,2138,1.16 [1.10-1.23],5.85572963125548e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OMD,Osteomodulin,23025,2168,0.58 [0.53-0.63],2.374148925680972e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OMG,Oligodendrocyte-myelin glycoprotein,22833,2139,0.92 [0.87-0.97],0.003088652650881
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OMP,Olfactory marker protein,19272,1835,0.97 [0.88-1.06],0.4773796973552511
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OPHN1,Oligophrenin-1,19860,1881,1.04 [1.00-1.08],0.0559866835950753
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OPLAH,5-oxoprolinase,19360,1834,1.10 [1.03-1.17],0.0045736330553169
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OPTC,Opticin,22833,2139,0.79 [0.72-0.86],2.2835111579739666e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ORM1,Alpha-1-acid glycoprotein 1,19860,1884,0.92 [0.74-1.15],0.4744067213579263
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OSBPL2,Oxysterol-binding protein-related protein 2,19860,1881,1.04 [0.92-1.16],0.5425600488031945
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OSCAR,Osteoclast-associated immunoglobulin-like receptor,22943,2163,1.27 [1.14-1.42],1.573455356610343e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OSM,Oncostatin-M,22808,2155,1.28 [1.21-1.35],7.413593608436774e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OSMR,Oncostatin-M-specific receptor subunit beta,23093,2169,2.20 [1.81-2.67],9.983124188105329e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OSTN,Osteocrin,19370,1843,1.04 [0.94-1.16],0.4241288880740196
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OTOA,Otoancorin,19272,1835,1.02 [0.94-1.11],0.5556648747750568
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OTUD6B,Deubiquitinase OTUD6B,19848,1888,1.03 [0.95-1.11],0.4629909882166613
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OTUD7B,OTU domain-containing protein 7B,19874,1884,1.12 [1.05-1.21],0.0008810477250954
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",19360,1834,1.02 [0.96-1.08],0.5457495442983453
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OXT,Oxytocin-neurophysin 1,23155,2176,1.15 [1.12-1.18],6.265032450743553e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,P4HB,Protein disulfide-isomerase,22823,2146,1.32 [1.20-1.46],1.3237877264029502e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PACS2,Phosphofurin acidic cluster sorting protein 2,19234,1836,1.09 [1.02-1.17],0.0172767943016684
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PADI2,Protein-arginine deiminase type-2,22537,2110,1.14 [1.08-1.21],5.45026227874753e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PADI4,Protein-arginine deiminase type-4,22405,2105,1.06 [1.01-1.11],0.0143706121389406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PAEP,Glycodelin,22750,2153,1.01 [0.97-1.04],0.7736024821927503
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,19874,1884,1.01 [0.97-1.05],0.5950139734381876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",19560,1852,1.09 [1.00-1.19],0.0573130956476517
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,22530,2127,1.31 [1.23-1.39],8.66555424128815e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PAGR1,PAXIP1-associated glutamate-rich protein 1,19360,1834,1.07 [0.97-1.19],0.1936773246423933
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,19169,1814,1.00 [0.92-1.10],0.9281663158461048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PAK4,Serine/threonine-protein kinase PAK 4,22446,2110,1.07 [1.01-1.13],0.0308114139584191
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PALLD,Palladin,19320,1836,1.07 [0.96-1.19],0.2268634851582658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PALM,Paralemmin-1,19731,1875,0.91 [0.79-1.05],0.2090463494977633
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PALM2,Paralemmin-2,19860,1881,1.91 [1.74-2.10],4.888040147272785e-41
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PALM3,Paralemmin-3,19234,1836,1.06 [1.00-1.13],0.0505308508417115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PAM,Peptidyl-glycine alpha-amidating monooxygenase,23138,2183,0.77 [0.67-0.88],9.270752752630918e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PAMR1,Inactive serine protease PAMR1,22954,2166,2.26 [1.97-2.61],4.776778128047826e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PAPPA,Pappalysin-1,22537,2110,0.99 [0.91-1.08],0.8335438631839085
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PARD3,Partitioning defective 3 homolog,19560,1852,1.05 [0.99-1.11],0.1311589547550123
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PARK7,Parkinson disease protein 7,22954,2166,1.05 [0.98-1.13],0.1750336482999161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PARP1,Poly [ADP-ribose] polymerase 1,22920,2165,1.15 [1.09-1.21],1.693543230754356e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PAXX,Protein PAXX,19456,1848,1.21 [1.10-1.32],7.795685091834018e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PBK,Lymphokine-activated killer T-cell-originated protein kinase,19204,1817,0.97 [0.84-1.11],0.6444665226189912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PBLD,Phenazine biosynthesis-like domain-containing protein,22446,2110,1.36 [1.28-1.46],7.699278837129513e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,19848,1888,1.11 [0.96-1.28],0.1423481670064083
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PCARE,Photoreceptor cilium actin regulator,19272,1835,1.04 [0.99-1.10],0.121435189988424
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,19417,1843,1.81 [1.68-1.95],3.9048443987476444e-53
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PCBP2,Poly(rC)-binding protein 2,19874,1884,1.06 [1.00-1.13],0.0448887193281193
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PCDH1,Protocadherin-1,23140,2178,1.36 [1.15-1.62],0.000358435273039
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PCDH12,Protocadherin-12,19874,1884,1.48 [1.25-1.76],5.259667941481767e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PCDH17,Protocadherin-17,22943,2160,1.86 [1.71-2.03],6.086145312302807e-45
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PCDH7,Protocadherin-7,19848,1888,1.15 [1.03-1.29],0.0156938389852449
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PCDH9,Protocadherin-9,19848,1888,1.59 [1.40-1.81],1.4164850949965205e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PCDHB15,Protocadherin beta-15,19841,1877,1.14 [1.03-1.27],0.0134892424336532
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PCNA,Proliferating cell nuclear antigen,19204,1817,1.05 [0.98-1.12],0.1814115735999352
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PCSK7,Proprotein convertase subtilisin/kexin type 7,19841,1877,1.13 [1.03-1.23],0.0068254989625757
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PCSK9,Proprotein convertase subtilisin/kexin type 9,23232,2193,1.66 [1.51-1.82],9.92977912728688e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PCYT2,Ethanolamine-phosphate cytidylyltransferase,19848,1888,1.17 [1.11-1.24],1.0078270884951057e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDAP1,28 kDa heat- and acid-stable phosphoprotein,19913,1888,1.04 [1.00-1.09],0.0783983192988911
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDCD1,Programmed cell death protein 1,23102,2173,1.34 [1.23-1.47],1.6008601819849503e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDCD1LG2,Programmed cell death 1 ligand 2,22833,2139,1.55 [1.39-1.73],1.1057591006732035e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDCD5,Programmed cell death protein 5,23155,2176,1.07 [1.01-1.14],0.0297502184380384
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDCD6,Programmed cell death protein 6,22943,2160,1.07 [1.01-1.13],0.0255691574151322
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDCL2,Phosducin-like protein 2,19204,1817,1.07 [0.98-1.16],0.1218766479600558
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",19204,1817,1.01 [0.93-1.11],0.7483398850948786
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",19234,1836,1.01 [0.94-1.09],0.7767595495426753
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",19456,1848,1.04 [1.00-1.09],0.0557879998606882
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDGFA,Platelet-derived growth factor subunit A,23232,2193,1.04 [0.99-1.10],0.099170916770736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDGFB,Platelet-derived growth factor subunit B,23025,2168,1.05 [1.00-1.09],0.043674988301533
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDGFC,Platelet-derived growth factor C,22405,2098,1.20 [1.05-1.38],0.009759744960115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDGFRA,Platelet-derived growth factor receptor alpha,22943,2160,1.53 [1.34-1.74],3.8358738792370865e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDGFRB,Platelet-derived growth factor receptor beta,23232,2193,1.17 [1.05-1.31],0.0039790906777636
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDIA2,Protein disulfide-isomerase A2,19204,1817,1.01 [0.90-1.13],0.8717411513426776
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDIA3,Protein disulfide-isomerase A3,19456,1848,1.29 [1.09-1.52],0.002736986915298
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDIA4,Protein disulfide-isomerase A4,19921,1897,1.08 [1.01-1.16],0.0314004689478735
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDIA5,Protein disulfide-isomerase A5,19204,1817,1.04 [0.97-1.12],0.2534102814488654
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDLIM5,PDZ and LIM domain protein 5,19874,1884,1.03 [0.99-1.07],0.1667854523141561
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDLIM7,PDZ and LIM domain protein 7,23025,2168,1.03 [1.00-1.06],0.0357049221679446
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",22405,2098,1.01 [0.93-1.09],0.8527395191943499
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDRG1,p53 and DNA damage-regulated protein 1,19370,1843,1.04 [0.95-1.13],0.3940736664531524
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,19204,1817,0.99 [0.92-1.08],0.861717501938001
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDZD2,PDZ domain-containing protein 2,19234,1836,1.08 [1.00-1.16],0.0529939851249134
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,19320,1836,1.84 [1.71-1.98],1.425525019010924e-59
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PEAR1,Platelet endothelial aggregation receptor 1,23232,2193,1.17 [0.99-1.38],0.0612839625682824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PEBP1,Phosphatidylethanolamine-binding protein 1,22954,2166,1.07 [1.00-1.14],0.0351274914385715
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PECAM1,Platelet endothelial cell adhesion molecule,22954,2166,1.39 [1.23-1.57],1.10672318423827e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PECR,Peroxisomal trans-2-enoyl-CoA reductase,19360,1834,1.04 [0.89-1.22],0.6207945401006132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PENK,Proenkephalin-A,19456,1848,1.04 [0.91-1.20],0.5485796633839878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PEPD,Xaa-Pro dipeptidase,19935,1893,0.75 [0.64-0.89],0.0007474330224338
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PER3,Period circadian protein homolog 3,19320,1836,1.05 [1.01-1.09],0.0137225840539047
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PF4,Platelet factor 4,19782,1880,1.06 [1.02-1.11],0.0091327500511461
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PFDN2,Prefoldin subunit 2,22446,2110,1.00 [0.93-1.08],0.9600773812438737
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PFDN4,Prefoldin subunit 4,19204,1817,0.97 [0.89-1.06],0.5659547843514318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PFDN6,Prefoldin subunit 6,19370,1843,0.93 [0.86-1.00],0.051605608013866
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",22798,2138,1.06 [1.01-1.11],0.0293303276960432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PGA4,Pepsin A-4,19935,1893,1.12 [1.05-1.19],0.0001905451311866
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",19913,1888,1.08 [0.99-1.17],0.0770108461749605
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PGF,Placenta growth factor,23215,2189,1.90 [1.67-2.16],9.937010192216648e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PGLYRP1,Peptidoglycan recognition protein 1,23120,2184,1.06 [0.97-1.15],0.2049573568387221
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,19681,1864,1.01 [0.86-1.17],0.94727475579078
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PGLYRP4,Peptidoglycan recognition protein 4,19234,1836,1.05 [0.98-1.13],0.1895966841700876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PGM2,Phosphoglucomutase-2,19370,1843,0.95 [0.87-1.02],0.1698431831526951
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PGR,Progesterone receptor,19320,1836,0.97 [0.93-1.02],0.2731062765307295
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PHACTR2,Phosphatase and actin regulator 2,19874,1884,1.04 [1.00-1.08],0.0755390047411103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PHLDB1,Pleckstrin homology-like domain family B member 1,19848,1888,1.11 [1.02-1.21],0.0124783677664303
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PHLDB2,Pleckstrin homology-like domain family B member 2,19204,1817,1.01 [0.96-1.06],0.7264159641876528
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,22750,2153,1.24 [1.08-1.41],0.001473893046175
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,19456,1848,1.32 [1.19-1.47],1.567003013271768e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PI16,Peptidase inhibitor 16,19935,1893,0.83 [0.69-0.99],0.0391054535824018
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PI3,Elafin,22646,2136,1.08 [1.02-1.16],0.0158074278761626
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",19874,1884,1.09 [1.03-1.16],0.0019236720375742
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PIGR,Polymeric immunoglobulin receptor,22657,2133,2.50 [2.28-2.73],3.607083048490671e-88
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,22920,2165,1.06 [1.00-1.12],0.0611336715013996
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,22954,2166,1.57 [1.39-1.78],3.179257456647669e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,19320,1836,1.06 [0.98-1.15],0.166305996185472
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PILRA,Paired immunoglobulin-like type 2 receptor alpha,22954,2166,1.59 [1.45-1.74],2.8574098310988304e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PILRB,Paired immunoglobulin-like type 2 receptor beta,22943,2160,1.38 [1.28-1.48],7.388434126941015e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,19456,1848,0.99 [0.93-1.06],0.8670788448819735
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PITHD1,PITH domain-containing protein 1,19169,1814,1.05 [0.99-1.11],0.0946851424145266
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PKD1,Polycystin-1,19913,1888,2.75 [2.33-3.24],2.368068070623088e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PKD2,Polycystin-2,19234,1836,1.16 [1.08-1.25],3.301588944611143e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PKLR,Pyruvate kinase PKLR,22945,2161,1.02 [0.97-1.08],0.4120840228637926
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PKN3,Serine/threonine-protein kinase N3,19560,1852,1.07 [1.01-1.14],0.0159994843755075
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLA2G10,Group 10 secretory phospholipase A2,22750,2153,1.09 [1.02-1.17],0.0086593060543189
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLA2G15,Phospholipase A2 group XV,23005,2159,2.55 [2.25-2.90],4.625202523165922e-47
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLA2G1B,Phospholipase A2,23199,2191,0.71 [0.65-0.77],2.283215373960302e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLA2G2A,"Phospholipase A2, membrane associated",22926,2161,1.04 [0.97-1.11],0.268890089541384
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLA2G4A,Cytosolic phospholipase A2,23025,2168,1.04 [1.00-1.09],0.0681722313382463
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLA2G7,Platelet-activating factor acetylhydrolase,22954,2166,0.46 [0.41-0.51],7.774631579557518e-49
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLAT,Tissue-type plasminogen activator,23154,2188,1.36 [1.26-1.46],1.3983717901590426e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLAU,Urokinase-type plasminogen activator,22954,2166,1.13 [1.00-1.27],0.0584124653003414
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLAUR,Urokinase plasminogen activator surface receptor,22755,2148,2.19 [1.93-2.48],5.710844668259439e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLB1,"Phospholipase B1, membrane-associated",19860,1881,0.88 [0.82-0.95],0.0009389910209421
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",19320,1836,1.03 [0.92-1.14],0.6422611341998579
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",19860,1881,1.05 [1.01-1.10],0.0200487151282504
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLEKHO1,Pleckstrin homology domain-containing family O member 1,19860,1881,1.16 [1.09-1.23],3.0082231119585045e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLG,Plasminogen,19439,1842,1.41 [1.15-1.74],0.0010566575172665
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLIN1,Perilipin-1,22446,2110,1.30 [1.18-1.43],5.186505296813838e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLIN3,Perilipin-3,22943,2160,1.23 [1.12-1.34],3.4315067147530115e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLPBP,Pyridoxal phosphate homeostasis protein,22943,2160,1.02 [0.97-1.08],0.414239862631792
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLSCR3,Phospholipid scramblase 3,19817,1875,1.23 [1.14-1.33],7.367889698112774e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLTP,Phospholipid transfer protein,23166,2184,0.65 [0.59-0.71],4.0500359981768513e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLXDC1,Plexin domain-containing protein 1,22405,2098,0.97 [0.86-1.10],0.6458700441244675
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLXDC2,Plexin domain-containing protein 2,19860,1881,1.54 [1.36-1.75],2.1509445127215145e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLXNA4,Plexin-A4,22920,2165,1.07 [1.02-1.12],0.0079324161971878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLXNB2,Plexin-B2,23116,2185,5.76 [5.10-6.50],2.4943266893908626e-178
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLXNB3,Plexin-B3,22868,2153,1.13 [1.05-1.22],0.0020103097259146
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,22842,2149,1.01 [0.99-1.03],0.2874299746270714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PMCH,Pro-MCH,19234,1836,1.02 [0.96-1.07],0.5798598264352883
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PMM2,Phosphomannomutase 2,19234,1836,1.06 [0.99-1.14],0.1081135063100567
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PMS1,PMS1 protein homolog 1,19370,1843,1.15 [1.06-1.25],0.0006832938711641
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PMVK,Phosphomevalonate kinase,22409,2109,1.03 [0.99-1.07],0.1280378891821374
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PNLIP,Pancreatic triacylglycerol lipase,19935,1893,1.13 [1.06-1.21],0.0002168143169071
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PNLIPRP1,Inactive pancreatic lipase-related protein 1,19860,1881,1.16 [1.10-1.23],1.2867658950306829e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PNLIPRP2,Pancreatic lipase-related protein 2,22907,2158,1.00 [0.99-1.01],0.9288772549085228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PNMA1,Paraneoplastic antigen Ma1,19360,1834,1.08 [1.00-1.16],0.0656510953512163
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PNMA2,Paraneoplastic antigen Ma2,19272,1835,1.05 [0.95-1.16],0.3419792294432864
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",22537,2110,0.99 [0.95-1.02],0.4342039163858338
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PODXL,Podocalyxin,22833,2139,0.79 [0.62-1.02],0.0704016765778336
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PODXL2,Podocalyxin-like protein 2,23005,2159,0.74 [0.65-0.85],1.359522646250477e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,POF1B,Protein POF1B,19320,1836,1.34 [1.23-1.47],6.672424184024062e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,POLR2A,DNA-directed RNA polymerase II subunit RPB1,19320,1836,1.09 [0.94-1.27],0.2482770602769185
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",22833,2139,1.26 [1.15-1.38],3.888686949766214e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,POMC,Pro-opiomelanocortin,19360,1834,0.97 [0.91-1.03],0.3427304885222896
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PON1,Serum paraoxonase/arylesterase 1,19935,1893,0.57 [0.50-0.66],1.6117657429579548e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PON2,Serum paraoxonase/arylesterase 2,22530,2127,1.33 [1.20-1.48],1.145843895511457e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PON3,Serum paraoxonase/lactonase 3,23025,2168,0.59 [0.56-0.63],2.0591941523628128e-76
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,POSTN,Periostin,19921,1897,0.75 [0.67-0.85],2.4456236902936503e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PPBP,Platelet basic protein,19782,1878,1.06 [1.01-1.12],0.0269166398714405
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PPCDC,Phosphopantothenoylcysteine decarboxylase,23155,2176,1.09 [1.01-1.18],0.0349086919485378
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PPIB,Peptidyl-prolyl cis-trans isomerase B,22972,2168,1.02 [0.98-1.06],0.3542258499321108
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PPIE,Peptidyl-prolyl cis-trans isomerase E,19560,1852,0.99 [0.92-1.06],0.7827229411840984
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",19921,1897,1.06 [0.99-1.13],0.0805902294206607
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PPL,Periplakin,19320,1836,1.21 [1.06-1.38],0.0050101974815007
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PPM1A,Protein phosphatase 1A,22405,2098,0.96 [0.85-1.09],0.5102531675586215
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PPM1B,Protein phosphatase 1B,19320,1836,0.98 [0.91-1.06],0.6256250662352467
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PPM1F,Protein phosphatase 1F,19913,1888,1.04 [0.96-1.12],0.3910015753760562
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PPME1,Protein phosphatase methylesterase 1,22833,2139,1.03 [0.97-1.10],0.3373487360683971
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,19841,1877,1.03 [0.98-1.09],0.2247172929126935
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,23005,2159,1.05 [1.01-1.09],0.0161864761762413
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,19560,1852,1.11 [1.05-1.18],0.0003017029413235
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,19874,1884,1.08 [1.02-1.14],0.0070907071886281
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,19874,1884,1.33 [1.20-1.47],8.184922669639452e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PPP1R2,Protein phosphatase inhibitor 2,22943,2160,1.05 [1.00-1.10],0.0361556015413549
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PPP1R9B,Neurabin-2,23215,2189,1.09 [1.04-1.13],4.059860167218098e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,19848,1888,1.05 [1.01-1.09],0.0103447700545182
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PPP3R1,Calcineurin subunit B type 1,22750,2153,1.06 [0.96-1.16],0.2515819628553651
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PPT1,Palmitoyl-protein thioesterase 1,19370,1843,0.97 [0.91-1.03],0.3213477996137704
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PPY,Pancreatic prohormone,22881,2151,1.08 [1.04-1.12],1.7357953416715453e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PQBP1,Polyglutamine-binding protein 1,22405,2098,1.05 [0.98-1.12],0.1499371087062577
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRAME,Melanoma antigen preferentially expressed in tumors,19204,1817,1.00 [0.84-1.19],0.9604171602561964
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRAP1,Proline-rich acidic protein 1,19921,1897,3.72 [3.28-4.22],1.0081265809429158e-92
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRC1,Protein regulator of cytokinesis 1,19841,1877,1.08 [0.98-1.19],0.1120354209404889
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRCP,Lysosomal Pro-X carboxypeptidase,23085,2181,3.24 [2.97-3.54],1.9073060283621336e-154
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRDX1,Peroxiredoxin-1,22273,2111,0.94 [0.90-0.98],0.0066356813741214
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRDX2,Peroxiredoxin-2,19594,1865,0.97 [0.90-1.04],0.3562806389929663
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",22537,2110,1.13 [1.07-1.19],8.331807706613255e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRDX5,"Peroxiredoxin-5, mitochondrial",23215,2189,1.02 [0.96-1.08],0.4635529381520074
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRDX6,Peroxiredoxin-6,23146,2176,0.84 [0.79-0.89],5.901993732392469e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PREB,Prolactin regulatory element-binding protein,22537,2110,1.45 [1.30-1.62],8.206217928487715e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRELP,Prolargin,22907,2158,0.96 [0.81-1.13],0.6218250389923785
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRG2,Bone marrow proteoglycan,19921,1897,1.02 [0.94-1.11],0.6515966783293556
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRG3,Proteoglycan 3,19921,1897,0.83 [0.77-0.91],3.359182039041887e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,22537,2110,1.08 [1.01-1.16],0.027495292609089
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,19370,1843,0.98 [0.85-1.14],0.8161416900994876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,22943,2160,1.05 [1.00-1.09],0.0620874590798414
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,19819,1877,1.13 [1.07-1.20],1.816075289632721e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRKCQ,Protein kinase C theta type,22537,2110,1.05 [0.96-1.15],0.2852543526566415
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRKD2,Serine/threonine-protein kinase D2,19234,1836,1.00 [0.89-1.11],0.934101501972142
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRKG1,cGMP-dependent protein kinase 1,19456,1848,1.03 [0.99-1.06],0.1579070552235161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,22405,2098,1.13 [1.07-1.19],2.7705290580803e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRL,Prolactin,23155,2176,0.98 [0.93-1.03],0.4273485677770955
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRND,Prion-like protein doppel,19860,1881,1.10 [1.01-1.19],0.0335319131943867
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PROC,Vitamin K-dependent protein C,23022,2164,1.15 [0.99-1.33],0.0657462290253255
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PROCR,Endothelial protein C receptor,19234,1836,0.99 [0.87-1.14],0.9289813410723586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PROK1,Prokineticin-1,22920,2165,1.10 [1.02-1.18],0.011580192887186
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PROS1,Vitamin K-dependent protein S,19935,1892,1.19 [1.00-1.41],0.0515171471379127
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRR4,Proline-rich protein 4,19307,1832,0.99 [0.93-1.06],0.7921652637202828
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRR5,Proline-rich protein 5,19320,1836,1.08 [0.98-1.19],0.1011205298150203
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRRT3,Proline-rich transmembrane protein 3,19360,1834,0.82 [0.73-0.92],0.0010615634381705
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRSS2,Trypsin-2,23056,2165,1.02 [0.95-1.09],0.5674831556902911
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRSS22,Brain-specific serine protease 4,19320,1836,1.21 [1.09-1.35],0.0002984872014425
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRSS27,Serine protease 27,22866,2155,1.20 [1.09-1.32],0.0001374928114697
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRSS53,Serine protease 53,19860,1881,1.01 [0.90-1.12],0.9226334439642682
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRSS8,Prostasin,22836,2149,2.35 [2.16-2.55],2.68228675088798e-89
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,22446,2110,1.00 [0.97-1.04],0.7829951903356688
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRTG,Protogenin,23146,2176,1.60 [1.38-1.85],2.743245082409815e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRTN3,Myeloblastin,22392,2111,1.13 [1.05-1.22],0.0007146562477282
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRUNE2,Protein prune homolog 2,19560,1852,1.49 [1.31-1.69],2.436499478028387e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PSAP,Prosaposin,19734,1880,1.63 [1.42-1.86],1.3796457619826004e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PSAPL1,Proactivator polypeptide-like 1,19848,1888,0.79 [0.72-0.86],9.836830960416841e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PSCA,Prostate stem cell antigen,19848,1888,1.01 [1.00-1.03],0.1007773441080225
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PSG1,Pregnancy-specific beta-1-glycoprotein 1,22750,2153,1.04 [1.00-1.08],0.0339762430959213
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PSIP1,PC4 and SFRS1-interacting protein,22920,2165,1.14 [1.08-1.20],5.94629557062115e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PSMA1,Proteasome subunit alpha type-1,22405,2098,0.97 [0.89-1.06],0.4635483524494038
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PSMC3,26S proteasome regulatory subunit 6A,19204,1817,0.91 [0.78-1.06],0.2322615089330051
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PSMD1,26S proteasome non-ATPase regulatory subunit 1,19874,1884,1.01 [0.93-1.10],0.8390456899643024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PSMD5,26S proteasome non-ATPase regulatory subunit 5,19370,1843,0.97 [0.89-1.06],0.5332274194965205
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PSMD9,26S proteasome non-ATPase regulatory subunit 9,22833,2139,0.98 [0.91-1.04],0.4727963969899093
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PSME1,Proteasome activator complex subunit 1,22707,2152,1.17 [1.06-1.30],0.001913728072016
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PSME2,Proteasome activator complex subunit 2,22650,2143,1.17 [1.05-1.30],0.0037074025349802
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PSMG3,Proteasome assembly chaperone 3,22920,2165,1.11 [1.03-1.19],0.0056548423061759
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PSMG4,Proteasome assembly chaperone 4,19320,1836,1.00 [0.92-1.07],0.9044088031425896
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PSPN,Persephin,22920,2165,1.02 [0.98-1.07],0.2877962828206492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PSRC1,Proline/serine-rich coiled-coil protein 1,22405,2098,1.08 [1.02-1.15],0.0075117133420682
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,18775,1787,1.02 [0.98-1.07],0.3256066810096616
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",22446,2110,0.96 [0.84-1.09],0.4963758774026149
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTGDS,Prostaglandin-H2 D-isomerase,22795,2140,1.41 [1.26-1.58],2.737024474153823e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTGES2,Prostaglandin E synthase 2,19187,1824,1.19 [1.10-1.29],1.547214213906394e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTGR1,Prostaglandin reductase 1,19913,1888,1.40 [1.33-1.47],6.07588670639734e-43
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTH,Parathyroid hormone,19370,1843,1.03 [0.98-1.09],0.2471766872320661
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,22920,2165,1.23 [1.13-1.34],1.3439751741949392e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTK7,Inactive tyrosine-protein kinase 7,22446,2110,1.41 [1.28-1.56],2.8694477414072478e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTN,Pleiotrophin,22530,2127,1.21 [1.12-1.30],4.650652342594412e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTP4A3,Protein tyrosine phosphatase type IVA 3,19320,1836,1.34 [1.24-1.44],2.7521684467551155e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,22750,2153,1.10 [1.05-1.15],9.668650880305216e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,22989,2166,1.02 [0.97-1.06],0.4604149788734336
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,19287,1833,1.05 [0.94-1.18],0.3836240551210093
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTPRB,Receptor-type tyrosine-protein phosphatase beta,19913,1888,2.49 [2.16-2.87],5.568104577657986e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTPRC,Receptor-type tyrosine-protein phosphatase C,19921,1897,1.95 [1.65-2.31],5.490803724600781e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTPRF,Receptor-type tyrosine-protein phosphatase F,23232,2193,0.47 [0.42-0.54],1.8532732090163488e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTPRH,Receptor-type tyrosine-protein phosphatase H,19848,1888,1.31 [1.20-1.43],9.826716544425896e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,19848,1888,1.58 [1.36-1.83],1.4065927143320372e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTPRM,Receptor-type tyrosine-protein phosphatase mu,22883,2160,1.84 [1.58-2.15],6.09815915552027e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,22675,2143,1.01 [0.90-1.13],0.8729605449250342
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTPRR,Receptor-type tyrosine-protein phosphatase R,19860,1881,0.86 [0.76-0.97],0.0126806521432704
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTPRS,Receptor-type tyrosine-protein phosphatase S,23232,2193,0.46 [0.40-0.53],2.6496257992427102e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,19913,1888,1.19 [1.03-1.37],0.0182266973244979
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,19456,1848,1.03 [0.96-1.11],0.4441861652618952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTS,6-pyruvoyl tetrahydrobiopterin synthase,22333,2102,1.59 [1.51-1.69],8.035706641609959e-60
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTTG1,Securin,19560,1852,1.06 [0.95-1.18],0.3133363104206537
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTX3,Pentraxin-related protein PTX3,22920,2165,1.18 [1.09-1.28],6.922436820348276e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PVALB,Parvalbumin alpha,23048,2168,1.01 [0.97-1.04],0.7580883870019366
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PVR,Poliovirus receptor,23155,2176,1.69 [1.54-1.84],2.807885892184177e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PXDNL,Peroxidasin-like protein,19841,1877,1.00 [0.93-1.08],0.930283691482214
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PXN,Paxillin,22446,2110,1.18 [1.11-1.27],1.0812550725699016e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PYDC1,Pyrin domain-containing protein 1,19360,1834,0.73 [0.65-0.83],5.565897375225654e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PYY,Peptide YY,19234,1836,1.35 [1.30-1.41],2.122433044766769e-45
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PZP,Pregnancy zone protein,19935,1892,1.22 [1.08-1.37],0.00094706252694
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,QDPR,Dihydropteridine reductase,22828,2150,1.32 [1.21-1.44],6.786492248735363e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,QPCT,Glutaminyl-peptide cyclotransferase,22960,2168,1.49 [1.30-1.71],1.1427870181822406e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,QSOX1,Sulfhydryl oxidase 1,19535,1846,1.38 [1.28-1.49],1.1002663422204612e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RAB10,Ras-related protein Rab-10,19913,1888,1.05 [0.97-1.14],0.2399244278967575
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RAB11FIP3,Rab11 family-interacting protein 3,19913,1888,1.05 [1.01-1.10],0.0116811309356457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RAB27B,Ras-related protein Rab-27B,19913,1888,1.09 [1.03-1.15],0.0014984857073126
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RAB2B,Ras-related protein Rab-2B,19841,1877,1.03 [0.96-1.10],0.461476984632956
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RAB33A,Ras-related protein Rab-33A,19234,1836,1.05 [0.98-1.12],0.1376062378223282
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RAB37,Ras-related protein Rab-37,22537,2110,0.99 [0.95-1.04],0.7800478333636812
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RAB39B,Ras-related protein Rab-39B,19234,1836,1.06 [1.01-1.10],0.0175321634676843
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,19272,1835,0.98 [0.91-1.05],0.546004538141399
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RAB44,Ras-related protein Rab-44,19841,1877,1.14 [1.05-1.23],0.0010604759340132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RAB6A,Ras-related protein Rab-6A,22920,2165,0.74 [0.68-0.81],8.775080060932041e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RAB6B,Ras-related protein Rab-6B,22446,2110,0.97 [0.89-1.05],0.4643882942746645
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RABEP1,Rab GTPase-binding effector protein 1,19456,1848,1.07 [1.01-1.13],0.0249144012393228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RABEPK,Rab9 effector protein with kelch motifs,22405,2098,1.02 [0.96-1.09],0.4985812009300553
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RABGAP1L,Rab GTPase-activating protein 1-like,22537,2110,1.06 [1.00-1.13],0.0624324074436889
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RAC3,Ras-related C3 botulinum toxin substrate 3,19370,1843,0.98 [0.91-1.05],0.4992659058717663
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RAD23B,UV excision repair protein RAD23 homolog B,22405,2098,1.00 [0.91-1.08],0.9110710085271162
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RAD51,DNA repair protein RAD51 homolog 1,19560,1852,1.00 [0.92-1.08],0.9381847835083604
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RALB,Ras-related protein Ral-B,19320,1836,1.07 [0.91-1.24],0.4198267761588053
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RALY,RNA-binding protein Raly,19841,1877,1.19 [1.10-1.29],6.3226318835910045e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RANBP1,Ran-specific GTPase-activating protein,19360,1834,1.05 [0.96-1.14],0.2950573693193339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RANBP2,E3 SUMO-protein ligase RanBP2,19272,1835,0.99 [0.86-1.14],0.8571260660340634
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RANGAP1,Ran GTPase-activating protein 1,22405,2098,0.96 [0.88-1.05],0.359223940244063
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RAP1A,Ras-related protein Rap-1A,19320,1836,0.98 [0.92-1.04],0.5068194991927599
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RAPGEF2,Rap guanine nucleotide exchange factor 2,19560,1852,0.99 [0.92-1.08],0.8684549215117687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RARRES1,Retinoic acid receptor responder protein 1,22405,2098,1.14 [1.03-1.27],0.0148489007856193
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RARRES2,Retinoic acid receptor responder protein 2,23093,2169,1.37 [1.28-1.47],6.082855392923588e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RASA1,Ras GTPase-activating protein 1,22446,2110,1.08 [0.96-1.22],0.1795049055393709
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,19204,1817,0.98 [0.88-1.09],0.740321845710022
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RASSF2,Ras association domain-containing protein 2,22405,2098,1.11 [1.05-1.18],0.000333333692859
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RBFOX3,RNA binding protein fox-1 homolog 3,19874,1884,1.56 [1.42-1.70],9.809262659640833e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RBKS,Ribokinase,22411,2121,1.25 [1.16-1.35],2.7355596818884528e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RBM17,Splicing factor 45,19874,1884,1.00 [0.95-1.06],0.9086212008312664
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RBM19,Probable RNA-binding protein 19,19234,1836,1.08 [0.99-1.19],0.098833720527986
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RBM25,RNA-binding protein 25,19204,1817,0.97 [0.87-1.07],0.4927897435135433
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RBP1,Retinol-binding protein 1,19370,1843,1.01 [0.95-1.08],0.7049368353516652
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RBP2,Retinol-binding protein 2,22833,2139,1.20 [1.15-1.26],1.4025434465277104e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RBP5,Retinol-binding protein 5,22833,2139,1.70 [1.60-1.81],2.47493336801735e-66
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RBP7,Retinoid-binding protein 7,19848,1888,1.24 [1.17-1.32],6.582724514578968e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RBPMS,RNA-binding protein with multiple splicing,19320,1836,1.05 [0.98-1.12],0.1900057207328317
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RBPMS2,RNA-binding protein with multiple splicing 2,19360,1834,1.09 [1.04-1.14],0.0001357625374577
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RCC1,Regulator of chromosome condensation,19841,1877,1.19 [1.11-1.28],3.210775060129664e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RCOR1,REST corepressor 1,22530,2127,1.11 [1.02-1.21],0.013729286574278
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,19360,1834,1.34 [1.08-1.66],0.0072783738971411
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,REEP4,Receptor expression-enhancing protein 4,19874,1884,1.10 [1.03-1.18],0.0051830525697968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,REG1A,Lithostathine-1-alpha,22827,2144,1.41 [1.32-1.51],1.8781354164478853e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,REG1B,Lithostathine-1-beta,23232,2193,1.26 [1.19-1.34],7.912950364361228e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,REG3A,Regenerating islet-derived protein 3-alpha,23232,2193,1.14 [1.07-1.21],1.6739798081515046e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,REG3G,Regenerating islet-derived protein 3-gamma,19841,1877,1.02 [0.91-1.14],0.7571341375147357
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,REG4,Regenerating islet-derived protein 4,22943,2163,1.76 [1.64-1.89],5.895042556168354e-57
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RELB,Transcription factor RelB,19320,1836,1.03 [0.94-1.12],0.5835346964976158
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RELT,Tumor necrosis factor receptor superfamily member 19L,22954,2166,1.17 [1.03-1.33],0.013209072574552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,REN,Renin,22943,2160,1.49 [1.43-1.54],6.268307455240081e-90
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,REPS1,RalBP1-associated Eps domain-containing protein 1,19320,1836,1.07 [0.96-1.20],0.217326298830162
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,REST,RE1-silencing transcription factor,19204,1817,1.02 [0.90-1.16],0.7410508698102867
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,22833,2139,2.16 [1.95-2.39],3.799013925480698e-48
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RETN,Resistin,22897,2163,1.13 [1.04-1.23],0.0058409744270362
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,REXO2,"Oligoribonuclease, mitochondrial",19234,1836,0.90 [0.81-0.99],0.0389301182407782
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RFC4,Replication factor C subunit 4,19841,1877,1.46 [1.22-1.74],4.268005825987382e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RGCC,Regulator of cell cycle RGCC,19874,1884,1.05 [0.99-1.12],0.0810342754499457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,19560,1852,1.02 [0.95-1.09],0.6500121283310325
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RGMA,Repulsive guidance molecule A,23155,2176,1.05 [0.93-1.18],0.430809763418184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RGMB,RGM domain family member B,23155,2176,0.88 [0.77-1.01],0.0626319865070152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RGS10,Regulator of G-protein signaling 10,19874,1884,1.02 [0.95-1.10],0.5978706700082992
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RGS8,Regulator of G-protein signaling 8,22537,2110,1.02 [0.96-1.08],0.5943499847836504
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RHOC,Rho-related GTP-binding protein RhoC,22628,2143,1.03 [1.00-1.07],0.0482158271406416
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RICTOR,Rapamycin-insensitive companion of mTOR,19320,1836,1.01 [0.92-1.11],0.798692514327037
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,19456,1848,1.61 [1.49-1.74],7.930043196620665e-35
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RILP,Rab-interacting lysosomal protein,23084,2173,1.04 [0.98-1.11],0.2075787475539041
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RILPL2,RILP-like protein 2,19913,1888,1.02 [0.97-1.07],0.4076277888739409
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,19234,1836,1.04 [0.97-1.11],0.2481225743133626
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RLN1,Prorelaxin H1,19874,1884,1.04 [0.95-1.15],0.3909207686407357
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RLN2,Prorelaxin H2,19420,1844,1.00 [0.93-1.08],0.9932908117282704
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RNASE1,Ribonuclease pancreatic,19935,1893,1.67 [1.42-1.95],2.2271438092381758e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RNASE10,Inactive ribonuclease-like protein 10,19360,1834,1.08 [0.99-1.19],0.0986331057018194
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RNASE3,Eosinophil cationic protein,22830,2151,1.05 [1.01-1.08],0.004909629528795
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RNASE4,Ribonuclease 4,19286,1819,1.88 [1.64-2.16],2.1998523032960942e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RNASE6,Ribonuclease K6,19801,1875,1.56 [1.41-1.72],8.179264091302423e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RNASEH2A,Ribonuclease H2 subunit A,19874,1884,1.13 [1.03-1.23],0.0070994967519185
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RNASET2,Ribonuclease T2,23122,2186,2.09 [1.84-2.38],4.1215842547890697e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RNF149,E3 ubiquitin-protein ligase RNF149,19360,1834,1.65 [1.44-1.89],6.247074243823573e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RNF168,E3 ubiquitin-protein ligase RNF168,19320,1836,0.93 [0.83-1.05],0.2588584802414853
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RNF31,E3 ubiquitin-protein ligase RNF31,19320,1836,1.04 [0.92-1.17],0.5205247454738466
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RNF4,E3 ubiquitin-protein ligase RNF4,19560,1852,1.01 [0.94-1.08],0.7616628710840458
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RNF41,E3 ubiquitin-protein ligase NRDP1,22405,2098,1.09 [1.03-1.15],0.0035014960292058
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RNF43,E3 ubiquitin-protein ligase RNF43,19560,1852,1.06 [0.98-1.14],0.1400003632297252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RNF5,E3 ubiquitin-protein ligase RNF5,19360,1834,0.99 [0.93-1.06],0.8538799491729745
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ROBO1,Roundabout homolog 1,22943,2163,2.39 [2.08-2.76],4.175802625795697e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ROBO2,Roundabout homolog 2,23155,2176,1.78 [1.51-2.08],1.6877220688880353e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ROBO4,Roundabout homolog 4,19360,1834,0.97 [0.76-1.25],0.8312005836456853
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,22943,2160,1.02 [0.90-1.14],0.8017359401459994
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RP2,Protein XRP2,22833,2139,1.05 [0.96-1.15],0.2628219277832888
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RPA2,Replication protein A 32 kDa subunit,19320,1836,1.20 [1.05-1.37],0.0069472681696536
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RPE,Ribulose-phosphate 3-epimerase,19560,1852,1.06 [0.99-1.12],0.0806968137734812
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RPGR,X-linked retinitis pigmentosa GTPase regulator,19370,1843,1.00 [0.90-1.12],0.99443833401506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RPL14,60S ribosomal protein L14,19360,1834,1.13 [1.02-1.25],0.0201378668987004
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RPS10,40S ribosomal protein S10,19234,1836,0.99 [0.89-1.11],0.922979730742384
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RRAS,Ras-related protein R-Ras,19370,1843,1.04 [1.00-1.07],0.0324355006363428
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RRM2,Ribonucleoside-diphosphate reductase subunit M2,22405,2098,1.25 [1.17-1.34],1.3068378676584195e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,22405,2098,1.10 [1.04-1.16],0.0013663141020831
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RRP15,RRP15-like protein,19272,1835,1.07 [1.02-1.13],0.004311545859108
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RSPO1,R-spondin-1,22750,2153,0.90 [0.80-1.00],0.060623496979755
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RSPO3,R-spondin-3,23146,2176,0.82 [0.71-0.94],0.0039425524111452
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RTBDN,Retbindin,22833,2139,1.05 [0.93-1.19],0.4077161460684021
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RTKN2,Rhotekin-2,19234,1836,0.99 [0.91-1.08],0.855608023284021
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",19874,1884,1.05 [1.00-1.10],0.061548467741346
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RTN4R,Reticulon-4 receptor,23146,2176,2.62 [2.41-2.85],3.4658181738862096e-114
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RUVBL1,RuvB-like 1,22405,2098,1.01 [0.97-1.05],0.6169176930683624
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RWDD1,RWD domain-containing protein 1,23155,2176,1.07 [1.01-1.13],0.0332090388077385
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RYR1,Ryanodine receptor 1,19234,1836,1.06 [0.93-1.20],0.3924175197595692
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,S100A11,Protein S100-A11,22770,2134,1.14 [1.06-1.23],0.0002494157125208
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,S100A12,Protein S100-A12,22605,2118,1.04 [0.98-1.09],0.1883250083517648
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,S100A13,Protein S100-A13,19320,1836,1.10 [0.97-1.24],0.1317414882848666
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,S100A14,Protein S100-A14,19874,1884,0.80 [0.73-0.87],1.2191837520314135e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,S100A16,Protein S100-A16,22405,2105,0.93 [0.87-1.00],0.0457211179507677
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,S100A3,Protein S100-A3,19841,1877,1.04 [0.95-1.14],0.4157736638607417
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,S100A4,Protein S100-A4,23005,2159,1.06 [0.99-1.13],0.0952406596547492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,S100G,Protein S100-G,19874,1884,1.02 [0.93-1.11],0.6792536955264107
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,S100P,Protein S100-P,22530,2127,1.23 [1.15-1.30],3.107307566108818e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SAA4,Serum amyloid A-4 protein,19935,1892,1.05 [0.92-1.19],0.486813221677928
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SAFB2,Scaffold attachment factor B2,19874,1884,1.29 [1.11-1.50],0.0007645795298392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SAG,S-arrestin,19272,1835,0.95 [0.86-1.04],0.2419927603351302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SAMD9L,Sterile alpha motif domain-containing protein 9-like,22920,2165,1.06 [1.01-1.12],0.0184452825593732
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SAP18,Histone deacetylase complex subunit SAP18,19560,1852,1.00 [0.94-1.06],0.920797446428338
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SARG,Specifically androgen-regulated gene protein,19842,1882,1.07 [1.02-1.11],0.0018534152378435
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SART1,U4/U6.U5 tri-snRNP-associated protein 1,19234,1836,1.19 [1.09-1.31],0.0001770204055661
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SAT1,Diamine acetyltransferase 1,19234,1836,1.00 [0.91-1.10],0.9887519476601248
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SAT2,Thialysine N-epsilon-acetyltransferase,19560,1852,1.23 [1.16-1.30],4.551080843495277e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SATB1,DNA-binding protein SATB1,19874,1884,1.13 [0.98-1.31],0.0962815817371127
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SBSN,Suprabasin,19885,1894,0.68 [0.60-0.77],1.4240587534747055e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCAMP3,Secretory carrier-associated membrane protein 3,22833,2139,1.12 [1.07-1.17],4.438444898934377e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCARA5,Scavenger receptor class A member 5,23155,2176,2.04 [1.80-2.30],5.883541511160984e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCARB1,Scavenger receptor class B member 1,22446,2110,0.95 [0.88-1.02],0.1618921737728997
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCARB2,Lysosome membrane protein 2,22301,2117,1.58 [1.42-1.76],5.644960593208925e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCARF1,Scavenger receptor class F member 1,23232,2193,1.17 [1.08-1.28],0.0002998534681416
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCARF2,Scavenger receptor class F member 2,23155,2176,1.57 [1.38-1.80],3.1929479458759114e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCG2,Secretogranin-2,23051,2170,1.73 [1.55-1.94],7.56921306818461e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCG3,Secretogranin-3,22943,2163,0.83 [0.74-0.93],0.0016047182745433
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCGB1A1,Uteroglobin,22947,2157,0.91 [0.85-0.97],0.0040243746506307
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCGB2A2,Mammaglobin-A,19234,1836,1.04 [0.90-1.21],0.5601588518545948
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCGB3A1,Secretoglobin family 3A member 1,19456,1848,1.02 [0.86-1.21],0.8399224888466204
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCGB3A2,Secretoglobin family 3A member 2,22989,2166,0.93 [0.89-0.98],0.0044920691856144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCGN,Secretagogin,22537,2110,1.35 [1.24-1.47],2.0448634226030287e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCIN,Adseverin,19272,1835,0.96 [0.91-1.03],0.2593781036134562
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCLY,Selenocysteine lyase,23084,2173,1.65 [1.53-1.77],2.858053274356505e-40
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCN2A,Sodium channel protein type 2 subunit alpha,19272,1835,1.04 [0.95-1.14],0.3766173840684668
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCN2B,Sodium channel subunit beta-2,19370,1843,1.09 [0.93-1.27],0.3071691264232118
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCN3A,Sodium channel protein type 3 subunit alpha,19370,1843,1.04 [0.91-1.18],0.5456982943322479
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCN3B,Sodium channel subunit beta-3,19272,1835,0.91 [0.82-1.01],0.0752919165049132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCN4B,Sodium channel subunit beta-4,19360,1834,1.00 [0.90-1.11],0.995681435852528
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCP2,Non-specific lipid-transfer protein,22405,2098,1.04 [0.99-1.09],0.0974392682353045
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCPEP1,Retinoid-inducible serine carboxypeptidase,19295,1829,1.39 [1.28-1.51],1.3413992360203904e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCRG1,Scrapie-responsive protein 1,19913,1888,1.02 [0.87-1.20],0.7755200660347474
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCRIB,Protein scribble homolog,19360,1834,1.08 [1.03-1.13],0.0013434965081823
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCRN1,Secernin-1,22920,2165,1.00 [0.93-1.07],0.961002833930376
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCT,Secretin,19370,1843,1.04 [0.95-1.14],0.4241877841932753
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SDC1,Syndecan-1,22943,2160,1.49 [1.36-1.63],3.1009760940742214e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SDC4,Syndecan-4,22943,2160,0.91 [0.84-0.99],0.0226507419721207
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SDCCAG8,Serologically defined colon cancer antigen 8,19841,1877,1.06 [1.02-1.11],0.0015365599498802
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SDHB,Succinate dehydrogenase,19848,1888,1.11 [1.04-1.18],0.0027377221591028
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SDK2,Protein sidekick-2,19456,1848,1.22 [1.09-1.36],0.0003264195740945
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SEC31A,Protein transport protein Sec31A,19360,1834,1.09 [1.03-1.16],0.0046719717731439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SEL1L,Protein sel-1 homolog 1,19360,1834,1.38 [1.24-1.55],6.672764353685245e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SELE,E-selectin,23232,2193,1.89 [1.75-2.03],4.56463492581099e-63
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SELENOP,Selenoprotein P,19935,1892,1.18 [0.97-1.43],0.0919676942064845
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SELL,L-selectin,19935,1892,0.69 [0.57-0.83],0.0001073822157387
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SELP,P-selectin,23056,2165,1.17 [1.09-1.25],5.101137672127207e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SELPLG,P-selectin glycoprotein ligand 1,22920,2165,2.13 [1.87-2.43],1.661524845866246e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SEMA3F,Semaphorin-3F,22943,2160,1.49 [1.29-1.72],2.9371393657941294e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SEMA3G,Semaphorin-3G,19456,1848,1.17 [1.07-1.29],0.0010531549731498
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SEMA4C,Semaphorin-4C,22833,2139,0.96 [0.84-1.11],0.5872126495938654
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SEMA4D,Semaphorin-4D,23155,2176,1.10 [0.97-1.25],0.1404523181192978
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SEMA6C,Semaphorin-6C,19320,1836,1.25 [1.06-1.46],0.0065119444700043
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SEMA7A,Semaphorin-7A,23154,2188,2.07 [1.89-2.28],1.537275569962243e-51
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SEPTIN3,Neuronal-specific septin-3,19874,1884,1.08 [1.02-1.14],0.0089379189296506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SEPTIN7,Septin-7,19560,1852,1.10 [1.02-1.19],0.0182304651139333
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SEPTIN8,Septin-8,19824,1876,1.26 [1.11-1.43],0.000324290020623
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SEPTIN9,Septin-9,22833,2139,1.06 [0.93-1.21],0.357520527301561
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINA1,Alpha-1-antitrypsin,19564,1853,1.71 [1.00-2.93],0.0512697838130367
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINA11,Serpin A11,23232,2193,1.18 [1.07-1.29],0.0004174547784056
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINA12,Serpin A12,22287,2107,1.12 [1.09-1.15],1.3361586736322097e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINA3,Alpha-1-antichymotrypsin,19873,1883,0.75 [0.56-1.01],0.0562004262376245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINA4,Kallistatin,19576,1847,1.89 [1.57-2.29],4.218825745964726e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINA5,Plasma serine protease inhibitor,19646,1856,1.38 [1.23-1.56],1.2509341204867401e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINA6,Corticosteroid-binding globulin,19935,1892,1.53 [1.16-2.02],0.0028200185705424
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINA7,Thyroxine-binding globulin,19935,1892,1.85 [1.47-2.34],1.9343809680290242e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINA9,Serpin A9,22736,2131,1.25 [1.19-1.32],5.117610580444176e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINB1,Leukocyte elastase inhibitor,22873,2154,1.03 [0.99-1.08],0.1386268740251446
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINB5,Serpin B5,22530,2127,0.97 [0.89-1.05],0.3946150871921938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINB6,Serpin B6,23076,2169,1.03 [0.96-1.09],0.4457271783776039
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINB8,Serpin B8,23215,2189,1.11 [1.05-1.17],0.0004074034368374
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINB9,Serpin B9,22750,2153,1.05 [0.93-1.18],0.4226936505766038
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINC1,Antithrombin-III,19902,1887,0.86 [0.64-1.16],0.3134445497723313
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPIND1,Heparin cofactor 2,19902,1887,2.22 [1.91-2.59],6.028290521083009e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINE1,Plasminogen activator inhibitor 1,23232,2193,1.19 [1.13-1.27],1.89141588300876e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINE2,Glia-derived nexin,19913,1888,1.07 [1.01-1.15],0.0333812230118106
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINF1,Pigment epithelium-derived factor,19628,1863,2.66 [2.29-3.09],6.652794465522721e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINF2,Alpha-2-antiplasmin,19556,1849,1.87 [1.34-2.61],0.0002204217376408
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPING1,Plasma protease C1 inhibitor,19902,1887,1.01 [0.80-1.28],0.9317325002215674
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINH1,Serpin H1,19560,1852,1.07 [1.03-1.11],9.060880334361888e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINI1,Neuroserpin,19425,1846,0.70 [0.60-0.82],1.2868485380283954e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINI2,Serpin I2,19848,1888,1.12 [1.05-1.21],0.0015640124945787
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,22446,2110,1.02 [0.96-1.08],0.5403573294686825
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SETMAR,Histone-lysine N-methyltransferase SETMAR,22665,2146,1.02 [0.90-1.16],0.7797934728052502
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SEZ6,Seizure protein 6 homolog,19370,1843,1.11 [0.97-1.28],0.1365354163281748
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SEZ6L,Seizure 6-like protein,23005,2159,1.09 [0.95-1.25],0.2337136153936061
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SEZ6L2,Seizure 6-like protein 2,22833,2139,0.97 [0.82-1.14],0.6976774611650365
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SF3B4,Splicing factor 3B subunit 4,22833,2139,0.96 [0.91-1.01],0.0897605610265754
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SFRP1,Secreted frizzled-related protein 1,22664,2144,1.24 [1.15-1.35],1.595681159677544e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SFRP4,Secreted frizzled-related protein 4,19456,1848,1.43 [1.28-1.60],2.600742037646436e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SFTPA1,Pulmonary surfactant-associated protein A1,22405,2098,0.96 [0.90-1.03],0.2974484910117917
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SFTPA2,Pulmonary surfactant-associated protein A2,22405,2098,1.00 [0.93-1.07],0.925106153202336
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SFTPD,Pulmonary surfactant-associated protein D,22943,2160,1.13 [1.07-1.19],2.4218950633768675e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SGSH,N-sulphoglucosamine sulphohydrolase,19590,1858,1.34 [1.25-1.45],7.928294423238441e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SH2B3,SH2B adapter protein 3,22405,2098,1.02 [0.98-1.07],0.2323850562367185
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SH2D1A,SH2 domain-containing protein 1A,22920,2165,1.11 [1.05-1.18],0.0003654896024113
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,19272,1835,1.06 [0.99-1.13],0.1207221702899548
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SH3BP1,SH3 domain-binding protein 1,19848,1888,1.14 [1.05-1.24],0.0014442127300998
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SH3GL3,Endophilin-A3,19443,1843,1.01 [0.96-1.07],0.6810416798295027
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SH3GLB2,Endophilin-B2,19860,1881,1.08 [1.01-1.15],0.0172303989625127
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SHBG,Sex hormone-binding globulin,19935,1893,0.58 [0.53-0.63],3.176617368698078e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SHC1,SHC-transforming protein 1,19204,1817,0.96 [0.92-1.00],0.0436190479775411
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SHD,SH2 domain-containing adapter protein D,19200,1830,1.00 [0.95-1.06],0.854779401096774
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SHH,Sonic hedgehog protein,19320,1836,1.13 [1.02-1.25],0.0191918012660769
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SHISA5,Protein shisa-5,19921,1897,1.73 [1.50-2.00],5.62800461165028e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SHMT1,"Serine hydroxymethyltransferase, cytosolic",22989,2166,1.15 [1.10-1.21],5.711137475329742e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SHPK,Sedoheptulokinase,19560,1852,0.99 [0.88-1.10],0.8143537267784283
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIAE,Sialate O-acetylesterase,22964,2156,1.34 [1.24-1.45],3.9890927447186613e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIGLEC1,Sialoadhesin,23025,2168,1.65 [1.51-1.80],6.967091897209433e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIGLEC10,Sialic acid-binding Ig-like lectin 10,22920,2165,1.73 [1.58-1.90],8.224448853094058e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIGLEC15,Sialic acid-binding Ig-like lectin 15,22446,2110,1.00 [0.95-1.06],0.9124748285299256
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIGLEC5,Sialic acid-binding Ig-like lectin 5,22954,2166,1.04 [1.01-1.08],0.0138191406314889
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIGLEC6,Sialic acid-binding Ig-like lectin 6,23146,2176,1.92 [1.73-2.14],4.175648193905259e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIGLEC7,Sialic acid-binding Ig-like lectin 7,22943,2160,2.80 [2.47-3.17],9.00107418106848e-59
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIGLEC8,Sialic acid-binding Ig-like lectin 8,19360,1834,1.56 [1.42-1.72],1.584189691333643e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIGLEC9,Sialic acid-binding Ig-like lectin 9,23111,2175,1.53 [1.36-1.73],3.8646866820433786e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIL1,Nucleotide exchange factor SIL1,19360,1834,1.14 [1.00-1.29],0.0486908458429467
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,23007,2169,1.21 [1.13-1.29],6.474984786256681e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIRPB1,Signal-regulatory protein beta-1,22863,2153,1.32 [1.22-1.43],5.11502999287036e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIRT1,NAD-dependent protein deacetylase sirtuin-1,19320,1836,0.99 [0.94-1.04],0.6844312378027599
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIRT2,NAD-dependent protein deacetylase sirtuin-2,22833,2139,1.04 [1.00-1.09],0.0636668494738334
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",22446,2110,0.99 [0.92-1.06],0.7346724505695492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIT1,Signaling threshold-regulating transmembrane adapter 1,22537,2110,1.56 [1.46-1.67],8.639163111555362e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SKAP1,Src kinase-associated phosphoprotein 1,22718,2148,1.19 [1.13-1.25],2.1299218358956275e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SKAP2,Src kinase-associated phosphoprotein 2,23025,2168,1.06 [1.02-1.10],0.0032148102376675
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SKIV2L,Helicase SKI2W,19234,1836,0.98 [0.87-1.10],0.7356187284675075
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLA2,Src-like-adapter 2,19874,1884,1.06 [1.01-1.10],0.0093153044760097
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLAMF1,Signaling lymphocytic activation molecule,22537,2110,1.36 [1.28-1.46],3.296602620388513e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLAMF6,SLAM family member 6,22405,2098,1.27 [1.15-1.40],9.408859014280284e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLAMF7,SLAM family member 7,22920,2165,1.23 [1.16-1.31],5.3047292829452426e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLAMF8,SLAM family member 8,22405,2098,1.45 [1.35-1.57],1.1038809974079188e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLC12A2,Solute carrier family 12 member 2,19234,1836,1.12 [0.96-1.31],0.157750000098882
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLC13A1,Solute carrier family 13 member 1,19841,1877,1.04 [0.97-1.12],0.2915938237607908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLC16A1,Monocarboxylate transporter 1,22446,2110,1.14 [1.07-1.22],2.657016141967674e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLC1A4,Neutral amino acid transporter A,19370,1843,1.00 [0.91-1.09],0.9526368170826518
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLC27A4,Long-chain fatty acid transport protein 4,22446,2110,1.12 [1.06-1.18],6.723781674076625e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLC28A1,Sodium/nucleoside cotransporter 1,19204,1817,1.09 [1.01-1.17],0.0250747968716331
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLC34A3,Sodium-dependent phosphate transport protein 2C,19204,1817,0.94 [0.85-1.04],0.1977284661533898
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLC39A14,Zinc transporter ZIP14,22446,2110,0.96 [0.85-1.08],0.4624699307038865
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLC39A5,Zinc transporter ZIP5,22920,2165,0.99 [0.92-1.06],0.7648963666959576
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLC44A4,Choline transporter-like protein 4,19370,1843,0.97 [0.90-1.04],0.3804014848101423
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLC4A1,Band 3 anion transport protein,19921,1897,0.94 [0.86-1.03],0.1845439452114558
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLC51B,Organic solute transporter subunit beta,19234,1836,0.99 [0.93-1.06],0.8213257124458136
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,19456,1848,1.06 [1.01-1.12],0.0259369557593158
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,19848,1888,1.25 [1.16-1.34],9.310484750312523e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",19204,1817,1.02 [0.95-1.11],0.567989736353884
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLIT2,Slit homolog 2 protein,22446,2110,1.25 [1.17-1.33],1.2717392729964811e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLITRK1,SLIT and NTRK-like protein 1,19320,1836,0.77 [0.67-0.88],0.0001892210756071
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLITRK2,SLIT and NTRK-like protein 2,23146,2176,1.47 [1.34-1.61],2.8886182876059873e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLITRK6,SLIT and NTRK-like protein 6,22530,2127,1.02 [0.92-1.14],0.7046758458290234
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLK,STE20-like serine/threonine-protein kinase,19560,1852,1.04 [0.98-1.10],0.1601868542737341
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLMAP,Sarcolemmal membrane-associated protein,19848,1888,1.11 [1.06-1.17],2.805681769845587e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLURP1,Secreted Ly-6/uPAR-related protein 1,19778,1883,0.96 [0.85-1.09],0.5191130689587471
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SMAD1,Mothers against decapentaplegic homolog 1,22405,2098,1.08 [1.04-1.14],0.0004117237800427
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SMAD2,Mothers against decapentaplegic homolog 2,19841,1877,1.07 [1.01-1.14],0.0268564075164512
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SMAD3,Mothers against decapentaplegic homolog 3,19841,1877,1.01 [0.93-1.10],0.744510662710538
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SMAD5,Mothers against decapentaplegic homolog 5,22833,2139,0.98 [0.81-1.20],0.8733233754104291
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SMARCA2,Probable global transcription activator SNF2L2,22446,2110,0.97 [0.92-1.02],0.2798052833664881
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SMC3,Structural maintenance of chromosomes protein 3,19204,1817,1.02 [0.93-1.10],0.7129332864743002
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SMNDC1,Survival of motor neuron-related-splicing factor 30,19848,1888,1.15 [1.08-1.22],3.916224896417649e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SMOC1,SPARC-related modular calcium-binding protein 1,23146,2176,1.70 [1.53-1.88],3.5611470259949266e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SMOC2,SPARC-related modular calcium-binding protein 2,23025,2168,1.26 [1.14-1.38],2.4860523834606283e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SMPD1,Sphingomyelin phosphodiesterase,23040,2167,1.31 [1.22-1.41],1.1181951056590321e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SMPD3,Sphingomyelin phosphodiesterase 3,19320,1836,0.94 [0.86-1.02],0.1475261128193161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,22981,2163,0.95 [0.90-1.00],0.0620426388273459
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,19841,1877,1.00 [0.94-1.06],0.912880830683518
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SMS,Spermine synthase,19272,1835,1.03 [0.96-1.10],0.3903099587205105
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SMTN,Smoothelin,19818,1877,1.09 [1.04-1.14],0.0002691147907846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SNAP23,Synaptosomal-associated protein 23,22943,2160,1.06 [1.01-1.10],0.016281927042706
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SNAP25,Synaptosomal-associated protein 25,19272,1835,1.00 [0.92-1.10],0.9487943309905156
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SNAP29,Synaptosomal-associated protein 29,23005,2159,1.06 [1.02-1.11],0.0048828514441407
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SNAPIN,SNARE-associated protein Snapin,19874,1884,0.94 [0.87-1.01],0.0978446408143222
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SNCA,Alpha-synuclein,19456,1848,1.06 [1.02-1.10],0.0033136507314115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SNCG,Gamma-synuclein,22750,2153,1.18 [1.11-1.25],4.9662892666207935e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",19360,1834,1.34 [1.18-1.53],9.389338714936417e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SNRPB2,U2 small nuclear ribonucleoprotein B'',19860,1881,1.21 [1.13-1.31],2.9716215411557735e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SNU13,NHP2-like protein 1,19234,1836,0.99 [0.92-1.06],0.6877683182876171
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SNX15,Sorting nexin-15,19456,1848,1.05 [0.97-1.14],0.2040196232152543
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SNX18,Sorting nexin-18,19848,1888,1.01 [0.92-1.12],0.8330186590682097
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SNX2,Sorting nexin-2,19841,1877,1.06 [1.01-1.11],0.0267352206221484
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SNX5,Sorting nexin-5,19360,1834,1.04 [0.90-1.21],0.576471304623557
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SNX9,Sorting nexin-9,22943,2160,1.07 [1.01-1.13],0.0163733612683671
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SOD1,Superoxide dismutase [Cu-Zn],22501,2113,1.07 [0.99-1.16],0.1027517047757848
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SOD2,"Superoxide dismutase [Mn], mitochondrial",22954,2166,1.21 [1.10-1.32],5.040776550316191e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SOD3,Extracellular superoxide dismutase,19935,1893,0.93 [0.86-1.00],0.0587491070877826
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SORBS1,Sorbin and SH3 domain-containing protein 1,19874,1884,1.19 [1.08-1.31],0.0003453597286403
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SORCS2,VPS10 domain-containing receptor SorCS2,22405,2098,1.25 [1.13-1.40],3.5369172807367746e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SORD,Sorbitol dehydrogenase,23046,2168,1.37 [1.29-1.45],3.255877551737543e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SORT1,Sortilin,22913,2159,1.39 [1.26-1.53],3.132795585477554e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SOST,Sclerostin,22913,2159,1.24 [1.12-1.37],1.9694205432132952e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,19370,1843,1.00 [0.91-1.10],0.9801430681557628
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SOX2,Transcription factor SOX-2,19831,1879,0.96 [0.80-1.16],0.6645176566521194
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SOX9,Transcription factor SOX-9,19370,1843,1.22 [1.03-1.44],0.0208073009380536
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,19874,1884,1.07 [0.93-1.23],0.334887932280433
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPAG1,Sperm-associated antigen 1,19874,1884,1.08 [1.01-1.16],0.0325802932023655
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPARC,SPARC,23005,2159,1.06 [1.00-1.12],0.0357573938976298
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPARCL1,SPARC-like protein 1,22978,2155,0.72 [0.62-0.83],7.71275163383268e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPART,Spartin,19456,1848,1.06 [1.00-1.13],0.0366553946917017
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPESP1,Sperm equatorial segment protein 1,19913,1888,0.96 [0.84-1.09],0.5458513151275424
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPINK1,Serine protease inhibitor Kazal-type 1,22954,2166,1.77 [1.63-1.92],1.166891325349611e-41
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPINK2,Serine protease inhibitor Kazal-type 2,19456,1848,0.80 [0.71-0.91],0.0004492380916184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPINK4,Serine protease inhibitor Kazal-type 4,22920,2165,1.43 [1.36-1.51],1.3849107650884223e-39
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPINK5,Serine protease inhibitor Kazal-type 5,22954,2166,0.83 [0.74-0.93],0.0007825022950571
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPINK6,Serine protease inhibitor Kazal-type 6,23146,2176,1.03 [0.96-1.11],0.4083216044726616
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPINK8,Serine protease inhibitor Kazal-type 8,19234,1836,1.07 [0.94-1.21],0.3069755630021739
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPINT1,Kunitz-type protease inhibitor 1,22866,2156,1.93 [1.71-2.19],2.7325344964608202e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPINT2,Kunitz-type protease inhibitor 2,23025,2168,1.37 [1.25-1.51],6.059425142728211e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPINT3,Kunitz-type protease inhibitor 3,19848,1888,0.95 [0.93-0.98],0.0001517311427293
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPOCK1,Testican-1,22750,2153,0.88 [0.77-1.02],0.0937028308528142
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPON1,Spondin-1,22943,2163,1.69 [1.53-1.86],5.532430111859043e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPON2,Spondin-2,22832,2150,2.02 [1.82-2.25],9.3088909428269e-39
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPP1,Osteopontin,23198,2189,0.95 [0.87-1.03],0.2310173492164747
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",19320,1836,1.06 [0.96-1.17],0.278865850693975
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPRING1,SREBP regulating gene protein,19204,1817,1.03 [0.96-1.11],0.3920512952015994
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPRR1B,Cornifin-B,19560,1852,0.99 [0.93-1.04],0.6150835653883977
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPRR3,Small proline-rich protein 3,19860,1881,1.05 [0.98-1.12],0.2073680603201609
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPRY2,Protein sprouty homolog 2,22537,2110,1.02 [0.98-1.07],0.2942458546147814
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",19272,1835,1.16 [1.01-1.33],0.038263228771394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPTLC1,Serine palmitoyltransferase 1,19860,1881,1.12 [1.00-1.24],0.0407154831303013
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SRC,Proto-oncogene tyrosine-protein kinase Src,22969,2156,1.02 [0.99-1.06],0.1449018863094061
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SRP14,Signal recognition particle 14 kDa protein,22833,2139,1.19 [1.12-1.26],1.8445265374263893e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SRPK2,SRSF protein kinase 2,22920,2165,1.09 [1.05-1.14],5.519888518739172e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SRPX,Sushi repeat-containing protein SRPX,19913,1888,1.23 [1.09-1.38],0.000628944942244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SSB,Lupus La protein,22446,2110,0.98 [0.92-1.05],0.6029950947713232
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",19320,1836,1.09 [0.96-1.23],0.1879337775095531
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,22913,2159,1.13 [1.10-1.17],2.656928844583676e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,23056,2165,1.74 [1.60-1.90],9.048381003399636e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SSH3,Protein phosphatase Slingshot homolog 3,19204,1817,0.95 [0.82-1.11],0.5344956311499472
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SSNA1,Sjoegren syndrome nuclear autoantigen 1,19848,1888,1.15 [1.06-1.24],0.0009061383996041
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ST13,Hsc70-interacting protein,19456,1848,1.07 [0.99-1.16],0.0875625205416125
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",22833,2139,0.95 [0.87-1.04],0.3149150610475184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",23232,2193,1.57 [1.41-1.75],8.60713393331874e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",19320,1836,0.99 [0.90-1.09],0.8618621328982918
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STAB2,Stabilin-2,19921,1897,2.09 [1.79-2.45],7.043512478598948e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STAM,Signal transducing adapter molecule 1,19841,1877,1.00 [0.88-1.13],0.968387331481745
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STAMBP,STAM-binding protein,22718,2148,1.05 [0.99-1.12],0.1027958614714317
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STAT2,Signal transducer and activator of transcription 2,19320,1836,1.08 [1.02-1.15],0.0076080065658897
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STAT5B,Signal transducer and activator of transcription 5B,22833,2139,1.03 [1.00-1.05],0.0827030508193056
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,19204,1817,1.06 [0.99-1.13],0.1126028088139518
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STC1,Stanniocalcin-1,23155,2176,1.45 [1.35-1.57],2.588920525673991e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STC2,Stanniocalcin-2,22926,2164,1.51 [1.28-1.76],4.3784465198199673e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STEAP4,Metalloreductase STEAP4,19272,1835,1.00 [0.94-1.06],0.9266746813777508
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STIP1,Stress-induced-phosphoprotein 1,22908,2159,1.07 [1.01-1.13],0.0267849083615838
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STK11,Serine/threonine-protein kinase STK11,22530,2127,1.06 [1.00-1.12],0.0361298046873366
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STK24,Serine/threonine-protein kinase 24,22446,2110,1.05 [0.98-1.12],0.1387634850482147
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STK4,Serine/threonine-protein kinase 4,22943,2160,1.05 [1.01-1.10],0.0273725060519241
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STOML2,"Stomatin-like protein 2, mitochondrial",19204,1817,1.05 [1.00-1.10],0.0543269408300664
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STX16,Syntaxin-16,22405,2098,1.08 [1.01-1.16],0.0177711327906232
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STX1B,Syntaxin-1B,19370,1843,0.95 [0.85-1.07],0.3916261620081054
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STX3,Syntaxin-3,19860,1881,1.06 [0.95-1.19],0.312571154085829
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STX4,Syntaxin-4,22833,2139,1.15 [1.09-1.22],1.4534899810630173e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STX5,Syntaxin-5,19320,1836,1.09 [0.98-1.21],0.0993923845006655
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STX6,Syntaxin-6,22405,2098,1.08 [1.02-1.15],0.0074762238275016
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STX7,Syntaxin-7,19320,1836,1.14 [1.04-1.25],0.0059704987206624
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STX8,Syntaxin-8,22920,2165,1.13 [1.05-1.23],0.0013658207955158
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STXBP1,Syntaxin-binding protein 1,19874,1884,1.06 [1.00-1.13],0.03625680580185
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STXBP3,Syntaxin-binding protein 3,22405,2098,1.07 [0.98-1.17],0.1240225478949926
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SUGP1,SURP and G-patch domain-containing protein 1,19848,1888,1.09 [0.98-1.21],0.0948246608441417
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SUGT1,Protein SGT1 homolog,22405,2098,1.00 [0.95-1.05],0.944126749148782
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SULT1A1,Sulfotransferase 1A1,23155,2176,1.02 [0.99-1.05],0.2867571716820112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SULT2A1,Bile salt sulfotransferase,22920,2165,1.45 [1.38-1.52],2.0342104504236736e-52
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SUMF1,Formylglycine-generating enzyme,19320,1836,1.04 [0.98-1.11],0.1924117873527447
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,23155,2176,1.23 [1.14-1.32],6.49885589828933e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SUOX,"Sulfite oxidase, mitochondrial",19874,1884,1.42 [1.34-1.51],1.4349292338533353e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SUSD1,Sushi domain-containing protein 1,22530,2127,1.05 [0.97-1.14],0.250925154321501
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SUSD2,Sushi domain-containing protein 2,22954,2166,1.32 [1.16-1.50],2.295411910017976e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SUSD4,Sushi domain-containing protein 4,19841,1877,1.22 [1.09-1.35],0.0002926238726115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SUSD5,Sushi domain-containing protein 5,19358,1839,0.61 [0.54-0.70],2.781868715826148e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SV2A,Synaptic vesicle glycoprotein 2A,19370,1843,1.12 [1.05-1.20],0.0011152230738207
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SWAP70,Switch-associated protein 70,19848,1888,1.05 [0.93-1.18],0.4524202167767984
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SYAP1,Synapse-associated protein 1,19456,1848,1.04 [0.96-1.12],0.353107874081412
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,19272,1835,1.00 [0.93-1.08],0.9672746579632556
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SYT1,Synaptotagmin-1,19860,1881,0.86 [0.76-0.98],0.0185162098510771
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SYTL4,Synaptotagmin-like protein 4,19913,1888,1.09 [1.03-1.15],0.0036927906476677
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,19560,1852,1.02 [0.97-1.06],0.4280029388347319
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TACC3,Transforming acidic coiled-coil-containing protein 3,22833,2139,1.01 [0.97-1.04],0.6686125934718383
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TACSTD2,Tumor-associated calcium signal transducer 2,20316,1893,1.28 [1.11-1.48],0.0005766398188577
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TADA3,Transcriptional adapter 3,19841,1877,1.15 [1.03-1.28],0.0103101852180249
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TAFA5,Chemokine-like protein TAFA-5,22833,2139,1.12 [1.01-1.24],0.0288699115972203
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TAGLN3,Transgelin-3,19204,1817,1.03 [0.96-1.11],0.4154480961882688
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TALDO1,Transaldolase,19851,1890,1.32 [1.20-1.44],4.652040795540231e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TANK,TRAF family member-associated NF-kappa-B activator,22537,2110,1.10 [1.04-1.16],0.000442997861107
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TAP1,Antigen peptide transporter 1,19560,1852,1.03 [0.96-1.11],0.3862603699021718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TARBP2,RISC-loading complex subunit TARBP2,22446,2110,1.06 [1.01-1.12],0.0174642616673031
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",19370,1843,0.98 [0.92-1.04],0.4629899066413296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",19841,1877,1.18 [1.05-1.33],0.0043860175124144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TAX1BP1,Tax1-binding protein 1,19860,1881,1.20 [1.12-1.28],3.3268704922485176e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TBC1D17,TBC1 domain family member 17,22446,2110,1.07 [0.98-1.17],0.1194353729930453
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TBC1D23,TBC1 domain family member 23,22833,2139,1.05 [1.01-1.10],0.0212660509022478
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TBC1D5,TBC1 domain family member 5,22920,2165,1.06 [1.01-1.11],0.0239654165916877
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TBCA,Tubulin-specific chaperone A,19456,1848,1.04 [0.99-1.10],0.1045434505003745
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TBCB,Tubulin-folding cofactor B,22750,2153,1.03 [0.99-1.07],0.1526463308773731
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TBCC,Tubulin-specific chaperone C,22750,2153,1.04 [0.99-1.09],0.0985806128764324
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TBL1X,F-box-like/WD repeat-containing protein TBL1X,22405,2098,1.01 [0.96-1.06],0.713539751186933
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TBR1,T-box brain protein 1,19370,1843,1.08 [0.99-1.18],0.0724310695321727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TCL1A,T-cell leukemia/lymphoma protein 1A,22720,2152,1.02 [0.99-1.06],0.1947923819552607
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TCL1B,T-cell leukemia/lymphoma protein 1B,22530,2127,1.05 [1.00-1.10],0.0487825166626237
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TCN1,Transcobalamin-1,19551,1845,1.24 [1.11-1.38],0.0001231158833688
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TCN2,Transcobalamin-2,23198,2189,1.79 [1.60-2.00],4.8004969337025864e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TCOF1,Treacle protein,19913,1888,1.62 [1.46-1.79],1.4937641700132008e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TCP11,T-complex protein 11 homolog,19560,1852,0.99 [0.91-1.07],0.7311455048908839
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TCTN3,Tectonic-3,19913,1888,1.65 [1.43-1.90],6.401472580686513e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TDGF1,Teratocarcinoma-derived growth factor 1,22446,2110,1.03 [1.00-1.06],0.0221697187618296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TDO2,"Tryptophan 2,3-dioxygenase",19370,1843,1.16 [1.05-1.29],0.0052868578240992
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TDP1,Tyrosyl-DNA phosphodiesterase 1,19841,1877,1.09 [1.02-1.15],0.0061801463313602
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TDRKH,Tudor and KH domain-containing protein,22446,2110,1.10 [1.05-1.15],1.767442539285299e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TEF,Thyrotroph embryonic factor,19234,1836,1.05 [0.95-1.16],0.3689135719886177
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TEK,Angiopoietin-1 receptor,23005,2159,2.47 [2.09-2.92],1.6770459803744268e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TERF1,Telomeric repeat-binding factor 1,19320,1836,1.10 [0.94-1.28],0.2287582313493513
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TET2,Methylcytosine dioxygenase TET2,19527,1848,0.98 [0.94-1.03],0.4107885371092055
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TEX101,Testis-expressed protein 101,19370,1843,0.99 [0.92-1.07],0.8318990946921333
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TEX33,Testis-expressed protein 33,19560,1852,1.04 [0.93-1.16],0.4934598890810897
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TF,Serotransferrin,19935,1892,1.82 [1.48-2.22],6.495982679824543e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TFAP2A,Transcription factor AP-2-alpha,19272,1835,1.01 [0.93-1.09],0.8467706910874834
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TFF1,Trefoil factor 1,22846,2156,1.25 [1.20-1.31],6.834936723954209e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TFF2,Trefoil factor 2,22989,2166,1.52 [1.43-1.61],5.748224162777103e-43
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TFF3,Trefoil factor 3,22945,2152,1.52 [1.41-1.65],5.5242212228579975e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TFPI,Tissue factor pathway inhibitor,22909,2156,0.87 [0.77-0.99],0.0325463969702576
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TFPI2,Tissue factor pathway inhibitor 2,22941,2156,1.31 [1.22-1.40],1.465189327330656e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TFRC,Transferrin receptor protein 1,23049,2166,1.14 [1.03-1.25],0.0094909638013399
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TG,Thyroglobulin,19841,1877,0.92 [0.88-0.96],0.0003279020050858
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TGFA,Protransforming growth factor alpha,22920,2165,1.55 [1.44-1.67],8.546475045928672e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TGFB1,Transforming growth factor beta-1 proprotein,23178,2185,1.52 [1.39-1.65],7.526183522510817e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TGFB2,Transforming growth factor beta-2 proprotein,19841,1877,1.05 [0.97-1.15],0.2306867370123522
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TGFBI,Transforming growth factor-beta-induced protein ig-h3,22832,2147,1.18 [1.02-1.35],0.0223641900309938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TGFBR1,TGF-beta receptor type-1,19320,1836,1.13 [0.93-1.39],0.2250747380119294
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TGFBR2,TGF-beta receptor type-2,23005,2159,1.39 [1.25-1.54],3.712397494682522e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TGFBR3,Transforming growth factor beta receptor type 3,23232,2193,0.71 [0.63-0.80],5.60882149627975e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TGM2,Protein-glutamine gamma-glutamyltransferase 2,22903,2154,0.98 [0.93-1.03],0.3691905807422918
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TGOLN2,Trans-Golgi network integral membrane protein 2,19935,1893,1.02 [0.86-1.20],0.8592803425028369
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,THAP12,52 kDa repressor of the inhibitor of the protein kinase,19169,1814,1.09 [1.04-1.15],0.0004343779954944
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,THBD,Thrombomodulin,22943,2160,1.23 [1.08-1.40],0.0014322836297414
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,THBS2,Thrombospondin-2,22954,2166,2.07 [1.92-2.24],1.3085658330995878e-75
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,THBS4,Thrombospondin-4,22986,2161,1.35 [1.25-1.47],3.387945916867281e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,THOP1,Thimet oligopeptidase,22835,2153,1.54 [1.38-1.72],5.746124463870856e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,THPO,Thrombopoietin,22530,2127,0.79 [0.71-0.87],1.6909550479181302e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,THRAP3,Thyroid hormone receptor-associated protein 3,19234,1836,1.04 [1.00-1.08],0.0669188632511123
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,THSD1,Thrombospondin type-1 domain-containing protein 1,19181,1823,1.03 [0.90-1.17],0.7060284096268905
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,THTPA,Thiamine-triphosphatase,19795,1874,1.00 [0.95-1.05],0.9489730326098
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,THY1,Thy-1 membrane glycoprotein,23155,2176,1.40 [1.23-1.59],2.887291998690712e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TIA1,Nucleolysin TIA-1 isoform p40,22280,2104,1.03 [1.00-1.06],0.0992314509398046
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TIE1,Tyrosine-protein kinase receptor Tie-1,23232,2193,1.22 [1.11-1.35],7.720101514671443e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",22414,2105,1.16 [1.07-1.26],0.000256317428599
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,19560,1852,1.28 [1.14-1.42],1.168881634948085e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,23056,2165,1.03 [0.95-1.13],0.4814608335317919
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,19913,1888,1.13 [1.02-1.26],0.0195654085493599
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,19860,1881,1.04 [0.98-1.09],0.1668036158143789
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TIMP1,Metalloproteinase inhibitor 1,22725,2130,1.94 [1.72-2.18],1.0000626562395614e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TIMP2,Metalloproteinase inhibitor 2,19913,1888,1.02 [0.87-1.19],0.8437473525648418
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TIMP3,Metalloproteinase inhibitor 3,23025,2168,1.08 [1.05-1.11],1.5128124248515786e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TIMP4,Metalloproteinase inhibitor 4,22954,2166,0.70 [0.64-0.78],5.5964820400711956e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TINAGL1,Tubulointerstitial nephritis antigen-like,22878,2154,1.10 [0.93-1.31],0.2803743404252661
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TJAP1,Tight junction-associated protein 1,23005,2159,1.05 [1.00-1.10],0.0473856353593683
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TJP3,Tight junction protein ZO-3,19272,1835,1.08 [0.97-1.20],0.1794728873973107
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TK1,"Thymidine kinase, cytosolic",19560,1852,1.16 [1.06-1.27],0.0010201684207794
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TLR1,Toll-like receptor 1,19320,1836,1.59 [1.36-1.87],7.871351912334032e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TLR2,Toll-like receptor 2,19560,1852,1.20 [0.99-1.45],0.0673611943635369
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TLR3,Toll-like receptor 3,23215,2189,1.28 [1.20-1.37],5.874153253618463e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TLR4,Toll-like receptor 4,19320,1836,1.26 [1.08-1.47],0.0040931847908422
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,19370,1843,1.09 [1.00-1.18],0.0384964022335078
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TMED1,Transmembrane emp24 domain-containing protein 1,19560,1852,0.98 [0.90-1.06],0.5708153612995808
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TMED10,Transmembrane emp24 domain-containing protein 10,19234,1836,1.00 [0.91-1.09],0.9617405520372336
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TMED4,Transmembrane emp24 domain-containing protein 4,19234,1836,0.94 [0.87-1.02],0.167864763394632
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TMED8,Protein TMED8,19848,1888,1.03 [0.99-1.08],0.1284620874747771
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TMEM106A,Transmembrane protein 106A,19841,1877,1.06 [1.00-1.13],0.0567332791306779
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TMEM132A,Transmembrane protein 132A,19360,1834,1.00 [0.93-1.07],0.9998284559557048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TMEM25,Transmembrane protein 25,19874,1884,1.03 [0.94-1.13],0.4618464432275566
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TMOD4,Tropomodulin-4,19204,1817,1.05 [0.94-1.18],0.3811196543241588
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TMPRSS11B,Transmembrane protease serine 11B,19272,1835,1.03 [0.97-1.10],0.2750417034124812
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TMPRSS11D,Transmembrane protease serine 11D,19824,1876,1.09 [0.97-1.23],0.1322146301154061
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TMPRSS15,Enteropeptidase,22833,2139,1.28 [1.23-1.34],8.117440260714395e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TMPRSS5,Transmembrane protease serine 5,22636,2145,0.93 [0.85-1.03],0.1692440576628086
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TMSB10,Thymosin beta-10,22954,2166,1.09 [1.04-1.15],0.0010112586191694
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNC,Tenascin,23056,2165,0.88 [0.81-0.95],0.0009312875387912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNF,Tumor necrosis factor,22499,2125,1.37 [1.26-1.49],2.729855412192539e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,19848,1888,1.08 [0.99-1.17],0.0891168996030802
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,22537,2110,0.99 [0.89-1.10],0.8477226447644227
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,19456,1848,1.05 [0.98-1.13],0.1689583804605399
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,22750,2153,1.95 [1.81-2.11],5.184257138438016e-65
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,22750,2153,1.32 [1.26-1.38],5.045877066474496e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,23019,2174,1.20 [1.11-1.30],8.114031908185425e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,23215,2189,1.94 [1.78-2.12],3.337231278523928e-52
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,22907,2158,2.30 [2.06-2.57],9.296395037457855e-49
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,23005,2159,1.75 [1.59-1.93],4.823082841395519e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,22943,2163,1.19 [1.07-1.32],0.0014143473262257
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,22537,2110,1.13 [1.04-1.23],0.0061448684225668
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,22943,2163,1.61 [1.44-1.81],3.2230550025937453e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,19456,1848,0.91 [0.82-1.02],0.1038904884162694
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,23146,2176,1.01 [0.90-1.13],0.8439429609130464
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,22954,2166,1.99 [1.79-2.22],2.410308988966394e-35
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,22954,2166,1.53 [1.42-1.64],3.7825181852373456e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,23155,2176,1.32 [1.16-1.51],3.04947442025551e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,23178,2185,1.56 [1.42-1.71],8.276322047641628e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,22750,2153,1.24 [1.17-1.32],3.17522543266636e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,23155,2176,1.18 [1.08-1.28],0.0001311028439379
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,22750,2153,1.39 [1.28-1.50],3.1071437497790107e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFSF10,Tumor necrosis factor ligand superfamily member 10,23215,2189,0.51 [0.44-0.59],5.617467041891159e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFSF11,Tumor necrosis factor ligand superfamily member 11,22920,2165,0.77 [0.72-0.82],4.317490736960566e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFSF12,Tumor necrosis factor ligand superfamily member 12,23215,2189,0.51 [0.44-0.58],2.6798292420528144e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFSF13,Tumor necrosis factor ligand superfamily member 13,23025,2168,1.61 [1.41-1.84],1.894049404795281e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,23195,2192,1.54 [1.36-1.75],2.5549959358449475e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFSF14,Tumor necrosis factor ligand superfamily member 14,22750,2153,1.21 [1.14-1.29],4.2622709430011495e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFSF8,Tumor necrosis factor ligand superfamily member 8,19921,1897,1.57 [1.40-1.76],4.5446793371596216e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNIP1,TNFAIP3-interacting protein 1,19860,1881,1.10 [1.04-1.15],0.0002297534111285
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNN,Tenascin-N,19921,1897,1.45 [1.32-1.61],3.53216947292082e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNNI3,"Troponin I, cardiac muscle",22530,2127,1.03 [0.98-1.08],0.2072833179246436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNPO1,Transportin-1,19560,1852,1.07 [0.95-1.21],0.2736590755995125
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNR,Tenascin-R,22750,2153,1.04 [0.95-1.14],0.4206373405863293
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNXB,Tenascin-X,22954,2166,0.84 [0.73-0.97],0.0212841105890531
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,19913,1888,1.13 [1.07-1.19],2.100492946494867e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TOP1,DNA topoisomerase 1,19848,1888,1.07 [1.03-1.11],0.0002344176506247
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TOP1MT,"DNA topoisomerase I, mitochondrial",19204,1817,1.03 [0.94-1.13],0.4773656380261784
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TOP2B,DNA topoisomerase 2-beta,19320,1836,1.14 [1.08-1.20],3.4647127385718034e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TOR1AIP1,Torsin-1A-interacting protein 1,19360,1834,1.12 [1.04-1.21],0.0024623023160002
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TP53,Cellular tumor antigen p53,22405,2098,1.15 [1.06-1.26],0.0011370378830655
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TP53BP1,TP53-binding protein 1,19320,1836,1.04 [0.99-1.10],0.1284949112659011
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TP53I3,Quinone oxidoreductase PIG3,19031,1798,1.30 [1.20-1.41],1.3669502220856934e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TP53INP1,Tumor protein p53-inducible nuclear protein 1,22530,2127,0.92 [0.80-1.06],0.2419619040951888
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TP73,Tumor protein p73,19370,1843,1.05 [0.92-1.20],0.4725290705246375
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TPBGL,Trophoblast glycoprotein-like,19370,1843,0.95 [0.85-1.06],0.3455527013721242
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TPD52L2,Tumor protein D54,19456,1848,1.04 [1.00-1.09],0.0452625682798393
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TPK1,Thiamin pyrophosphokinase 1,19913,1888,0.53 [0.45-0.62],8.144073250389168e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TPM3,Tropomyosin alpha-3 chain,19234,1836,1.09 [0.99-1.19],0.0833670386247053
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TPMT,Thiopurine S-methyltransferase,22405,2098,0.95 [0.90-1.00],0.0586369897340167
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TPP1,Tripeptidyl-peptidase 1,22755,2142,1.45 [1.36-1.56],1.638466085259188e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TPPP2,Tubulin polymerization-promoting protein family member 2,19560,1852,0.99 [0.94-1.05],0.7968910233855662
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TPPP3,Tubulin polymerization-promoting protein family member 3,22446,2110,0.85 [0.76-0.95],0.0030259307578277
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TPR,Nucleoprotein TPR,19234,1836,1.23 [1.14-1.32],1.4341985971263353e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TPRKB,EKC/KEOPS complex subunit TPRKB,19204,1817,1.00 [0.94-1.07],0.9611766557248914
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TPSAB1,Tryptase alpha/beta-1,23178,2186,1.14 [1.06-1.23],0.0004627977233507
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TPSD1,Tryptase delta,19874,1884,1.17 [1.05-1.30],0.0046759850748415
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TPSG1,Tryptase gamma,19320,1836,1.08 [0.92-1.27],0.3651935274524508
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TPT1,Translationally-controlled tumor protein,22537,2110,1.02 [0.96-1.08],0.5059915447085619
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TRAF2,TNF receptor-associated factor 2,22920,2165,1.05 [1.00-1.11],0.0642842305621185
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TRAF3,"TNF receptor-associated factor 3, Isoform 2",19320,1836,1.05 [0.94-1.18],0.3998006403766366
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,19234,1836,1.07 [0.98-1.16],0.1522585593275274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,19560,1852,1.05 [1.00-1.10],0.0520282225962332
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TREH,Trehalase,19921,1897,1.54 [1.45-1.64],1.8323588846292226e-42
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TREM2,Triggering receptor expressed on myeloid cells 2,22907,2158,1.36 [1.28-1.46],1.7972116529379934e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TREML1,Trem-like transcript 1 protein,19935,1893,0.99 [0.92-1.08],0.8631554729995501
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TREML2,Trem-like transcript 2 protein,22954,2166,1.08 [0.97-1.20],0.1790494592396315
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TRIAP1,TP53-regulated inhibitor of apoptosis 1,23146,2176,1.12 [1.05-1.19],0.0003248598476199
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TRIM21,E3 ubiquitin-protein ligase TRIM21,22920,2165,1.04 [0.99-1.10],0.1151438579136051
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TRIM24,Transcription intermediary factor 1-alpha,19524,1849,1.12 [1.05-1.20],0.0006777943590765
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,19848,1888,1.05 [1.01-1.10],0.0156660519774928
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TRIM26,Tripartite motif-containing protein 26,19204,1817,1.08 [1.00-1.16],0.0546636566688592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TRIM40,E3 ubiquitin ligase TRIM40,19370,1843,1.04 [0.97-1.10],0.2694050860758593
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TRIM5,Tripartite motif-containing protein 5,22920,2165,1.05 [1.00-1.10],0.0343575701054612
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TRIM58,E3 ubiquitin-protein ligase TRIM58,19841,1877,1.06 [1.01-1.12],0.0170821301576307
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TRPV3,Transient receptor potential cation channel subfamily V member 3,19234,1836,1.02 [0.94-1.11],0.5979463274305703
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TSC1,Hamartin,19320,1836,0.96 [0.90-1.03],0.2324227869935997
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TSC22D1,TSC22 domain family protein 1,19874,1884,1.07 [1.00-1.14],0.0439659658121316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TSHB,Thyrotropin subunit beta,22943,2160,0.99 [0.94-1.05],0.764020528663008
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TSLP,Thymic stromal lymphopoietin,22530,2127,1.03 [0.96-1.09],0.4025807320429493
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TSNAX,Translin-associated protein X,19234,1836,1.02 [0.91-1.14],0.7200211811033201
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TSPAN1,Tetraspanin-1,22530,2127,1.07 [1.02-1.11],0.0062016170048739
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TSPAN15,Tetraspanin-15,19234,1836,1.06 [0.98-1.16],0.1606862649280004
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TSPAN7,Tetraspanin-7,19272,1835,0.98 [0.94-1.03],0.5382765049855938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TSPAN8,Tetraspanin-8,19848,1888,1.09 [1.04-1.14],0.0003751639540887
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TSPYL1,Testis-specific Y-encoded-like protein 1,19320,1836,1.04 [0.93-1.17],0.4419585518713086
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TST,Thiosulfate sulfurtransferase,22411,2108,1.04 [0.99-1.09],0.1641907121895653
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TTF2,Transcription termination factor 2,19370,1843,1.09 [1.00-1.19],0.0601208790787712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TTN,Titin,19234,1836,1.07 [1.00-1.14],0.0475820883906506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TTR,Transthyretin,19718,1866,0.78 [0.65-0.93],0.004853567678497
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TUBB3,Tubulin beta-3 chain,19272,1835,0.99 [0.85-1.16],0.9070532881487592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TWF2,Twinfilin-2,19921,1897,1.04 [0.99-1.09],0.1650195707316498
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TXK,Tyrosine-protein kinase TXK,19560,1852,1.03 [0.97-1.09],0.3659665434697058
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TXLNA,Alpha-taxilin,22750,2153,1.11 [1.07-1.16],1.82311285488088e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TXN,Thioredoxin,19616,1859,0.97 [0.87-1.07],0.5366300441857011
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TXNDC15,Thioredoxin domain-containing protein 15,23005,2159,1.19 [1.04-1.37],0.0120797591941
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TXNDC5,Thioredoxin domain-containing protein 5,23155,2176,1.15 [1.09-1.21],5.469021928054688e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TXNDC9,Thioredoxin domain-containing protein 9,19860,1881,1.09 [1.01-1.18],0.0372590916258244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TXNL1,Thioredoxin-like protein 1,19239,1833,0.99 [0.95-1.04],0.7190872935886863
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",22954,2166,1.30 [1.21-1.41],3.149923769139758e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TYMP,Thymidine phosphorylase,22800,2143,1.15 [1.08-1.22],2.9925359512686105e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TYRO3,Tyrosine-protein kinase receptor TYRO3,22943,2160,1.21 [1.06-1.38],0.0060645480466837
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",19320,1836,1.13 [1.05-1.21],0.0009801845611009
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,UBAC1,Ubiquitin-associated domain-containing protein 1,22833,2139,0.95 [0.85-1.06],0.3656577855727837
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,UBE2B,Ubiquitin-conjugating enzyme E2 B,19841,1877,1.10 [0.95-1.28],0.2000873165203854
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,19913,1888,1.09 [1.01-1.17],0.0241183488558459
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,19320,1836,1.00 [0.92-1.08],0.9514888786208572
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,UBQLN3,Ubiquilin-3,19234,1836,1.12 [1.04-1.19],0.0014244614093713
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,UBXN1,UBX domain-containing protein 1,19456,1848,1.04 [0.98-1.11],0.1844075815717093
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,19848,1888,1.03 [1.00-1.06],0.0618976986846903
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,UGDH,UDP-glucose 6-dehydrogenase,19234,1836,1.01 [0.96-1.06],0.7373949465493435
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,UHRF2,E3 ubiquitin-protein ligase UHRF2,19234,1836,1.05 [0.92-1.19],0.4565722238777899
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ULBP2,UL16-binding protein 2,22750,2153,1.58 [1.44-1.72],1.409319400374652e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,UMOD,Uromodulin,23153,2186,0.75 [0.70-0.80],1.7835305208094422e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,UNC5D,Netrin receptor UNC5D,19320,1836,1.15 [0.97-1.37],0.1058295880043599
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,UNC79,Protein unc-79 homolog,19204,1817,1.11 [1.03-1.21],0.0085494684684113
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,UNG,Uracil-DNA glycosylase,19841,1877,0.99 [0.88-1.13],0.9268515448964172
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,UPB1,Beta-ureidopropionase,19913,1888,1.45 [1.39-1.51],2.750807263243523e-72
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,UPK3A,Uroplakin-3a,19272,1835,0.94 [0.86-1.03],0.2019903743145118
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,UPK3BL1,Uroplakin-3b-like protein 1,19517,1847,1.00 [0.91-1.08],0.9202546724732964
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,UROD,Uroporphyrinogen decarboxylase,19456,1848,1.11 [1.04-1.18],0.002144028503094
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,UROS,Uroporphyrinogen-III synthase,19370,1843,0.99 [0.93-1.06],0.7786764291638194
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,USO1,General vesicular transport factor p115,22833,2139,1.06 [1.01-1.11],0.010480601533085
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,USP25,Ubiquitin carboxyl-terminal hydrolase 25,19841,1877,1.09 [1.02-1.16],0.006116903425974
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,USP28,Ubiquitin carboxyl-terminal hydrolase 28,19860,1881,1.23 [1.10-1.36],0.0001322069946428
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,USP47,Ubiquitin carboxyl-terminal hydrolase 47,19234,1836,1.04 [0.99-1.10],0.1290348432765324
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,USP8,Ubiquitin carboxyl-terminal hydrolase 8,22530,2127,1.06 [1.01-1.10],0.0085148193110365
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,UXS1,UDP-glucuronic acid decarboxylase 1,22405,2098,1.08 [1.01-1.17],0.0358885708631876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VAMP5,Vesicle-associated membrane protein 5,22530,2127,1.19 [1.11-1.27],4.901969253982038e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VAMP8,Vesicle-associated membrane protein 8,19320,1836,1.07 [1.02-1.13],0.0055493544476304
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VASH1,Tubulinyl-Tyr carboxypeptidase 1,22920,2165,1.06 [1.01-1.11],0.0159279134789862
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VASN,Vasorin,22598,2120,1.01 [0.88-1.16],0.8797460726086755
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VASP,Vasodilator-stimulated phosphoprotein,19935,1893,1.04 [0.98-1.11],0.161033641605962
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,22833,2139,0.40 [0.32-0.48],1.3973621134868452e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VAV3,Guanine nucleotide exchange factor VAV3,19272,1835,1.04 [0.99-1.08],0.1224033357638385
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VCAM1,Vascular cell adhesion protein 1,23022,2164,1.75 [1.54-2.00],7.490725828058385e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VCAN,Versican core protein,23155,2176,0.92 [0.81-1.04],0.1740487922804986
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VCPKMT,Protein-lysine methyltransferase METTL21D,19204,1817,1.01 [0.96-1.06],0.763121042376953
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VEGFA,Vascular endothelial growth factor A,23143,2179,1.21 [1.14-1.29],2.3038371917830638e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VEGFB,Vascular endothelial growth factor B,19320,1836,1.02 [0.87-1.18],0.8340451638114215
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VEGFC,Vascular endothelial growth factor C,23005,2159,1.08 [1.01-1.15],0.0323945600913306
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VEGFD,Vascular endothelial growth factor D,23183,2183,1.23 [1.12-1.36],2.760488688172945e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VGF,Neurosecretory protein VGF,19874,1884,0.82 [0.71-0.95],0.0071593023380465
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VIM,Vimentin,22530,2127,1.02 [0.99-1.06],0.2032638992385623
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VIPR1,Vasoactive intestinal polypeptide receptor 1,19360,1834,0.90 [0.74-1.09],0.2769375822771426
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VIT,Vitrin,19913,1888,1.04 [0.93-1.17],0.4701682507010458
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VMO1,Vitelline membrane outer layer protein 1 homolog,22833,2139,1.30 [1.23-1.39],2.782646291679027e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VNN1,Pantetheinase,19935,1893,1.38 [1.30-1.48],2.1754608280517826e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VNN2,Vascular non-inflammatory molecule 2,22833,2139,1.36 [1.25-1.48],1.9504256618619216e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VPS28,Vacuolar protein sorting-associated protein 28 homolog,19560,1852,1.05 [0.98-1.12],0.1538106414735816
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VPS37A,Vacuolar protein sorting-associated protein 37A,22833,2139,1.06 [1.01-1.11],0.0137198341332436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VPS4B,Vacuolar protein sorting-associated protein 4B,19841,1877,1.02 [0.97-1.06],0.5095594665662719
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VPS53,Vacuolar protein sorting-associated protein 53 homolog,22833,2139,1.08 [1.02-1.13],0.003118357849594
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VSIG10,V-set and immunoglobulin domain-containing protein 10,19841,1877,1.27 [1.13-1.43],5.66527759048645e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,19234,1836,1.16 [1.02-1.31],0.0235718160566057
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VSIG2,V-set and immunoglobulin domain-containing protein 2,19841,1877,1.47 [1.39-1.56],1.3647983316798865e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VSIG4,V-set and immunoglobulin domain-containing protein 4,22926,2164,1.58 [1.45-1.73],2.4120214402321984e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,22907,2156,1.11 [1.05-1.18],0.0004151798522193
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VSNL1,Visinin-like protein 1,19860,1881,1.30 [1.18-1.43],2.2905395475484185e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VSTM1,V-set and transmembrane domain-containing protein 1,22446,2110,1.10 [1.02-1.18],0.0147637878119395
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VSTM2B,V-set and transmembrane domain-containing protein 2B,19560,1852,0.99 [0.88-1.11],0.8244873018926614
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,22530,2127,1.21 [1.15-1.29],2.1155873731501284e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,23155,2176,1.04 [0.99-1.10],0.1603916736087038
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VTCN1,V-set domain-containing T-cell activation inhibitor 1,22405,2098,1.17 [1.04-1.32],0.0095152430305349
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,19456,1848,1.15 [1.07-1.24],0.0002611066065485
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VWA1,von Willebrand factor A domain-containing protein 1,23119,2174,1.24 [1.13-1.35],2.5460829911485834e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VWA5A,von Willebrand factor A domain-containing protein 5A,19204,1817,1.01 [0.95-1.07],0.6942436557797504
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VWC2,Brorin,22675,2144,1.18 [1.07-1.29],0.0004935661982066
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VWC2L,von Willebrand factor C domain-containing protein 2-like,19874,1884,0.76 [0.68-0.86],1.2630788125149528e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VWF,von Willebrand factor,23232,2193,1.07 [1.02-1.13],0.0052518884727674
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,WARS,"Tryptophan--tRNA ligase, cytoplasmic",22954,2166,1.27 [1.15-1.40],4.09166310236716e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,WAS,Wiskott-Aldrich syndrome protein,22537,2110,1.01 [0.95-1.07],0.8607152651311726
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,WASF1,Wiskott-Aldrich syndrome protein family member 1,22530,2127,1.05 [1.00-1.09],0.0312709571200083
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,WASF3,Wiskott-Aldrich syndrome protein family member 3,22446,2110,0.96 [0.92-1.01],0.1018490052554006
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,WASHC3,WASH complex subunit 3,19860,1881,1.11 [1.04-1.17],0.0005062220696355
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,WASL,Neural Wiskott-Aldrich syndrome protein,19320,1836,0.95 [0.87-1.02],0.1719354619824558
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,WDR46,WD repeat-containing protein 46,19841,1877,1.11 [0.99-1.24],0.0772556212824937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,WFDC1,WAP four-disulfide core domain protein 1,19432,1846,1.13 [1.05-1.22],0.0012687463604672
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,WFDC12,WAP four-disulfide core domain protein 12,23099,2172,0.98 [0.92-1.04],0.4928581025636104
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,WFDC2,WAP four-disulfide core domain protein 2,21796,2050,1.47 [1.35-1.60],4.103377021957177e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",22665,2146,0.86 [0.78-0.94],0.0012913062176957
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",22943,2163,0.70 [0.63-0.78],6.636560094663445e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,WIF1,Wnt inhibitory factor 1,23146,2176,0.61 [0.55-0.69],1.7383655870630057e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,WNT9A,Protein Wnt-9a,22537,2110,1.09 [0.95-1.25],0.1960435456453952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,22750,2153,1.17 [1.09-1.25],2.185990862679711e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,XCL1,Lymphotactin,23146,2176,1.21 [1.14-1.29],1.775774811565044e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,XG,Glycoprotein Xg,23128,2182,0.95 [0.85-1.06],0.356733283356156
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,XIAP,E3 ubiquitin-protein ligase XIAP,19320,1836,1.11 [1.03-1.20],0.0068957304808059
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,XPNPEP2,Xaa-Pro aminopeptidase 2,23005,2159,0.94 [0.91-0.97],0.0001708945835713
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,XRCC4,DNA repair protein XRCC4,22446,2110,1.17 [1.06-1.29],0.0020371786958895
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,YAP1,Transcriptional coactivator YAP1,19860,1881,1.51 [1.30-1.75],5.6749358060983496e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",19848,1888,1.05 [1.02-1.09],0.0009569207117737
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,YES1,Tyrosine-protein kinase Yes,22833,2139,1.06 [1.03-1.10],0.0003803719262159
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,YJU2,Splicing factor YJU2,19841,1877,1.10 [0.97-1.26],0.1349637440196559
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,YOD1,Ubiquitin thioesterase OTU1,19234,1836,1.05 [0.98-1.13],0.1638989350785965
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,YTHDF3,YTH domain-containing family protein 3,22537,2110,1.06 [1.02-1.11],0.0076490911930116
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,YWHAQ,14-3-3 protein theta,19456,1848,1.07 [1.00-1.13],0.0378972321394993
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,YY1,Transcriptional repressor protein YY1,19320,1836,1.15 [0.98-1.34],0.0859361373803599
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ZBP1,Z-DNA-binding protein 1,19320,1836,1.11 [1.00-1.24],0.0453485783584618
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ZBTB16,Zinc finger and BTB domain-containing protein 16,22405,2098,1.09 [1.03-1.15],0.0013879333663279
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ZBTB17,Zinc finger and BTB domain-containing protein 17,22530,2127,1.21 [1.12-1.30],1.1904376233817877e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ZCCHC8,Zinc finger CCHC domain-containing protein 8,19234,1836,1.08 [1.01-1.16],0.0267743253206578
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ZFYVE19,Abscission/NoCut checkpoint regulator,19848,1888,1.02 [0.98-1.08],0.3295308639892356
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ZHX2,Zinc fingers and homeoboxes protein 2,19860,1881,1.30 [1.17-1.44],3.866665456090717e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ZNF174,Zinc finger protein 174,19320,1836,1.07 [0.95-1.21],0.2627324973930227
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ZNF75D,Zinc finger protein 75D,19560,1852,0.99 [0.92-1.06],0.7798297597185266
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ZNF830,Zinc finger protein 830,19841,1877,0.97 [0.92-1.03],0.3693067679147682
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ZNRD2,Protein ZNRD2,19848,1888,1.17 [1.11-1.25],1.8151341896337385e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,19841,1877,1.08 [1.00-1.17],0.0593663698388095
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ZP3,Zona pellucida sperm-binding protein 3,19360,1834,1.02 [1.00-1.03],0.0656526067502043
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ZP4,Zona pellucida sperm-binding protein 4,19204,1817,1.04 [0.91-1.20],0.5658796510108297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ZPR1,Zinc finger protein ZPR1,19272,1835,0.97 [0.92-1.02],0.1856603379526808
